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ABSTRACT 
 
 
THE DYNAMIC REGULATION OF INTESTINAL STEM CELLS BY NOTCH 
SIGNALING  
 
by 
 
Alexis J. Carulli 
 
Chair:  Linda C. Samuelson 
 
The intestinal epithelium has one of the fastest cellular turnover rates in 
the body. To keep up with the constant demand for newly differentiated 
absorptive and secretory cells, the intestinal crypt contains a highly active 
intestinal stem cell (ISC) compartment. Presently, two populations of ISCs are 
thought to exist: the active crypt base columnar stem cell (CBCC) and slower-
cycling quiescent stem cells (QSCs). Both populations of ISCs must be regulated 
to maintain intestinal homeostasis as well as accommodate cellular needs during 
times of intestinal growth, altered nutritional status, injury and repair. The Notch 
signaling pathway is one of many molecular messengers used to regulate these 
processes. Previous studies determined that Notch plays crucial roles in 
regulating differentiated cell fate, proliferation and CBCC survival. My thesis work 
has focused on understanding the specificity and kinetics underlying Notch 
regulation of CBCCs. 
 First, I used transgenic animal models to probe the specificity of Notch 
receptors in regulating intestinal homeostasis by conditionally deleting the 
Notch1 (N1) and/or Notch2 (N2) receptors in the intestinal epithelium. I 
discovered that N1 is the dominant Notch receptor regulating cell fate decisions, 
as deletion of N1 but not N2 led to a marked increase in secretory cell 
 
 
 xiii 
production. Additionally, I showed that N1 is important for stem cell maintenance, 
as N1 deletion resulted in a loss of approximately half of the CBCC population. 
Furthermore, I determined that N1 is required for post-irradiation intestinal 
recovery, an important discovery that has clinical implications for targeted anti-
Notch drugs as cancer treatments. 
 Our lab has shown that long-term (chronic) pharmacologic Notch inhibition 
with the drug Dibenzazepine (DBZ) leads to decreased CBCCs and decreased 
transit-amplifying (TA) cell proliferation, but the mechanism behind these 
changes was unknown. To approach these questions, I utilized a single dose of 
DBZ (acute treatment) to track the consequences of Notch inhibition on stem 
cells over time. Surprisingly, while acute DBZ did result in decreased CBCC 
number it also led to increased TA proliferation rather than the decreased 
proliferation observed with chronic DBZ. Like chronic DBZ, acute DBZ was 
sufficient to initiate a secretory cell differentiation program, suggesting that the 
increased proliferative cells were secretory progenitors. I devised a discrete 
compartmental mathematical model of the intestinal crypt to test several 
hypotheses to reconcile the proliferation differences observed with acute and 
chronic Notch inhibition. The model favored a mechanism where Notch signaling 
regulates both the symmetry of CBCC division into TA cells, as well as 
repopulation of the CBCC compartment, presumably by activation of QSCs. 
Further work investigating the role of Notch inhibition on QSCs suggests that 
Notch regulation of CBCC replacement is through regulation of the CBCC niche 
rather than direct regulation of QSCs. 
 In summary, my thesis work has further probed the role of Notch in 
intestinal epithelial homeostasis and CBCC maintenance. I show that loss of 
Notch signaling leads to a dynamic shift of CBCCs into the TA cell compartment 
and that N1 is the key receptor regulating these changes. 
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CHAPTER 1 
 
 
INTRODUCTION* 
 
 
 
 
Adult stem cells are crucial for maintaining proper function and repair of 
gastrointestinal tissues. The small intestinal epithelium is a complex tissue 
composed of a number of distinct differentiated cell types that must be 
continually replenished from rapidly dividing intestinal stem cells (ISCs) housed 
in the proliferative crypt region (Figure 1-1). The organized structure of the crypt 
as well as the fast rate of regeneration have made the intestine an ideal model 
for studying stem cell biology. ISC research not only aims to advance our 
understanding of stem cell physiology, but also to provide insight into intestinal 
pathologies. As ISCs are thought to drive intestinal and colorectal cancers1, 2, 
understanding how aberrant stem cell regulation initiates such processes is a 
major interest in the field. Additionally, ISCs are required for epithelial repair after 
intestinal damage, such as exposure to irradiation and chemical mutagens3-7. 
Thus, investigating the repair response is important for managing radiation 
therapies and environmental exposures as well as developing treatments for 
intestinal disease. Finally, ISC tissue engineering provides hope for regenerative 
therapies that can treat lost or damaged intestinal tissue8-10. For all of these  
                                            
* Note this chapter is an expansion of the following published review article: 
Carulli AJ, Samuelson LS, and Schnell S. Unraveling intestinal stem cell 
behavior with models of crypt dynamics. Integrative Biology 2014; 6:243-
57. 
 
Figure 1-1.  Intestinal epithelial structure and cell composition. The intestinal 
epithelium is organized into crypt and villus regions, with the stem and progenitor 
zone localized in the crypt. Current models favor the existence of two stem cell 
populations, the +4 stem cell and the crypt base columnar cell (CBCC), which are 
thought to be quiescent and active stem cells, respectively. Transit-amplifying 
(TA) progenitors arise from the stem cell compartment and differentiate into 
absorptive enterocytes or secretory goblet, enteroendocrine, tuft, or Paneth cells. 
Most of the differentiated cell populations migrate up the villi, but, uniquely, the 
Paneth cells move downward and reside between the CBCCs.  
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reasons, the impetus to unravel this cell’s identity, function, and regulation 
remains a priority.  
One of the greatest areas of interest in ISC biology is discovering the 
regulatory networks that modulate stem cell function. The Notch signaling 
pathway is a conserved cell-cell signaling pathway that is crucial throughout early 
development and organogenesis, as well as maintenance of many adult 
tissues11, 12. In the intestine, Notch has proven to be an essential regulator of 
proliferation, differentiated cell fate, and, importantly, stem cell maintenance13-18. 
Our understanding of how Notch regulates ISCs, however, is limited. Thus, the 
goal of this thesis is to present new investigation into the mechanisms behind 
Notch-regulated ISC homeostasis. Using transgenic mouse models, 
pharmacologic intervention, irradiation damage modalities and in silico 
mathematical modeling, the chapters ahead explore the sensitive dynamics of 
Notch regulation and the interconnection between ISCs and transit-amplifying 
(TA) progenitor cells.  
To properly introduce these themes, Chapter 1 introduces three broad 
topics: (1.1) the history and current understanding of intestinal stem and 
progenitor cells and the genes that define and regulate them, (1.2) the Notch 
signaling pathway, (1.3) current efforts in mathematical modeling of the intestinal 
crypt. Finally, the chapter concludes with an overview of the experimental 
approaches and main findings obtained in this thesis (1.4). 
  
 
1.1: INTESTINAL STEM AND PROGENITOR CELLS 
 
A Historical Debate 
There has been much debate over the location and identity of the ISC. 
Early studies suggested that the ISC was located approximately 4 cell positions 
from the base of the crypt, commonly referred to as the “+4 cell”3, 19, 20. 
Alternatively, it was proposed that crypt base columnar cells (CBCCs), small 
undifferentiated cells intercalated between the Paneth cells at the base of the 
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crypt, were the true ISCs21, 22. The prevailing theory today suggests that there are 
two stem cell populations in the intestine: an active stem cell (ASC) that is 
responsible for the bulk of proliferation and crypt maintenance, and a quiescent 
or reserve stem cell (QSC) that divides more slowly and is important for 
replenishing ASCs during crypt recovery after injury6, 23, 24. Recent findings, 
however, have called this two stem cell system into question, and thus a 
definitive catalog of ISC populations remains an active area of investigation7, 25-27. 
 
Early stem cell markers 
Clearly, the way to reconcile the +4/CBCC cell debate was to identify a 
reliable marker that would allow for visualization, isolation and genetic 
manipulation of ISCs. The first method that allowed visualization of putative stem 
cells was retention of a radioactive tritiated thymidine label21. These “label 
retaining cells” (LRCs) localized to the +4 position of the crypt and were thought 
to be stem cells due to their long-lived nature, although no functional data was 
obtained to validate this hypothesis3. 
The development of Vil1 promoter constructs capable of expression in all 
intestinal epithelial cells, including stem and progenitor cells, allowed the genetic 
manipulation of ISCs in transgenic mice for the first time28, 29. The capability to 
manipulate ISCs continues to be widely utilized to probe gene function for 
intestinal development or disease; however, the widespread Vil1-promoted 
transgene expression did not allow specific identification or manipulation of ISCs.  
The first more specific molecular marker of ISCs was the RNA-binding 
protein Musashi-1, which was shown by antibody staining to be expressed in the 
same location as LRCs30. Musashi-1 is also expressed in CBCCs and lower crypt 
TA cells31, which has limited its usefulness as a tool to manipulate specific stem 
cell populations. In 2007, the Wip1 phosphatase was shown to be expressed in 
ISCs and to regulate apoptosis and tumor formation at the stem cell level1. In situ 
hybridization and protein expression primarily localized Wip1 to the +4 position, 
but abundant CBCC labeling was observed as well, which has restricted its use 
as a specific stem cell marker1. 
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Lgr5 marks CBCCs 
In a landmark paper published in 2007, the leucine-rich-repeat–containing 
G-protein–coupled receptor 5 (Lgr5), was found to be a specific marker of 
CBCCs32. The Clevers group functionally demonstrated that LGR5+ cells were 
stem cells capable of producing all of the mature cell types of the intestine32. This 
conclusion was achieved through lineage tracing, a technique that allows 
permanent activation of a reporter gene in a cell and all of its progeny and is the 
gold standard for defining a stem cell in vivo33. In addition, isolated LGR5+ cells 
were subsequently shown to produce intestinal enteroids, intestine-like tissue 
grown in perpetuity in vitro, another indication of this cell’s stem-like function34. 
Importantly, activation of Wnt signaling in the LGR5+ cell population showed 
progressive formation of intestinal adenomas, a feature expected of aberrantly 
regulated stem cells2. Thorough quantitative studies have demonstrated that 
LGR5+ cells are highly proliferative, cycling approximately every 24 hours32, 35. 
This rate of proliferation confirms that if the LGR5+ CBCC is not the only stem 
cell population in the gut, it certainly is doing the bulk of the work, and thus has 
been indisputably considered the ASC. Notable additional markers subsequently 
identified for the ASC population include Ascl236, Olfm437, Smoc225, and Sox95, 38 
(Figure 1-2) although a multi-scale stem cell signature analysis identified 
countless others25. 
 
The +4 cell as a quiescent stem cell 
Although the LGR5+ CBCC had been established as the ASC, a surge of 
additional studies surfaced that continued to support the idea of a stem cell 
population that resides approximately in the +4 position. Immunostaining and 
lineage tracing studies identified a number of putative markers of this population 
including Bmi139, 40, Lrig141, mTert42 and Hopx43 (Figure 1-2). Of note, the gene 
Dclk1 has been cited numerous times in the literature as a putative +4 stem cell 
marker24, 44; however other studies reported that Dclk1 marks tuft cells, a 
differentiated cell type found in the stomach and intestine, rather than stem  
Figure 1-2. Intestinal stem cell markers. Molecular and functional markers that 
have been described for various proposed stem cell and potential stem cell 
populations. Of note, both TA cells and +4 cells have been shown to be Label 
Retaining Cells (LRCs). Sox9-EGFP ¬has been shown to mark both CBCCs and 
clonogenic enteroendocrine cells, depending on the level of EGFP expression. 
The gene Dclk1 has been proposed to be a stem cell marker, but it has also 
been shown to be a specific marker of differentiated tuft cells. It is possible that 
there is an independent +4 cell population that is also marked with Dclk1, but 
this has not been verified by lineage tracing. 
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cells45-47. Interestingly, recent lineage tracing studies showed that Dclk1 might 
additionally mark tumor stem-like cells48, although a new tumor expression study 
suggests that this might not extend to human intestinal cancers49. Although it is 
still unclear exactly what cells express Dclk1, it is likely that this gene is not 
useful for marking normal ISCs.  
Similar to the Lgr5 studies, the +4 cell lineage tracing experiments 
demonstrated that these markers were present in a stem cell population that was 
able to produce all of the differentiated intestinal cell types. Additionally, Wnt-
activated LRIG1+ cells showed even more aggressive adenoma formation than in 
the comparable LGR5 studies, again suggesting that these cells harbored stem-
like function41. As opposed to ASCs, however, many of these cells were shown to 
cycle more slowly, furnishing the idea that these markers were identifying a QSC 
population39, 41-43.  
It is important to note that Potten’s original studies did not suggest that the 
+4 cell was a quiescent cell population. Rather, it was thought that, like ASCs, 
this cell cycled approximately once per day and that the property of label 
retention was due to retention of an “immortal strand” of DNA that protected stem 
cells from accumulating mutations during DNA replication23. This hypothesis is 
highly controversial and has been challenged by several groups50, 51. In 
particular, Escobar et al.50 combined mathematical modeling with careful pulse-
chase labeling experiments to show that stem cells randomly sort their 
chromosomes. These findings further bolster the idea that the label retaining 
property of the +4 population is due to the cell being a long-lived, slower-cycling 
stem cell. 
One predicted function of a QSC population is to act as a reserve stem 
cell compartment. This feature was demonstrated in a number of studies that 
showed activation of QSCs in the post-irradiation injury setting5, 6, 43. Additionally, 
specific ASC ablation with diphtheria toxin led to activation of BMI1+ cells to 
generate differentiated intestinal epithelial cells. These QSCs appear to replace 
LGR5+ cells, thus repopulating the depleted ASC pool6, 40. Similarly, isolated 
BMI1+ cells were shown to create enteroids in vitro that ultimately contained 
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LGR5+ ASCs6. Interestingly, ablation of BMI1+ cells with diphtheria toxin results 
in complete epithelial collapse, suggesting that, unlike ASCs, these cells are 
indispensible for epithelial homeostasis39. 
Together, these findings support a two-stem cell paradigm in the gut: the 
LGR5+ cell is the ASC that divides every day and supports homeostasis under 
normal conditions and the +4 cell is the QSC that usually divides slowly and only 
occasionally contributes to homeostasis at baseline. In an injury setting the 
QSCs are activated and expanded and allow for crypt repopulation and repair of 
the ASC pool.  
 
Overlapping markers: the QSC dispute 
Despite the abundant lineage tracing data that supports the idea that Bmi1 
and other +4 genes mark QSCs, there continues to be doubt that these cells are 
truly an independent stem cell population. Much of the argument originates from 
studies that find putative QSC markers to be expressed in ASCs. Sorted ASCs 
were shown to express high levels of Bmi1 mRNA36 and an independent study 
showed that ASCs expressed higher levels of Lrig1 than any other cell in the 
epithelium52. A robust transcriptomic and proteomic approach that aimed to 
elucidate a definitive stem cell signature for the ASC showed that many QSC 
markers, including Bmi1, mTert, Hopx, and Lrig1, are not only expressed in the 
ASC, but single molecule transcript counting showed mRNA expression was 
located throughout the crypt rather than in a localized +4 cell population25, 26. To 
make matters more complex, Munoz et al.25 was unable to replicate the lineage 
tracing data of Capecchi and colleagues39 which showed that BMI1+ cells were 
predominantly located in the +4 position. Additionally, they observed that lineage 
tracing from BMI1+ cells occurred with similar kinetics as the ASC lineage tracing, 
calling into question the quiescent nature of this cell population25. Consequently, 
a molecular marker that uniformly and specifically marks +4 cells remains to be 
identified. 
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Transit-amplifying cells  
Like most adult tissue stem cells, ISCs do not directly form the 
differentiated cell types of the intestine; rather, they contribute to an intermediate 
progenitor pool. These cells are referred to as transit- or transiently-amplifying 
(TA) cells because they divide approximately every 12-18 hours, 4-6 times prior 
to fully differentiating into the various epithelial lineages, fundamentally 
amplifying the population in the crypt20, 53, 54. Figure 1-3 shows the TA cell 
compartment and unanswered questions associated with this cell population. As 
TA cells divide it is assumed that they become committed to specific lineages 
and cell types, finally leading to mitotically-inactive fully mature absorptive or 
secretory cells as they migrate out of the crypt. The specific timing and nature of 
these differentiation events and how they might affect TA clonogenicity is largely 
unknown. 
Early mutagenic marking studies showed that multipotent progenitors exist 
as well as progenitors committed to a single differentiated cell type33. It is well 
established that a binary decision occurs between absorptive and secretory cell 
fates, which is largely controlled by the Notch signaling pathway, however it is 
unclear exactly when and how this occurs55. Some studies suggest that this is 
the first decision of TA cells13. Others report that the specific type of secretory 
lineage is first determined, but that this differentiation trajectory can be aborted if 
the cell is later specified to be an absorptive cell56. Some studies have identified 
an intermediate cell with both Paneth and goblet cell features, which might 
suggest that these cells share a common progenitor13, 57, although other studies 
describe a common Paneth/endocrine precursor7. Clearly, a definitive lineage 
fate map in the gut is still forthcoming. Additionally, it is unknown during which 
round of TA cell division these decisions take place. A paucity of specific markers 
or functional assays for different TA progenitors cells has been a stumbling block 
for progress on these fronts. Some markers like Msi130 and Prom158, 59 have 
been proposed, but these label both stem and progenitor cells,  
 
 
Figure 1-3.  TA cell amplification and clonogenicity. Schematic of the TA cell 
compartment. Left: The TA cells are thought to divide 4-6 times, but the exact 
number and regulation of TA cell divisions is not known. Five rounds of division 
(T1-T5) are illustrated above with increasing numbers of cells in each 
subsequent division. TA cells are thought to become more differentiated during 
each division, but the details of this process are not well understood. Right: a TA 
cell is shown to de-differentiate and replace a lost CBCC (curved arrow). Exactly 
which TA cells possess clonogenicity is unknown.
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and it is uncertain whether they differentially label TA subpopulations. 
Additionally, Ngn3 marks TA cells that are fated to become endocrine cells60, but 
this only applies to a small subset of the TA population. In Chapter 3, I use the 
gradient of GFP expression that exists in the crypt of the Lgr5-GFP mouse model 
to differentiate between stem cells and TA cells. 
 
TA cells are facultative stem cells 
Studies by Potten20,61 indicate that TA cells possess potential stem cell 
capabilities in the event that the stem cells are lost or damaged. Irradiation 
studies suggest that the first two rounds of TA cell division possess some 
regenerative capacity20. Later TA divisions, however, were shown to have lost 
this capability, suggesting that this property is either cell age- or crypt location-
dependent20.  
Recently, a cell expressing the Notch ligand Dll1 was identified as a multi-
potent progenitor cell that was definitively not a stem cell, as evidenced by its 
lack of robust lineage tracing and inability to form enteroids in vitro27. 
Interestingly, this cell population was shown to gain stem-like function by Wnt 
stimulation in vitro and crypt damage in vivo27. This study further supports the 
idea that early TA progenitors possess plasticity and can act as potential stem 
cells. Interestingly, other studies have shown a subpopulation of enteroendocrine 
cells in the crypt that co-express stem cell markers and seem to function as stem 
cells in vitro and in vivo5, 62, 63. This raises the possibility that committed TA cells 
or even fully differentiated cells may possess stem-like potential. 
 Recently, Winton and colleagues7 returned to the approach of label 
retention to isolate and manipulate QSCs. In this study, LRCs were defined as 
non-Paneth cells in the crypt that retained a YFP label for 10+ days7. Isolation of 
these cells by FACS followed by transcriptome profiling showed that these LRCs 
were a distinct subpopulation of LGR5+ cells that expressed both secretory cell 
and stem cell markers. Using a clever split Cre construct and dimerization agent, 
Buczacki et al.7 was able to lineage trace from LRCs and found that these cells 
contributed exclusively to differentiated Paneth and endocrine cell populations, a 
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property consistent with a bipotential secretory cell progenitor. Interestingly, with 
ASC injury the LRCs gained full clonogenic capacity and were shown to lineage 
trace into all differentiated cell populations7. This study supports the idea that 
there is not a dedicated population of QSCs, but rather a population of semi-
differentiated progenitor cells that can act as a reserve stem cell population in the 
event of ASC loss.  
 
Neutral drift dynamics and epigenomics 
Many believe that stem cell identity is not cell-intrinsic, but rather a 
consequence of the local signaling environment, or niche, such that any cell 
within the niche will have stem-like properties. One heavily-studied aspect of 
crypt biology that has fueled this belief is the process of crypt monoclonality, 
where heterogeneous crypts, presumably fed by many stem cells, become 
derived from a single stem cell over time35, 64, 65. The Winton and Clevers groups 
have independently investigated this process by modeling the rate it takes for a 
lineage trace to encompass an entire crypt35, 64. These studies conclude that this 
occurs through neutral competition of stem cell progeny for niche space, or 
neutral drift35, 64. This finding implies that the progeny of a stem cell division event 
are not one stem and one non-stem daughter cell, but rather two identical cells 
that are only further defined by the niche available to them.  
A recent study by the Shivdasani lab comparing epigenetic signatures of 
ISCs, secretory and absorptive progenitor cells, and differentiated cells showed 
that the genomes of these populations are largely primed to express the same 
transcripts66. The conclusion of this study extends the implications of the neutral 
drift dynamics findings to suggest that most cells in the crypt are able to 
interconvert depending on the niche signals available, and that lineage-defining 
decisions are not permanent changes66. 
In contrast, a recent report by the Kaestner lab also investigating the 
epigenetic changes that occur during intestinal differentiation came to different 
conclusions67. They find that DNA methylation by the DNMT1 methyltransferase 
is required for proper intestinal epithelial differentiation by repressing enhancers 
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involved in stemness67. The two studies together could suggest that epigenetic 
regulation is important for cell fate decisions and differentiation but that genomic 
flexibility remains to allow interconversion depending on niche signals.  
 
Niche signaling pathways 
Several signaling pathways are known to be important for intestinal 
epithelial homeostasis, and many of these have been implicated in forming and 
sustaining the stem cell niche (Figure 1-4).   
Wnt signaling is important for stem cell establishment in the developing 
intestine, as well as crypt development during the postnatal period68, 69. In the 
adult intestine, Wnt responsive cells are stimulated by soluble ligands that are 
released from both the surrounding mesenchymal cells as well as crypt epithelial 
cells, leading to a Wnt activity gradient from crypt to villus42, 69. Wnt signal is 
required for stem and TA progenitor cell proliferation and has been implicated in 
regulating aspects of cell differentiation70, likely through cross-talk with the Notch 
signaling pathway69. R-spondins are a family of proteins that potentiate the Wnt 
signal in the presence of Wnt ligand71. LGR5 itself is the receptor for RSPO1 and 
is thus inextricably linked to the level of Wnt signal that reaches the stem cell 
nucleus72-74. Indeed, exogenous WNT and RSPO are required for growth of in 
vitro enteroids34, 75. Interestingly, ASCs and QSCs appear to have different 
requirements for Wnt signaling, as ASCs depend on Wnt for survival, but BMI1+ 
QSCs appear to be unaffected by Wnt repression6. Of note, aberrant Wnt 
signaling is observed in almost all cases of colorectal and intestinal cancers68, 76.  
 The Notch signaling pathway plays a critical role in controlling lineage 
specification of differentiated cells in the intestinal epithelium; i.e. active Notch 
signaling leads to the formation of the absorptive lineage while absence of Notch 
results in secretory cell types55. Notch regulates intestinal proliferation, as 
blocking Notch reduces proliferation18, 77 and Notch activation has been shown to 
increase proliferating cell number17, 78. In addition, Notch was recently shown to 
be essential for maintenance of ASC number and function13. Together these  
studies suggest Notch may be distinctly required for ASC maintenance and for 
Figure 1-4. The stem cell niche. (A) An illustration of two opposing theories 
regarding the role of the stem cell niche. Left: The niche (green arrows) 
completely specifies the stem cell. Right: the niche partially specifies a cell that 
possesses certain features of intrinsic stemness (yellow). Only cells that acquire 
both extrinsic and intrinsic signals become stem cells. (B) Signaling pathways 
implicated in niche specification. Activation of the Bone Morphogenetic Pathway 
(BMP) occurs at a gradient that is higher in the villi and lower in the crypts. 
Conversely, Wnt activity is highest in the crypts. The Wnt gradient is established 
by secretion of Wnt ligands both from the mesenchymal myofibroblasts 
(WNT2a) as well as from epithelial cells. WNT3, in particular, is expressed in 
Paneth cells. The Notch signaling pathway is also critical for niche specification. 
Notch ligand presentation must occur from adjacent cells, and there is evidence 
that Paneth cells present DLL4, and that a subset of secretory progenitors 
express DLL1. It is unclear if other TA cell populations can present Notch ligand 
to stem cells.
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TA cell fate. A more detailed description of the Notch signaling pathway will 
follow in section 1.2. 
Other signaling pathways shown to be involved in intestinal homeostasis 
and development include Bone Morphogenetic Protein (BMP), Hedgehog, Hippo, 
Eph/Ephrin, and Epidermal Growth Factor (EGF)/ErbB. Many of these pathways 
play important roles in stem cell function and are likely contributing to the niche69. 
Briefly, BMP signaling occurs in a gradient in the epithelium, with the highest 
signal in the villi and the lowest at the base of the crypt79. Lower signaling levels 
are also associated with expression of the antagonist Noggin in the crypt 
region79. BMP appears to limit crypt formation and stem cell number as 
repression of the pathway with excessive Noggin results in aberrant crypt 
formation and tumors80, 81. Eph/Ephrin signaling is required for normal Paneth cell 
localization82, which might have critical implications in niche formation as 
discussed below. The EGF pathway is important for regulating different cellular 
functions, including proliferation and differentiation, and has been shown to be 
important for the intestinal adaptation response post-resection83. The putative 
QSC marker LRIG1 is a negative regulator of EGF signaling84, 85, which is 
consistent with the quiescent nature of these cells41, 52. Of note, recombinant 
EGF and BMP antagonist Noggin are growth factors required for enteroid 
culture34, 75.  
It is believed that many of these essential signals originate from the 
myofibroblasts in the mesenchyme underlying the epithelial basement 
membrane86. Recent studies, however, have challenged this mesenchyme-
centric hypothesis. Evidence in a number of different tissues supports a model 
where stem cell progeny may also play an important role in defining the stem cell 
niche87.  
 
The Paneth cell as niche  
Paneth cells secrete antimicrobial peptides and are thought to have a role 
in regulating host-microbial interactions88. Unlike other differentiated cells, which 
migrate up the villi and are sloughed off the tip on the order of 3-5 days, Paneth 
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cells migrate down to the base of the crypt, where they persist for approximately 
3 weeks89, perhaps longer90. In this position Paneth cells are in close association 
with CBCCs and thus have recently been implicated in specifying the stem cell 
niche. Over 80% of the CBCC surface area is in contact with neighboring Paneth 
cells91. As some niche signals, like Notch pathway components, are dependent 
on cell-cell interaction, the Paneth cell is the ideal candidate for ligand 
presentation. Indeed, expression-profiling studies suggest that Paneth cells 
express Notch, Wnt, and EGF ligands91. Additionally, the formation of epithelial-
only enteroids supports the idea that mesenchymal signals may not be essential 
for niche formation34. In fact, LGR5+ cell/Paneth cell doublets increased enteroid 
formation efficiency over 10-fold higher than LGR5+ cells alone91.  
Opponents of this theory cite that these in vitro culturing techniques rely 
on a large number of growth factors for successful enteroid formation. As 
mentioned above, these include a BMP antagonist, Notch ligand, EGF, WNT3a 
and the Wnt potentiator RSPO1, as well as a synthetic basement membrane-like 
matrix; all factors that could be provided by the mesenchyme or other adjacent 
epithelial cells in vivo34. Additionally, several studies have shown that genetic 
deletion of Paneth cells does not have deleterious effects on the intestine92-94. 
Furthermore, colonic stem cells appear to function similarly to small intestinal 
ASCs but the colon does not contain Paneth cells, although a study by 
Rothenberg et al.95 identified cKit+ cells that may function like Paneth cells to 
support stem cells in the colon.  
A recent study by the Clevers group96 indicated that mesenchymal Wnt 
signals may in fact play an essential role. The study showed that a Wnt ligand 
secreted from the Paneth cell, WNT3, is essential for in vitro enteroid growth but 
deletion of Wnt3 in vivo does not affect homeostasis96. They identified WNT2B as 
a mesenchymal Wnt signal that could compensate for the lost WNT3 signal96. 
These results may explain why genetic models that lack Paneth cells may form a 
normal stem cell compartment. It is therefore very likely that a combination of 
epithelial and mesenchymal signals determine the stem cell niche. 
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A full understanding of the niche is critical for advances in in vitro tissue 
engineering technology. It is hoped that the use of in vitro systems will quicken 
the pace of discovery and allow more detailed signaling and mechanistic data to 
be discovered. Additionally, the use of human organoids is anticipated to allow 
easier translation of these findings into the human health context97-99. 
Since current enteroid culturing conditions employ undefined components like 
Matrigel, which are unlikely to ever receive FDA approval100, all necessary 
external signaling and growth factors will need to be delineated before moving 
forward with applied clinical approaches. 
 
Irradiation and stem cells 
Irradiation-induced intestinal damage has been a widely used 
methodology for studying stem cell biology. As noted above, many QSC markers 
have been defined by their activation and expansion in the post-irradiation 
setting. Still, there is some debate over exactly how different ISC populations 
respond to irradiation damage. Originally, Potten described his +4 population as 
exquisitely sensitive to irradiation, dying at doses as low as 1Gy3, 101. This may 
suggest that the more recently discovered QSCs are not marking the same 
population, as they are not sensitive to low doses of irradiation. Additionally, 
although it was thought that ASCs were destroyed by moderate doses (8-12Gy), 
one report shows that some LGR5+ stem cells not only survive irradiation 
treatment, but also possess enhanced non-homologous end joining to repair 
double-stranded DNA breaks caused by the damage4.  
Furthermore, combination of irradiation with diphtheria toxin-induced 
LGR5+ cell ablation showed that ASC-deficient intestine can recover when less 
than 6Gy is applied, but doses above this threshold resulted in permanent 
intestinal damage102. Interestingly, ASC-deficient crypts were still able to mount a 
post-irradiation proliferative response, but crypt-fission activity and crypt 
organization was lost leading to intestinal architecture collapse102. This suggests 
that QSCs are still activated with irradiation damage, but the crypt cannot 
properly recover without ASCs. 
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Recently, LGR5+ cells were shown to express the receptor ROBO1 and its 
ligand SLIT2103. Treating mice with recombinant SLIT2 and the Wnt agonist 
RSPO1 leads to an increase in the number of LGR5+ stem cells, and surprisingly 
protects the intestine from chemoirradiation treatment104. This is further evidence 
that ASCs are required for irradiation recovery, and is a promising therapeutic 
avenue for protecting against irradiation damage.  
Additionally, the Notch signaling pathway has been implicated in providing 
radioresistance in cancer stem cells, and Notch blockade improved the 
therapeutic response to radiation treatment105. This suggests that normal stem 
cells with Notch activity, like ISCs, likely have multiple mechanisms to resist 
radiation damage. In Chapters 2 and 3 I show continued evidence that Notch is 
required for ASC maintenance, as numerous forms of Notch inhibition result in 
inability to recover from irradiation. 
 
Tamoxifen and stem cells 
Most of the data that has been compiled in the field and reviewed above 
has been dependent on reporter activation in transgenic mouse model systems. 
These inducible Cre transgenics have revolutionized mouse genetics by allowing 
both temporal and spatial regulation of a gene of interest. Sensitive temporal 
control is achieved by fusion of the Cre recombinase to a modified ligand-binding 
domain of the estrogen receptor (CreERT and CreERT2), such that Cre is only 
translocated to the nucleus to induce recombination in the presence of synthetic 
estrogen antagonists106-108. The tamoxifen-inducible Cre/Lox system is essential 
for conditional activation of reporter genes in stem cells, but also allows for 
specific deletion or expression of a gene of interest. 
Alarmingly, a new study calls into question experiments that have utilized 
tamoxifen as a method to activate stem cell lineage tracing. This study showed 
that tamoxifen alone was sufficient to induce apoptosis of both LGR5+ and LGR5- 
cells located near the +4 region109. Previously tamoxifen had been shown to 
cause parietal cell apoptosis in the gastric epithelium, but this is the first report 
linking tamoxifen to stem cell damage110. In this study, apoptosis was a key 
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factor leading to lineage tracing from LGR5+ cells, as tracing events were 
strikingly reduced in genetic models that block apoptosis109. These results 
suggest that the LGR5+ cell might not be the true ASC after all, but rather a 
dependable replacement for loss of the true stem cell located at the +4 position. 
Interestingly, the evidence suggests that this highly-tamoxifen sensitive cell 
population is the same low-dose irradiation-sensitive population described in 
Potten’s early studies109.  
In response to this finding, Winton and colleagues investigated the effect 
of high and low tamoxifen doses on stem cell clonality111. In contrast to the above 
report, they found no tamoxifen-dependent changes in clone number or size and 
concluded that tamoxifen was unlikely to cause stem cell death111. Because 
tamoxifen usage is ubiquitous in the field, it is clear that more research needs to 
be done to reconcile these findings.  
 
Non-transgenic applications of ISC research 
A chief goal of ISC research is to directly apply what is learned to treat 
human diseases. Since many of the approaches used in animal models rely on 
complicated transgenics that would be infeasible to replicate in humans, there is 
great interest in developing non-transgenic methods to identify and separate 
stem cells that could be used in the clinical setting.  
One widely-used approach is antibody staining of human specimens to 
determine biomarkers for diagnosis and prognosis of diseases. Accordingly, 
many ISC markers have recently been associated with colon cancer progression 
and outlook. LGR5 expression, for instance, is increased in tumors compared to 
normal neighboring tissue112, 113 and higher levels of LGR5 are linked with 
chemotherapy resistance114. Expression of OLFM4 was shown to differentiate 
between serrated sessile lesions and other colorectal cancer types115 as well 
mark cancers associated with improved survivability116. The QSC marker BMI1 
also displays increased expression in colorectal tumors117 and higher levels of 
BMI1 are associated with worse outcomes118.  
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Aside from merely identifying the presence of stem cell markers in human 
tissues, there is great interest in actually isolating ISCs from patients to analyze, 
expand, or modify ex vivo. One method that has been attempted to achieve this 
is side population sorting, a technique that separates populations of cells that 
have low retention of a dye, like Hoescht, with fluorescence-activated cell sorting 
(FACS). This system was first discovered in hematopoietic stem cells119, 120 and 
relies on the expression of the ABCG2 efflux transporter, which has been found 
to distinguish a number of different tissue stem cells121. The Henning group has 
adapted this approach to investigate ISC populations122. They have found that 
there are two groups of side population sorted cells, an upper side population 
and lower side population122. The upper side population was found to contain a 
large percentage of proliferating cells as measured by incorporation of the 
thymidine analog 5-ethynyl-2´-deoxyuridine (EdU). In contrast, the lower side 
population had almost no EdU uptake and is thus presumed to be a quiescent 
population. Combined studies using the Lgr5-GFP mouse demonstrated that the 
LGR5+ cells were almost exclusively localized in the upper side population. 
Transcript analysis of the populations showed expression of both ASC and QSC 
markers in the upper side population, which is not surprising due to the overlap in 
marker expression discussed above. In contrast, the quiescent lower side 
population was enriched with QSC markers. Thus, this technique is a promising 
way to separate different ISC populations based on cycling rate rather than 
marker expression that can easily be applied to human tissue. 
 
ISCs: a work in progress 
 In summary, although much has been discovered about ISCs, many 
questions and controversies continue to divide the field. The largest dispute 
concerns the existence and function of QSCs and how these cells may overlap 
with ASCs and progenitor cells. Other questions include regulation of ISC 
number, required niche signals and their origin, and ISC injury response. This 
thesis addresses many of these themes by investigating the specific Notch 
receptors required for stem cell maintenance (Chapter 2), ASC and TA plasticity 
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(Chapter 3-4), and the requirement of Notch for post-irradiation epithelial 
recovery (Chapter 2-3).  
 
 
 
 
1.2: THE NOTCH SIGNALING PATHWAY 
 
A direct cell contact pathway 
 As shown in Figure 1-5, Notch signal requires the interaction of two 
neighboring cells, a signal-receiving cell that expresses the transmembrane 
Notch receptor and a signal-sending cell, which expresses a transmembrane 
Notch ligand. In mammals there are 4 Notch receptors (Notch1-4) and 5 ligands 
(Delta-like1,3,4, Jagged1-2)123, all of which have variable temporal-spatial 
expression. Successful interaction of receptor and ligand results in the Notch 
intracellular domain (NICD) being released and transmitted to the nucleus where 
it can activate target gene transcription. No secondary messengers are 
generated by the signal and the Notch receptor is destroyed in the process124, 
thus generating a short-lived transcriptional signal to instill Notch effects.   
 
Notch receptor activation and regulation 
 The Notch receptor undergoes many modifications and enzymatic 
cleavage events along the path to activation, which can modulate Notch 
signaling. In the ER, glycosylation of the Notch extracellular domain (NECD) 
occurs, catalyzed by the enzyme O-fucosyltransferase (O-FUT), which adds a 
fucose moiety and acts as a chaperone for the receptor125, 126. Additional fucose 
and glucose modifications subsequently occur in the trans-Golgi network 
mediated by Fringe proteins127. In mammals there are three Fringe proteins: 
Lunatic, Manic and Radical Fringe, which have varied and non-redundant activity 
in a number of tissues128. The accumulated number and location of glycosylation 
events function to alter receptor-ligand interactions124. In fact, two independent  
Figure 1-5.  The Notch Signaling Pathway. (1) The immature Notch 
extracellular domain (NECD) is fucosylated in the ER by O-FUT. (2) Further 
glycosylation of NECD occurs in the Golgi by FRINGE proteins. Meanwhile, 
ubiquitin modifications by MINDBOMB result in ligand recycling and 
maturation. (3) FURIN-mediated S1 cleavage of the receptor results in mature 
Notch intracellular domain (NICD) and NECD. (4) The mature receptor is 
trafficked to the membrane chaperoned by O-FUT. (5) In the absence of ligand 
activation, ITCH mediates degradation of Notch receptor. Meanwhile, in the 
nucleus RBP-J associates with co-repressors blocking transcription of Notch 
target genes. (6) Binding of receptor and ligand exposes the S2 site, which is 
cleaved by ADAM proteases, releasing NECD. (7) NECD is trans-endocytosed 
with ligand by the signal-sending cell. S3 cleavage is catalyzed by the 
gamma-secretase complex. NICD is released from the membrane. (8) NICD 
translocates into the nucleus where it binds to a co-regulatory complex 
activating transcription of Notch target genes. (9) The Notch signal is 
terminated by CDK8 through NICD phosphorylation and degradation.  
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groups used hybrid receptor constructs composed of mis-matched NICD/NECD 
pairs to demonstrate that differences in Notch receptor activity is primarily 
attributed to NECD interactions129, 130, underscoring the importance of these post-
translational modifications. 
 While the immature Notch receptor is in the Golgi, it undergoes its first 
proteolytic cleavage event, S1. This furin-mediated enzymatic cleavage results in 
the separation of the NICD and NECD to form a mature heterodimer131. The 
receptor is then trafficked to the membrane and, after interaction with ligand, two 
more cleavage events take place. S2 cleavage is catalyzed by ADAM 
metalloproteases and results in shedding of the NECD132. NECD remains 
associated with the ligand and is endocytosed by the signal-sending cell. It is 
thought that the tension of endocytosis leads to receptor conformational changes 
allowing S2 site exposure and successful recruitment of ADAM proteases133. In 
the intestine ADAM10 has been shown to be the protease responsible for this 
cleavage event134. The final cleavage, S3, is performed by the gamma-secretase 
complex, which releases NICD from the membrane to enter the nucleus135. 
 Once in the nucleus, NICD associates with a protein complex, including 
the DNA-binding protein RBP-J and the transcriptional activator MAML, to 
activate target gene transcription136. Alternatively, when NICD is not in the 
nucleus, RBP-J associates with a co-repressor complex ensuring target gene 
inactivation123. The duration of the Notch signal is relatively short, as NICD has a 
limited half-life137. Interaction with the co-activation complex leads to CDK8 
recruitment and phosphorylation, which quickly targets NICD for ubiquitin ligase-
mediated degradation137.  
 
Additional regulatory mechanisms 
 Like the receptors, Notch ligands require post-translational modifications 
for proper activation. This involves ubiquitination, endocytosis, and recycling 
back on the membrane, a process initiated by the Neuralized and Mindbomb 
family of E3-ubiquitin ligases138, 139. Absence of this step leads to ligand 
endocytosis and degradation138. 
 24 
 Notch receptors are also actively endocytosed and degraded when not 
engaged by ligand. ITCH, DTX1 and DTX2 are E3 ligases that ubiquitinate 
receptors to incite lysosomal degradation140. Additionally, NUMB, an endocytic 
adaptor protein, functions to remove Notch from the membrane and associates 
with a number of different factors to promote receptor degradation11, 141. NUMB is 
segregated asymmetrically into daughter cells and is thought to regulate cell fate 
switches and asymmetric stem cell division124.  
 
Notch patterning mechanisms 
 Notch is critical for patterning throughout development. This is 
accomplished by several different mechanisms: lateral inhibition, lineage 
decisions, and boundary development142. The variety of outcomes offered by 
these patterning mechanisms allow this simple pathway to play key roles in the 
development or homeostasis of almost every organ or tissue system. A 
comprehensive list has been compiled by Andersson et al.11 and has been 
summarized in Table 1-1.  
 
Notch target genes 
 Despite its fundamental role in development and homeostasis only a few 
Notch target genes have been well characterized. These consist of the HES and 
HEY (or HERP) families of basic helix-loop-helix (bHLH) transcription factors143. 
bHLH proteins can function as both transcriptional activators or transcriptional 
repressors, but the HES/HEY family members function primarily as repressors143. 
In many cases this leads to repression of differentiation factors and cell cycle 
inhibitors. In the intestine, for instance, HES1 blocks the transcription of Atoh1, 
the transcription factor linked to secretory cell fate18, 78, 144, 145 as well as the 
cyclin-dependent kinase inhibitors p27Kip1 and p57Kip2 16, 146-148. Other tissue 
specific target genes have been identified, such as c-Myc in developing and 
leukemic T cells149, 150, and we have identified the ASC-marker Olfm4 to be a 
direct Notch target in the intestine13. Although Notch regulates many important  
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Table 1-1. Notch regulation in multiple tissue systems*
Organ/Tissue Processes regulated
Brain Balance between gliogenesis and neurogenesis, stem cell maintenance, 
neuroepithelial cell polarity
Breast Alveolar development, luminal cell fate, regulation basal cell proliferation
Craniofacial 
structures
Palate morphogenesis, tooth development
Ear Defines sensory epithelium, hair cell and supporting cell fate
Esophagus Regulates epithelial homeostasis
Eye Fiber cell differentiation, lens development
Heart Cardiac patterning
Hematopoietic 
system
Hematopoiesis, balance of B-cell/T-cell development, myeloid homeostasis
Intestine Regulates proliferation vs. differentiation, stem cell maintenance
Kidney Defines podocytes and proximal tubules
Limbs Digit morphogenesis
Liver Ductal plate formation, intrahepatic bile duct morphogenesis
Lungs Tracheal branching morphogenesis
Muscle Regulates satellite cell transition to myogenic precursors and myoblasts
Neural crest Cardiac patterning, Schwann cell proliferation, melanocyte stem cell 
maintenance
Pancreas regulates endocrine cell differentiation, endocrine precursor maintenance, 
inhibits terminal differentation of acinar cells, controls epithelial branching
Pituitary Regulates growth and proliferation. Specifies malanotropes and gonadotropes
Placenta Fetal angiogenesis, maternal circulatory and spongiotrophoblast development
Prostate Epithelial differentiation, branching morphogenesis, stromal survival
Sex organs 
and germ cells
Leydig progenitor cell maintenance, spermatogenesis, ooctyle growth
Skin Cell adhesion, proliferation, hair follicale differentiation and homeostasis
Spine/pinal 
cord/somites
Somite segmentation
Spleen Generation of T lineage-restricted progenitors and marginal zone B-cells, CD8- 
dendritic cell homeostasis
Stomach Luminal and glandular cell fate switch
Thymus Thymic morphogenesis, gamma delta T-cell differentiation
Thyroid Regulates cell number, differentation and endocrine function of thryrocytes 
and C-cells
Vasculature Arteriovenous specification, endothelial and vascular smooth muscle 
differentiation, blood vesssel sprouting and branching
* Table contents paraphrased from Andersson et al, 2011. Specific references are listed therein 
Red text indicates tissues where Notch is implicated in stem and progenitor cell maintenance as 
published in Andersson et al. Blue text is additional information from VanDussen et al., 2012
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processes in numerous tissues, surprisingly few target genes have been 
described. Identification of Notch target genes that mediate key cellular 
responses in the intestine will be an important future goal to understand the 
mechanism of action.  
 A new study in developing and leukemic T cells suggests that Notch 
transcriptional regulation may occur at a superenhancers, increasing promoter 
permissiveness at a large number of loci151. This may explain how Notch 
regulates widespread transcriptional programs with only a few known direct 
target genes. 
 
Notch components in the intestine 
 Notch signaling has been shown to play fundamental roles in intestinal 
homeostasis, and many efforts have been made to define the Notch components 
expressed in this tissue. In situ hybridization (ISH) has been employed to map 
receptor, ligand and target gene expression. Notch1 and Notch2 appear to be the 
primary receptors expressed in the epithelium152, although studies publishing 
expression patterns have reported inconsistent results. In one study, Notch1 was 
shown to be expressed throughout the crypt while Notch2 expression was found 
only in a few cells153. Other reports have shown ISH results with much broader 
Notch2 crypt expression14. Notch3 and Notch4 expression are present in the 
intestine but are confined to the mesenchymal tissue152, 153. A mesenchymal 
component of Notch1 has also been identified153. Notch ligands Jag1, Dll1, and 
Dll4 are all expressed in the intestinal epithelium, specifically localized to the 
crypt region152, 153. Finally, Hes1, 5, 6, and 7 are all expressed in the crypt 
epithelium, although Hes5 was also found in the mesenchyme152. 
  
Notch intestinal function uncovered with inhibition studies 
 Genetic and pharmacologic Notch inhibitory models and their intestinal 
phenotypes are listed in Table 1-2. In summary, inhibition of the pathway results 
in a profound transformation of the intestinal epithelium from predominantly 
absorptive enterocytes to secretory cells15, 16, 18, 27, 154, 155. This occurs due to de- 
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Category Gene/Target S* P^ Additional Findings Reference
f-RBP-J é ê weight loss, death Van Es et al., 2012; Riccio 
et al., 2008
Rosa26-LSL-
dnMAML
é ê Dempsey, unpublished
f-N1 No phenotype
f-N2 No phenotype
f-N1 + f-N2 é ê weight loss, death
f-N1 é weight loss, decreased 
stem cells
Chapter 2
f-Dll1 é mild phenotype
f-Dll4 no phenotype
f-Jag1 no phenotype
f-Dll1+f-Dll4 é ê weight loss, death, 
decreased stem cells
f-Dll1+f-Jag1 é mild phenotype
f-ADAM10 é ê Dempsey, unpublished
f-Mindbomb é ê mislocalized Paneth 
cells
Koo et al., 2009
f-Pofut1 é ê Guilmeau et al., 2008
Target gene f-Hes1 é precociuos Paneth cell 
differentiation
Jensen et al., 2000; 
Suzuki et al., 2005
chronic DBZ é ê weight loss, death, 
decreased stem cells
Milano et al., 2004; Van 
Es et al., 2005 ; 
Vandussen et al., 2012acute DBZ é é decreased stem cells Chapter 3
α-N1 N1 é ê mild phenotype, toxicity 
with irradiation
Wu et al., 2010; Tran et 
al., 2013; Chapter 2
α-N2 N2 no phenotype Wu et al., 2010
α-N1 + α-N2 N1+N2 é ê weight loss, death, 
decreased stem cells
Wu et al., 2010; Tran et 
al., 2013; Chapter 2
α-Dll1 Dll1 no phenotype Chapter 2
α-Dll4 Dll4 no phenotype Ridgeway et al., 2006, 
Chapter 2
α-Dll1 + α-
Dll4
Dll1 + Dll4 no phenotype Tran et al., 2013,   
Chapter 2
Table 1-2. Intestinal phenotypes of Notch inhibition models
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repression of Atoh1, as discussed above. While some studies have suggested 
that only goblet cells are aberrantly formed with Notch inhibition, our lab and 
others have shown that all secretory lineages are increased including goblet,  
Paneth, enteroendocrine, and tuft cells13, 148, 154. In addition to cell lineage 
specification, these Notch inhibition also results in decreased epithelial 
proliferation15, 16, 18, 154, 155. Finally, pharmacologic inhibition by dibenzazepine 
(DBZ) treatment or genetic inhibition by Dll1/Dll4 deletion showed loss of ASCs 
cells, suggesting a role for Notch in stem cell maintenance13, 15. 
 
Notch redundancy in the intestine 
 Since multiple Notch receptors and ligands are expressed in the crypt 
there has been interest in determining if these factors are functioning in specific 
cell populations or if they play distinct roles in the epithelium. To determine which 
Notch receptors function in ISCs, mouse genetic reporter models have been 
engineered to activate a reporter gene in cells undergoing active Notch signaling 
(Table 1-3). These Cre reporter mice have shown that both Notch1 and Notch2 
are expressed in a stem cell population14. However, Notch2 tracing occurred at a 
much lower frequency than Notch114, which could indicate that Notch2 is present 
in a more rare stem cell population, like a QSC, although construct mosaicism 
could also lead to this phenotype. 
 NOTCH1 and NOTCH2 were shown to be functionally redundant since 
genetic deletion of either receptor reportedly had no phenotype16. Other studies 
contested that Notch1 deletion has a mild secretory cell phenotype compared to 
pan-deletion155, 156. My work in Chapter 2 extends these findings to show that 
Notch1 is the primary receptor regulating both secretory cell fate decisions and 
stem cell maintenance. 
 Similar questions of redundancy have been addressed for epithelial Notch 
ligands. While DLL1, DLL4, and JAG1 are all expressed in the crypt, only 
combined deletion of Dll1 and Dll4 results in a severe secretory hyperplasia 
phenotype15. This suggests that DLL1 and DLL4 are the main ligands  
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Gene Construct Reference
NIP-Cre (N1-ICD 
replaced by CreERT2)
Vooijs et al., 2007, 
Pellegrinet et al., 2011
N1-CreERT2 Fre et al., 2011
N2-CreERT2 Fre et al., 2011
Dll1-GFP-ires-CreERT2 Van Es et al., 2012
Table 1-3. Notch reporter models
Finding
Fully labeled crypts/vili indicate that N1 
actiity occurs in stem cells
Fully labeled crypts/vili indicate that N1 is 
expressed in stem cells
Rare fully labeled crypts/vili indicate that N2 
is expressed in some stem cells
Short-lived secretory cell clones indicate 
Dll1 is expressed in secretory progenitor 
cells. Lineage tracing post-irradiation 
suggest that Dll1+ precursors revert back to 
stem cells with injury
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responsible for cell fate and stem cell maintenance, and that their function is 
largely redundant. 
 
Notch in disease  
Mutations in the Notch signaling pathway genes are associated with a 
number of human diseases, including T-cell acute lymphoblastic leukemia (T-
ALL) (Notch1), CADASIL (Notch3), Alagille syndrome (Jag1, Notch2), Hajdu-
Cheney syndrome (Notch2) and serpentine fibula polycystic kidney syndrome 
(Notch2)157. Additionally, alterations in Notch signaling have been associated 
with intestinal diseases, including inflammatory bowel diseases158, 159 and colon 
cancer160-162. Thus, Notch is a promising therapeutic target for disease. Since 
Notch is required for many tissue systems, a perfectly refined understanding of 
the effect of Notch activation or inhibition in targeted systems will need to be 
achieved. A large focus of this thesis, discussed in Chapter 2, is to understand 
the requirement of NOTCH1 and NOTCH2 in the intestine, which will be 
important information for treatment regimes targeted in the gut or delivered 
systemically. 
 
 
1.3: MATHEMATICAL MODELING OF THE INTESTINAL CRYPT 
 
A powerful system 
Mathematical and computational models are immensely powerful tools 
that can be used to probe biological systems in ways that may be very difficult to 
address experimentally. First, models can be used to test several parallel 
hypotheses to help narrow down the most likely biological explanation, which can 
be validated by in vivo analysis.  New experimental findings can then be 
implemented into the model, and reiterations can relay new questions. Repeated 
refining of the model through coupled experimentation can lead to the 
identification of the key mechanisms underlying the behavior of the system as a 
whole.  
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Modeling has long been used as a method to investigate cellular 
mechanisms of intestinal crypt homeostasis, tumorigenesis, and injury. The full 
potential of these models was not realized, however, due to the limited 
availability of stem cell markers to identify the location and numbers of ISCs as 
well functional assays to validate the models in vivo. Much progress has been 
made on these fronts, resulting in a recent resurgence in modeling efforts to 
study ISC function and crypt dynamics.  
 Modeling has been critical for understanding the viability of the immortal 
strand hypothesis as well as neutral drift dynamics. Additional modeling 
approaches have been used to understand cell-cell adhesion, flow, and migration 
within the crypt163, 164, which is important for understanding how stem cell 
progeny migrate out of the crypts as well as how Paneth cells travel to the base. 
 
Modeling stem cell number 
In light of the continued ASC/QSC dispute, there is no agreed upon 
number of total stem cells in the crypt. Interestingly, even the number of ASCs 
continues to be debated. Snippert et. al35 calculated the number of stem 
cells/crypt to be 14 +/- 2 cells. This was based on counting the number of GFP-
labeled LGR5+ cells intercalated between Paneth cells at the base of the crypt. 
More recent studies have challenged the idea that mere expression of Lgr5 
defines an ASC. The Winton lab has taken a stem cell marker-independent 
functional approach to define stem cells and has found that the number of stem 
cells per crypt is closer to six111. Additionally, this method identified that the rate 
of functional stem cell turnover much lower than previously predicted111.  With 
these new data, Kozar et al.111 re-modeled the neutral drift dynamics from the 
Clevers data set as well as their own experimental data. They found that their 
new parameters fit both sets of data better than the previously tested values111. 
This study provided further evidence for neutral drift dynamics in the crypt while 
also challenging the accepted values for stem cell number and cell cycle rates. 
This example demonstrates one of the most important strengths of modeling 
approaches: the ability to test publicly available data sets and possibly draw new 
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conclusions as more information from biological study is discovered and 
subsequently implemented in the modeling process. 
 
 
Types of crypt models 
Apart from the specific mathematical analyses used in these models, there 
are two broad modeling approaches that have been applied in this field: spatial 
models and compartmental models. Spatial models use a geometric lattice, 
algorithm or boundary conditions to organize individual cells in space. These 
models typically consider both crypt physical forces and cell-cell interactions and 
have recently been reviewed by De Matteis165. Compartment models, on the 
other hand, utilize the unique cellular organization of the intestine, with 
proliferating stem and progenitor cells at the base of the crypts and most 
differentiated cells migrating up the villi, to group cell lineages into discrete cell 
population compartments for analysis.  
A recent trend in crypt modeling is to try to incorporate everything that is 
known about the crypt, including crypt geometry, migration, stem cell division, 
niche signals, differentiation, and other factors into one comprehensive model166, 
167. While these models have been able to seemingly replicate many 
experimental outcomes, these efforts must be interpreted with caution, as these 
models are created to fill a set of known outcomes and are often filled with 
assumptions that cannot be validated experimentally. Models of this nature 
typically have rule-based algorithms that depend on cell location and identity to 
determine cell behavior. With all of the ambiguity surrounding the existence and 
function of QSCs, TA cell plasticity and required niche signals, it is premature to 
develop these types of comprehensive models of the crypt. For instance, a 
computational model of the crypt by Pin et al.167 defines QSCs as the same 
population as ASCs, but located higher up the crypt in a different Wnt gradient. 
While this is an interesting hypothesis, current data, summarized above, cannot 
determine if QSCs are an independent population, a subset of LGR5+ cells, or 
progenitor cells. 
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An alternate approach would be to tackle narrow questions to limit the 
amount of assumptions in the model. Compartmental models, which look at 
different cell lineages in the intestine as separate independent compartments, 
are ideally suited to answer many of the questions that dominate the ISC field. 
Depending on the specific question being asked, these compartments can be 
made as nuanced or broad as desired. For instance, we can consider a model 
with a stem cell compartment that is inclusive of all types of stem cells, or we can 
define compartments more specifically and designate ASC, QSC, and facultative 
TA cells as separate stem cell compartments. The advantage of this approach is 
that models can be developed to what is known at present and updated as more 
definitive information about stem cell populations becomes known. The benefit of 
working with such a model is that the simple design allows for addressing very 
specific questions. 
In Chapter 4 I utilize compartmental modeling to investigate stem cell 
dynamics in a system of acute Notch inhibition. To provide credence for using 
this technique, in the following section, I discuss in detail compartmental models 
that have successfully investigated various aspects of crypt homeostasis and 
tumorigenesis168, crypt recovery post-irradiation169, and crypt development170. I 
discuss the impact these models have made on the field and compare the 
various techniques employed. Finally, I discuss how compartmental modeling 
can be used to answer some of the lingering questions remaining in the ISC 
biology field. 
 
Compartmental models of homeostasis and tumorigenesis 
 The level of cellular proliferation and turnover in the intestine is quite 
remarkable. In humans, an estimated 1011 cells are shed and replaced every 
day171. Colon cancer remains the third most prevalent and third most deadly 
cancer172, thus, appreciating how normal proliferation is kept in check is essential 
for understanding when these processes go awry and lead to tumor formation. 
Early theories proposed that tumor initiation could be mediated by mutations that 
led to increased cellular proliferation of immortal stem cells173. Fearon and 
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Vogelstein174 contextualized these mutations with their genetic model for tumor 
initiation in the colon, characterized as a systematic acquisition of mutations: 
both activation of oncogenes and loss of tumor suppressors. More recently, 
modeling of colorectal tumors showed that as tumors grow they become more 
heterogeneous as new mutations are acquired175, 176. This heterogeneity implies 
that more than one treatment approach is needed to eradicate the tumor. 
Modeling has also been used to directly determine how therapies should be 
applied. For example, a model of colon cancer carcinogenesis and tumor 
response to irradiation has been developed to better tune dosing of radiation 
therapy177. 
In 1995, Tomlinson and Bodmer178 probed the mechanisms through which 
mutations act to incite tumor initiation with their computational model of crypt 
homeostasis and tumorigenesis. This simple model divided the crypt into 3 
compartments: stem cells, semi-differentiated cells, and fully-differentiated cells, 
with cell populations determined by the rates of death, differentiation, renewal, 
and removal (Figure 1-6). The model was simplified to assume that all cell 
divisions occurred synchronously and updated at each subsequent generation. 
This study178 explored normal cell division as well as the resulting effect on 
cellular homeostasis when changing the rates of cells undergoing death or 
differentiation in each compartment. The findings were striking: under normal 
conditions, this model found that there are very stringent parameters that must 
be met in order for steady-state to be reached; small perturbations in rates of 
death, differentiation, or renewal led to exponential growth or decay. Importantly, 
the model178 suggested that alterations in stem cell number that lead to 
tumorigenesis might be through mechanisms other than simply increased stem 
cell proliferation rate, highlighting that it is not necessarily the mechanism of a 
tumorigenic mutation that is of key importance, but the crypt compartment that is 
affected.  
Several models have been adapted from the general framework of the 
Tomlinson and Bodmer178 study. In particular, Johnston and colleagues168 aimed 
to improve the model by eliminating synchronous division as a simplification to  
Figure 1-6.  A compartmental model of crypt homeostasis and 
tumorigenesis. (A) An illustration of the colonic crypt as modeled by Johnston 
et al. Unlike the small intestine the colon does not have villi nor traditional 
Paneth cells. (B) Compartmental model diagram adapted from Figure 1 of 
Johnston et al.167. Cell populations include stem cells, semi-differentiated cells 
and fully differentiated cells. Cell flows into and out of the compartments are 
indicated by arrows and are defined by rates of death, differentiation, and 
renewal from the stem and semi-differentiated compartments. There is no 
renewal in the fully differentiated compartment and cells leave by removal.
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more closely match crypt physiology. To do this they created two different 
revisions of the model: an “age-structured model” using partial differential 
equations that takes into account asynchronous cell divisions and a “continuous  
model” using ordinary differential equations (ODEs) that looks at the average cell 
population over time. In the age-structured model they explored the effect of cells 
in each compartment being in different stages of the cell cycle prior to 
undergoing renewal, differentiation, or death at certain time points. The resultant 
population of semi-differentiated cells from a crypt that started with all cells at the 
same point of the cycle was compared to one that started with an evenly 
distributed age profile. Since this resulted in similar populations, they concluded 
that it was unnecessary to specifically follow each cell’s age, and validated the 
use of the continuous model to study this system.  
Johnston et al.168, like the Tomlinson and Bodmer model178, found that 
both the age-structured and continuous models were “structurally unstable”, that 
is they reach stable steady-state cell populations only at very precise parameter 
values. Any deviation from these values results in exponential growth or decay of 
the crypt. In the intestine, unbounded growth would be equivalent to 
tumorigenesis and decay would result in eventual crypt loss. Due to this 
complication, Johnston et al.168 sought to test feedback mechanisms to model 
the steady-state that occurs in the actual crypt during homeostasis. Two 
alternative feedback models were tested, “linear feedback” and “saturating 
feedback”. In the linear feedback model, logistic growth of the stem cell 
population was implemented leading to a limited population size. In this case, 
tuning the parameters below a certain point resulted in exponential decay, but 
unlike the model without feedback, no set of parameters resulted in exponential 
growth. Effectively, the linear feedback model creates a crypt that is incapable of 
initiating tumors no matter how many mutations are accumulated that change cell 
renewal and differentiation rates, unless the mutation compromised the feedback 
mechanism.  
In the saturating feedback model168, rather than limiting total population 
size, feedback was incorporated to only limit the rate of differentiation. With this 
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feedback, three states of stem cell population growth were possible: crypt 
extinction, homeostasis, and exponential growth. Thus, the saturating feedback 
model establishes a simple model to explore the initiation and growth kinetics in 
tumorigenesis associated with multiple mutation acquisition. Alterations in the 
rate of renewal, differentiation, and death due to genetic mutations would change 
the governing rate parameters, leading to altered steady-state populations.  
Several studies have confirmed that the Johnston et al.168 model predicts 
experimental findings in tumorigenesis179, 180. Additionally, there have been 
adaptations of the model for colon cancer and other systems. For example, one 
study maintained the general framework of the model but included telomere 
length as a parameter that was regulated by location in the stem cell niche181. In 
another study182, the Johnston et al.168 scaffold was used to build a model for 
hematopoiesis and treatment of Chronic Myeloid Leukemia (CML). This study182 
tested synchronized discrete, age-structured, and continuous models with 
feedback mechanisms to determine that modulating growth factor signaling 
through the use of tyrosine kinase inhibitors should be able to cure CML by 
regulating CML progenitor cell populations. 
 
A compartmental crypt post-irradiation model 
 As discussed above, irradiation leads to severe intestinal damage. In fact, 
understanding both early and late injury responses has been a key interest in the 
field183. Additionally, acute irradiation damage has been used as a mechanism to 
study pathways involved in intestinal recovery, and, as mentioned above, has 
been a key tool in studying activation of QSCs. The acute irradiation response 
can be distilled into two stages. Initially, there is crypt apoptosis, mitotic arrest, 
and a decrease in both crypt and villus cell numbers184, 185. Next, there is a robust 
rebound “overshoot” in population before homeostasis is re-established184. 
Paulus et al.169 aimed to create a model that would faithfully replicate the post-
irradiation recovery to test their hypothesis that the damage control response 
resided solely in the stem cell compartment. They engineered a compartmental 
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model of the crypt to map the effect of the post-irradiation response on stem and 
TA cell populations (Figure 1-7). 
Prior to the publication of Paulus et al.169, several models had been 
designed to describe the intestinal response to irradiation. Many of these  
attempts were fueled by the observation that irradiation injury leads to shortened 
villi prior to crypt expansion and proliferative cell surge184. This was first 
investigated in the compartmental model by Sato et al.186, which posited that 
irradiation-induced changes to cell number and proliferation were generated from 
a feedback mechanism where villus damage sends signals to the crypts to 
regenerate.  One complication with this hypothesis was the observation of subtle 
changes in the crypt prior to the onset of villar atrophy, suggesting that not all of 
the effects originated from a villus feedback mechanism187.  
Paulus et al.169 challenged the idea that the irradiation recovery response 
had any aspect of villus-to-crypt feedback. Rather, they hypothesized that all 
cellular consequences could be traced back to changes in the stem cell 
compartment. Their study tested whether a stem cell-centric response could 
replicate the experimental findings in cell number, labeling index (incorporation of 
a tritiated thymidine label), and mitotic index in the post-irradiation recovery. To 
begin their model, they drew from a comprehensive data set that included 35 
time points after various irradiation doses from 2.5-12Gy. In these experiments, 
mice were administered tritiated thymidine 40 minutes prior to sacrifice, and ileal 
crypts were scored for labeling index and mitotic activity on histological sections. 
Paulus et al.169 used an agent-based approach, a computational model 
where cells are modeled as autonomous decision-making entities called agents 
that behave according to a set of rules defined from experimental observations of 
the phenomenon under investigation. Unlike many agent-based models that align 
cells to a geometrical lattice, this model situated the cells into one of six 
compartments: stem cells (A), four TA cell compartments (T1-T4) and 
differentiated cells (D) (Figure 1-7A). Each compartment contained sub-
compartments allocated to specific portions of the cell cycle (Figure 1-7B). 
Movement of cells from one compartment to the next was based on two  
Figure 1-7.  A compartmental model of crypt post-irradiation recovery. (A) 
Diagram of the cell population compartments of the crypt post-irradiation model 
adapted from Figure 2 of Paulus et al.168. Cell populations include stem cells 
(A), TA cells (T1-T4), differentiated cells (D), and previously proliferative cells 
that stopped cycling due to irradiation injury (D’). Cells move from one 
compartment to the next after completing the cell cycle. Cells in A and T1 can 
re-enter their compartment with the probability pA and pT1, respectively. (B) 
Diagram of different cell cycle subcompartments are shown. (i) 
Subcompartments during steady state when the cell cycle time is 24 hours for A 
and 12 hours for T compartments. Cells (white circles) advance to the next 
subcompartments every hour of the simulation. For clarity we have included 
G1, S, G2 and M phases of the cell cycle, but the lengths of G2 and M that 
were used during the Paulus et al.168 simulation was not made clear in the 
manuscript. (ii) Normal stochasticity in the model. Cell cycle time was allowed 
to vary slightly for each individual cell. This variation was limited to the G1 
compartment and was achieved by skipping a subcompartment. Renewal in the 
A and T1 compartment was accomplished by re-entering the first G1 
subcompartment after completing M phase. (iii) Alteration in subcompartments 
after maximal irradiation injury, where cell cycle lengths are decreased to 8 
hours. 
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regulated processes during the simulation: cell cycle time and self-maintenance 
probability; all other parameters were held constant. During the simulations, cell 
cycle time was very highly regulated based on experimental findings: 24 hours 
for stem cells and 12 hours for TA cells during steady-state; but after irradiation 
injury, cell cycle for both populations was shortened, with a minimum cell cycle 
time of 8 hours. Additionally, the number of stem cells in the crypt influenced 
stem cell cycle time, while TA cells were not regulated in this fashion. The model 
also embraced the idea of TA cells as potential stem cells, although it is assumed 
that only T1 cells have self-renewal capabilities. Therefore, after completing the 
cell cycle, cells in the A and T1 compartments either moved to the next 
compartment or re-entered the same compartment with the probabilities pA and 
pT1. 
Paulus et al.169 used data from administration of 8Gy irradiation to fit their 
parameters: cell death, “irreversible proliferative inhibition” i.e. removal of 
previously proliferative cells to a non-proliferative compartment (D’), mitotic 
delay, cell numbers, cell cycle times, and villus transit time. With these 
parameters, they were able to replicate the observed labeling index and cell 
numbers, including the expected overshoot in population, simply by regulating 
cell cycle time and self-maintenance probability.  To validate their model, they 
changed the initial values to match the observed cell numbers after 2.5Gy and 
12Gy irradiation, and again were able to replicate the labeling index and 
overshoot populations observed after these levels of irradiation damage. 
The Paulus et al.169 model served its goal to debunk the idea that the 
irradiation-response is a villus feedback mechanism. More recent studies have 
made it clear that the acute post-irradiation response is a crypt-centric process 
fueled by stem cell proliferation5, 39. Interestingly, although some stem cells 
undergo apoptosis after irradiation, a recent study showed that surviving ASCs 
possess radioresistance by activating DNA-damage repair processes4. 
Additionally, a recent study investigating lineage tracing of SOX9-EGFP during 
post-irradiation showed a marked increase in SOX9-EGFP low cells (which are 
thought to be CBCCs), but also found increased numbers of SOX9-EGFP high 
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cells (which are thought to be differentiated enteroendocrine cells5.)  This finding 
suggests that more mature cells can de-differentiate to replace lost stem cells, 
not just the T1 compartment as proposed by Paulus et al.169. 
 
A compartmental model of stem cell expansion during development  
 In the adult intestine, stem cell divisions must result, on average, in one 
stem cell and one TA cell in order to maintain homeostasis. This is usually 
termed asymmetric stem cell division, since the two daughter cells are of different 
lineages. Asymmetric division is one of the defining characteristics of stem cells 
as it allows for self-renewal188, 189. However, stem cells must also possess the 
ability to divide symmetrically to increase numbers in development and after 
injury190. This property is especially crucial as the intestine grows in length and 
develops crypts during postnatal development.191  
There have been a number of mathematical models probing the question 
of stem cell symmetry in adult tissues.  Clayton et al.192 devised the first model of 
this kind for the mammalian epidermis, demonstrating that stem cells had 
flexibility in cell division symmetry. Their probabilistic model of clone labeling 
concluded that adult skin stem cells were undergoing asymmetric division 84% of 
the time and symmetric division 16% of the time192. In the intestine, mathematical 
models of stem cell symmetry have come to slightly different conclusions. As 
mentioned above, neutral drift studies have suggested that stem cell division 
results in two equipotential daughter cells, which compete for spots in the niche. 
Essentially this means that stem cell divisions never truly occur asymmetrically, 
rather that population asymmetry occurs via stochastic availability of niche 
positions35, 64. While these studies call into question asymmetric division, they do 
indicate precedence for symmetric division in the intestine, the mechanism 
assumed to be essential for stem cell expansion.  
Itzkovitz et al.170 aimed to answer the question of exactly how shifts 
between asymmetric and symmetric stem cell division can create a mature crypt 
in the developing intestine in the optimal, or shortest, amount of time. The main 
question the group focused on was if there were multiple types of cell division 
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occurring simultaneously or if all cells completed similar types of division during 
the same window of time. This compartmental model defined two cell 
populations: stem cells and non-stem cells. Differentiated cell populations were 
not directly addressed, however non-stem cell extrusion was included as a 
possible outcome of cell division. The system is defined by a set of stochastic 
ODEs where the state variables are the population of stem cells and non-stem 
cells. The parameters include rates of stem cell and non-stem cell division, as 
well as extrusion from the non-stem cell compartment. The number of cells are 
governed by the probabilities that each compartment will undergo symmetric or 
asymmetric cell division.  
Since more than one type of symmetric stem cell division is addressed in 
the model, a shorthand nomenclature is used for this discussion: symmetric (S) 
or asymmetric (A), with a number indicating stem cell (1) or non-stem cell (2) 
progeny (Figure 1-8). The authors170 started with the assumption that 
development of mature intestine occurred with a certain probability of S1 and A 
stem cell divisions, but no S2 division. They next utilized optimal control theory193 
to determine the probabilities of each of these division events to take the initial 
population of cells at birth to the population of cells in the mature crypt in the 
least time possible. As the immature gut contains only a short supply of 
differentiated cells at birth191, 194, the authors rationalized that time was the 
driving force for creating a mature crypt.  
By solving for minimal time, they found that all stem cells would always 
divide the same way at the same time, either S1 or A, never mixed170.  With this 
criteria, there are two options for behavior, 1) cells will always divide the same 
way with no transition to another type of symmetry or 2) cells can switch which 
type of symmetry they undergo one or multiple times until maturation is achieved. 
The authors found that in order to reach mature crypts in the minimal amount of 
time symmetry would need to switch once and only once during development. 
Thus if the stem cells started with S1 division they would all switch to A division 
and continue dividing asymmetrically until the mature crypt was established. 
Alternatively, stem cells could begin with A division and switch to S1. This type of  
Figure 1-8.  A compartmental model of crypt development.  This figure has 
been adapted from Figure 3 of Itzkovitz et al.169 (A) Definitions of types of stem 
and non-stem cell divisions. Stem cells can undergo two types of symmetric 
division, S1 and S2, or asymmetric division, A. Non-stem cells always divide 
symmetrically or are extruded from the crypt. (B) Depiction of the two types of 
“bang-bang” model outcomes. The rounds of division have been limited to 5 for 
clarity. The left cell lineage tree shows bang-bang division that shows a switch 
from S1 stem cell division to A division. The right lineage tree shows A division 
preceding S1 division. (C) Depiction of the “overshoot” model where stem cells 
undergo S1 division followed by S2 division. The final cell composition is the 
same as the bang-bang models, but it only takes 4 rounds of divisions instead of 
5 to achieve this. 
43
Asymmetric Symmetric
S1 S2 A
Extrusion
Divisions:
1 2 3 4 5 1 2 3 4 5 1 2 3 4
 
S1 A A 
 
S1 S1
 
S2
A
B c
Stem Cell Division Non-Stem Cell Division
Symmetric 
-or-
 44 
control mechanism containing a single on/off switch in behavior is referred to as 
“bang-bang control”195, 196.  
Next, the authors170 embraced the idea that stem cells could divide 
symmetrically into two non-stem cells (S2 division) (Figure 1-8).  Strikingly, they 
found that if S1 divisions occurred for the duration of crypt development, with the 
last round of divisions switching to S2, they could also achieve mature crypt 
populations, without any A divisions. Importantly, this approach led to 
overshooting the mature crypt stem cell population, before attaining normal 
levels. Interestingly, this “overshoot” model resulted in mature crypt formation in 
less time than with bang-bang control (Figure 1-8). 
Itzkovitz et al.170 then investigated in vivo their “bang-bang” vs. “overshoot” 
control findings. They used Lgr5 in situ hybridization to visualize stem cells and 
performed a kinetic analysis to measure proliferation rates. First, they found that 
the proliferation rate of stem cells and non-stem cells was maximal during crypt 
development, which was in accordance with their prediction for attaining mature 
crypts in minimal time. In fact, they measured stem cell cycle time (15.7 hours) to 
be essentially the same as TA cell time (16.9 hours), a marked decrease from 
the normal adult stem cell cycle time (22.4 hours). They were able to feed these 
proliferation rates back into their model to determine that the type of “bang-bang” 
control that would be favored is S1 division followed by A division. Additionally, 
their Lgr5 in situ data showed that developing crypts were initially filled, almost 
exclusively, with stem cells, and only later contained non-stem cell progeny, 
nicely corroborating this prediction. Importantly, they did observe Lgr5- non-stem 
cell progeny prior to the last round of division, which surprisingly favored the less 
efficient “bang-bang” model over the “overshoot” model. Finally, they performed 
lineage tracing studies that showed that they never observed S2 division, 
suggesting that the “overshoot” mechanism did not occur. Interestingly, this is in 
direct contrast to the findings in adult intestines, where S2 division is predicted to 
frequently occur35, 64. This inconsistency could point to a difference in the 
regulation of stem cell symmetry specifically during development or could call 
these earlier results into question. 
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The Itzkovitz et al.170 model exemplifies the importance of closely linking 
mathematical modeling efforts with in vivo validation. Had they only relied on 
their modeling data they may have assumed that the mechanism of crypt 
development was the “overshoot” model since it reached maturity in less time 
than the “bang-bang” control model.  
Although only recently published, the work by Itzkovitz et al.170 has 
spurred investigation into the discrepancy it introduced regarding the absence of 
S2 division in the developing intestine. Hu et al.197 reported both in vivo and 
modeling data suggesting that stem cell symmetry shifts from strict asymmetry 
(via A division) to population symmetry (via stochastic S1 and S2 division) with 
intestinal maturation. This report suggests that Itzkovitz et al.170 and the adult 
modeling studies by Lopez Garcia et al.64 and Snippert et al.35 could be correct 
and that stem cell symmetry is dependent on tissue age. 
 
A comparative look at crypt compartment models  
While the theoretical models discussed above share the feature of 
analyzing the intestinal epithelia as compartmental populations, the 
compartments that they utilize and the mathematical/computational approach 
that they employ are very different: Johnston et al.168 applied ODEs and partial 
differential equations, Paulus et al.169 embraced an agent-based model, and 
Itzkovitz et al.170 used a stochastic ODE system. These differences emphasize 
the versatility of the compartment modeling approach; many different types of 
questions can be addressed simply by restructuring the compartments and 
altering the theoretical framework. Since each approach is best suited to a 
specific type of system, it is wise to carefully consider which method will best 
answer the anticipated questions. There are strengths and weaknesses for each 
of these approaches.  
Johnston et al. model. The Johnston model168 comes to the conclusion 
that an ODE-derived “continuous” model is the simplest and most appropriate 
model of crypt homeostasis, and that changes in the rate parameters can be 
modulated to model both homeostasis and the process of tumorigenesis. Since 
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ODE models look at averages of cells over time, they assume that the cells in the 
system are uniform and that cell number is very large. Additionally, neither ODE 
nor partial differential equation models can resolve changes in small cell 
numbers that occur rapidly or transiently. While the number of cells in the 
intestinal crypt range in the several hundred, the number of stem cells is 
estimated to be 6 to 14 per crypt35, 111. This population number is too small to be 
well-described with a deterministic ODE model. When there are very small 
numbers like this, small random variations in stem cell number due to 
asymmetric vs. symmetric stem cell division can only be accurately captured with 
stochastic models. This does not invalidate the model, but does limit the 
questions that the model can answer.  For example, this model would be 
inappropriate to probe post-irradiation recovery where the changes in stem cell 
number change very quickly.  
Another weakness is that this model treats the TA, or semi-differentiated 
cell population, essentially as a stem cell population, which does not reflect crypt 
physiology. In order to appropriately capture the limited cell divisions in the TA 
compartment this model would need to use discrete equations or an agent-based 
system. 
 Paulus et al. model. The Paulus et al.169 model of crypt post-irradiation 
recovery takes a unique approach. They treat cells as individual agents, but 
distribute the cells into compartments and follow each one through sub-
compartments that reflect cell cycle time. One of the strengths of an agent-based 
approach is that all cells are accounted individually so the model allows for small 
cell numbers and rapid changes in cell populations. One of the disadvantages of 
agent-based models is that they have arbitrary physical units, which need to be 
explicitly defined a priori to interpret the simulation results with the experimental 
findings198. Unlike most agent-based models, however, the Paulus et al.169 model 
is free from a geometrical lattice and cells are not influenced by the behavior of 
neighbors. Although individual cell interactions cannot be resolved in a model like 
this, population-level behavior can be inferred. For instance, the probability that a 
T1 cell can re-enter the T1 compartment is dependent on the population of stem 
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cells in the A compartment. This approach could be used to ask questions about 
homeostasis or tumorigenesis, and would be informative to probe the interaction 
between different stem cell populations. 
Itzkovitz et al. model. The Itzkovitz et al. model170 used a stochastic ODE 
system to model the probabilities of symmetric or asymmetric stem cell division 
during the process of crypt development. One of the assumptions this approach 
makes is that the mechanisms controlling crypt development are optimized to 
take the shortest amount of time biologically possible. This is a stringent feature 
that leads to the conclusion that stem cell divisions occur via “bang-bang” control. 
If time were not the determining factor, the optimal control theory would be the 
wrong approach to take. A strength of this model is it was validated in vivo, and 
the model clearly helped to inform the appropriate experiments to perform in this 
respect. This is one of the most important aspects of these types of models: the 
ability to inform biological experiments to test mechanisms regulating the 
complex process of epithelial cell homeostasis.  
Weaknesses of this model include failure to address that the developing 
intestine does not receive all of the mature niche signals199. Since the niche is 
changing as crypt expansion occurs, it is possible that the rates of division 
intrinsic to the stem cell population could change throughout the process. They 
also assume that the crypt starts with one stem cell and zero TA cells, which 
does not account for any immature proliferative cells that may be located in the 
intervillus zone. The timing for TA cell appearance has not been critically 
determined, but cells expressing differentiated cell markers are apparent in 
prenatal intestine and intestinal function to absorb nutrients is essential upon 
birth, so differentiated cell populations must occur before crypts mature191. 
Finally, Itzkovitz et al.170 determined that there is a shift from stem cells dividing 
symmetrically to asymmetrically during crypt maturation. Notably, their in vivo 
studies determined that Paneth cells were not responsible for this shift because 
the timing occurred prior to Paneth cell maturation170. One option they did not 
address is whether signaling for the shift could occur through immature Paneth 
cell precursors, which have not been well defined in the immature intestine. 
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Immature intestine contains cells that express Paneth-like markers, which may 
provide signals to the developing ISCs to regulate their behavior. If the process 
of ISC maturation is totally independent from Paneth-like cell development, then 
it will be important to identify which signal may control this process during 
intestinal development. 
 
Future directions for modeling intestinal dynamics 
The models that have been discussed above utilized a compartmental 
framework to investigate the mechanisms of tumorigenesis, post-irradiation 
recovery, and development. All of these models have been able to answer 
specific questions about their system, and Paulus et al.169 and Itzkovitz et al.170  
validated their models with in vivo data. Itzkovitz et al.170 went even further to use 
their model to design new experimental approaches and used those results to 
further refine their model. We believe that similar techniques can be used to 
tackle some of the lingering questions that remain in the field of stem cell biology. 
1) How is stem cell number regulated? Modulations of several signaling 
pathways as well as various injury models have dramatic effects on stem cell 
numbers in the crypt. Some of these perturbations can result in loss of all CBCCs 
or reduction to a single stem cell. After recovery, stem cell populations return to 
normal, approximately 16 CBCCs/crypt. Compartmental modeling of stem cell 
populations in normal conditions compared to models of unbounded growth, can 
provide insights into exactly what signals are necessary for regulation of stem 
cell number. Use of CBCC markers like the Lgr5-GFP-CreERT2 mouse32 can be 
used to validate stem cell numbers in different conditions. Compartmental 
models can also help to answer the questions of whether all ASCs are equal or if 
there are subpopulations even within the Lgr5+ stem cell population. This would 
simply require sub-compartmentalizing these cells. Because a model like this 
would be working with very small numbers it would be best to use a stochastic 
model or an agent-based design to track cells individually. 
2) Are ISCs completely defined by the niche? A compartmental model 
investigating this aspect of stem cell biology could distinguish between two 
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possibilities: all cells are potential stem cells if they are exposed to niche signals 
or only cells possessing intrinsic stemness can become stem cells once they are 
in the niche. Like the Paulus et al.169 model this could be achieved by a 
subcompartment approach, where the large compartments would be niche and 
not niche, and the smaller compartments would be the cell populations. Total cell 
population censes would be measured with the inclusion of a intrinsically 
programmed cell compartment compared to a compartment that contained 
equipotential potential stem cells.   
3) Is there a dedicated QSC population? A compartmental model testing 
this question would need to address whether QSCs are always in existence, or 
whether they only arise during times of injury by de-differentiation of TA and 
differentiated cell populations. If QSCs are a true population then crypts 
containing these cells would have a slightly higher cell population than a crypt 
where QSCs are actually cells with other functions. Very refined cell counting in 
vivo would be required to determine if this additional cell compartment exists. 
4) What is the nature of the TA compartment? A model of TA cells could 
investigate the stringency of the number of divisions that these cells undergo. 
Proliferating cell numbers during homeostasis, injury, and post-injury could be 
utilized to determine if TA cells have an intrinsic division limit, or if the number of 
divisions is externally regulated. Although there are no specific markers for TA 
cells, TA cell number can be approximated by subtracting the number of stem 
cells from the total number of cells that proliferate during a 12-hour window. 
There are a number of other ways that these questions can be 
approached, combining in vivo and modeling techniques. A spatial model that 
takes into account crypt size boundaries as a regulatory mechanism, for 
instance, might best answer the stem cell number question. This would be 
combined with very careful measurements of crypt circumference to determine if 
stem cell number/crypt varies based on crypt size.  
Regardless of the specific modeling method used, the key issue is to keep 
the models focused and modest. By limiting the number of parameters in the 
system, we have the best chance to validate and refine the models 
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experimentally. This generates small-scale models that can be very powerful in 
generating new testable questions. Ideally, these smaller scale models would 
also be useable by non-experts, which would allow for more utilization of the 
combined in vivo/in silico approach and would fuel further advancement of the 
field. 
 
 
1.4: THESIS OVERVIEW 
The thesis research that I have undertaken has focused on how the Notch 
signaling pathway regulates stem cell dynamics. I have approached this question 
using mouse models of pharmacologic inhibition, and genetic inhibition or 
activation of the pathway and focusing on the temporal consequences of Notch 
inhibition.  
In Chapter 2, I investigate the specificity of Notch receptors in intestinal 
epithelial differentiation and stem cell maintenance with genetic models of 
Notch1 and Notch2 deletion. I discovered that NOTCH1 is the main receptor 
controlling differentiation in the intestinal epithelium as deletion of Notch1 alone 
results in secretory cell hyperplasia and stem cell loss. Additionally in Chapter 2, 
I use a Notch activation model to understand how constitutive Notch signaling 
affects the intestinal epithelial proliferation and differentiation profiles. To assess 
this I utilized the Villin-CreERT2 x Rosa26-LSL-NICD-nGFP model, which leads to 
expression of activated NICD in the intestinal epithelium. In this system I found 
that proliferation is increased, and that all types of differentiated cells are 
decreased. This is important since earlier works suggested that Notch activation 
results in an increase in the absorptive lineage at the expense of secretory 
cells17, 78.  
In Chapter 3 I investigate the short-term dynamics of stem cells after 
Notch signaling is turned off, by using an acute DBZ model. Since chronic Notch 
inhibition is typically associated with decreased proliferation and increased 
secretory cells, I was surprised to find that acute DBZ led to a both increased 
proliferation and increased secretory cell production, as well as decreased 
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CBCCs. I hypothesized that a Notch-dependent change in stem cell symmetry 
could explain both the proliferation and stem cell phenotypes observed in both 
chronic and acute Notch inhibition, and used a compartmental mathematical 
model to test this hypothesis. Furthermore, since CBCC loss is associated with 
QSC activation, I use a post-irradiation DBZ model and genetic deletion of Notch 
in QSCs (Bmi1-CreER x floxed-Rbp-j) to determine if Notch is required for QSC 
activation.  
In Chapter 4, I build and test a discrete compartmental model of the 
intestinal crypt for the purpose of testing our stem cell symmetry hypothesis. I 
found that stem cell symmetry could explain our chronic and acute DBZ 
proliferation findings, but only in the context of Notch-dependent stem cell 
repopulation. 
Finally, in Chapter 5 I put my work in the context of the field and 
demonstrate how these findings have provided important insights in ISC biology. 
I end with future directions and propose experimentation to further understand 
Notch receptor function in niche specification and ISC dynamics. 
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CHAPTER 2 
 
 
NOTCH1 IS THE PRIMARY RECEPTOR REGULATING INTESTINAL STEM 
CELL HOMEOSTASIS 
 
 
 
 
2.1: SUMMARY 
 The Notch signaling pathway controls intestinal epithelial differentiation, 
proliferation, and stem cell maintenance. Two Notch receptors, Notch1 (N1) and 
Notch2 (N2), are expressed in the epithelium, but the contribution of each 
receptor for these functions is unclear. In this study we use pan-epithelial genetic 
deletion of N1 and N2 to show that loss of N1 alone results in secretory cell 
hyperplasia and decreased LGR5+ stem cells. Interestingly, the secretory cell 
hyperplasia of the N1 deleted intestine almost completely normalizes by two 
months; however, N1 deletion renders the intestine incapable of post-irradiation 
recovery. Finally, we examine the combined roles of N1 and N2 on intestinal 
homeostasis. Our results suggest that N1 is the primary receptor involved in 
secretory cell fate decisions and stem cell maintenance, and that N2 plays a 
small role in differentiation, but a larger role in regulating proliferation. These 
results are critical for the continued understanding of intestinal stem cell 
regulation as well as potential complications with therapeutic Notch receptor 
blockade. 
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2.2: INTRODUCTION 
 In order to provide efficient digestive and barrier functions to the gut, the 
intestinal epithelium requires constant renewal of all of its absorptive and 
secretory cell populations, a process that is fueled by a highly proliferative 
intestinal stem cell compartment and regulated differentiation process.  
 The Notch signaling pathway is required for proper regulation of intestinal 
epithelial cell fate. Active Notch signaling is essential for specification of the most 
common cell type in the epithelium, the absorptive enterocyte1-3. Inhibition of the 
pathway by pharmacologic or genetic means leads to formation of secretory cell 
types such as mucin-producing goblet cells, hormone-secreting enteroendocrine 
cells, and antimicrobial peptide-secreting Paneth cells, at the expense of 
absorptive cells4-7. Notch signaling, in addition to Wnt, has been shown to be  
crucial for maintenance of proliferating progenitors1, 3, 5, 8, and we previously 
determined that Notch was necessary for stem cell survival4.  
 Expression of the 4 known Notch receptors (N1-4) and 5 ligands (Dll1, 3, 4 
and Jag1 and 2) is temporally and spatially controlled for proper development 
and homeostasis of many tissues. N1 and N2 are both expressed in the adult 
intestinal epithelium9-11, but individual roles for each receptor is not well 
understood. 
 Previous studies investigating N1 and N2 function utilizing humanized 
inhibitory antibodies suggested a role for N1 in regulating intestinal homeostasis, 
as α-N1 treatment showed a mild secretory cell hyperplasia12 and decreased 
intestinal proliferation and toxicity when paired with irradiation damage13 (see 
Appendix 1). Specific intestinal epithelial genetic deletion studies, in contrast, 
reported that N1 and N2 single deletions had no phenotype, and thus N1 and N2 
were thought to be fully functionally redundant in the gut14. Due to the important 
therapeutic implications of intestinal Notch regulation, it is critically important to 
reconcile these disparate findings. 
 In this study we use a genetic deletion model to definitively show that N1 
is the predominantly active Notch receptor in the intestinal epithelium, as N1 
deletion results in secretory cell transformation and impaired stem cell 
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maintenance and repair function. Furthermore, we investigate the dynamic 
regulation of lost N1 signal and expand on the understanding of how N1 and N2 
function together to regulate proliferation and differentiation in the intestine.  
  
2.3: MATERIALS AND METHODS 
Mice 
Floxed-Notch1 (N1F/F)15 (Jackson Lab, no. 007181), floxed-Notch2 (N2F/F)16 
(Jackson Lab, no. 010525), floxed-Rbpjκ (RbpjF/F)17 (gift from T. Honjo), Rosa-
LSL-NICD-IRES-nGFP (NICD)18 (Jackson Lab, no. 008159), Villin-CreERT2 19 
(gift from S. Robine) and Lgr5-GFP-IRES-CreERT2 (Lgr5-GFP)20 (Jackson Lab, 
no. 008875) alleles were verified by PCR genotyping with the primers listed in 
Supplementary Table 2-1.  All crosses were maintained on a C57BL/6 strain 
background. Mice were housed in ventilated and automated watering cages with 
a 12-hour light cycle under specific pathogen-free conditions. Protocols for 
mouse usage were approved by the University of Michigan Committee on Use 
and Care of Animals. 
 
Animal treatment protocols and tissue collection 
 To activate CreER recombination, mice were injected intraperitoneally with 
100mg/kg tamoxifen (Sigma) once per day for 5 days and tissue was collected 
on day 6 unless otherwise noted. To induce intestinal injury, animals were 
exposed to one dose of 12Gy whole body irradiation from a 137Cs source. 
Animals were fasted overnight and injected intraperitoneally with 25 mg/kg 5-
ethynyl-2´-deoxyuridine (EdU) (Life Technologies) 2 hours prior to tissue 
collection. Intestinal tissue was harvested and fixed in 4% paraformaldehyde 
overnight as previously described4.  Tissue prepared for frozen sections was 
fixed in 4% PFA for 1 hour and incubated in 30% sucrose overnight before 
embedding in OCT (Tissue-Tek). 
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Immunohistochemistry 
5µm paraffin sections were stained with Periodic acid Schiff and Alcian Blue 
(PAS/AB) (Newcomer Supply) and Alkaline Phosphatase (Vector Laboratories) to 
visualize mucin-containing goblet cells and enterocytes respectively. EdU-Click-it 
(Life Technologies) was used to evaluate proliferating cell number. 
Immunostaining with rat α-MMP7 (1:400, Vanderbilt Antibody and Protein 
Resource), rabbit α-MUC2 (1:200, Santa Cruz) and rabbit α-Ki67 (1:200, 
Thermo) was performed as described21.  GFP transgene expression was 
visualized on 5µm frozen sections without antibody staining. Images were 
captured on a Nikon E800 microscope with Olympus DP controller software.  
Presented images are representative sections from terminal ileum unless 
otherwise noted. 
 
Quantitative morphometric analysis 
All slides were blinded for cell counting. Goblet cell hyperplasia was measured as 
the number of crypts that displayed increased goblet cells over total crypts per 
section. EdU morphometrics was achieved by counting the total number of 
epithelial EdU+ cells per well-oriented crypt and averaged per animal. EdU 
counts were performed by two individuals. 
 
Crypt isolation and flow cytometry 
Crypt isolation was performed on proximal jejunum: centimeters 4-8 for crypt 
RNA and 9-15 for flow cytometry as measured from the pylorus. Tissue was 
incubated in 15mM EDTA (Sigma) in DPBS (Gibco) at 4°C for 35 minutes, 
vortexed for 2 minutes, and filtered through a 70µm cell strainer (BD Bioscience). 
Prior to processing for RNA isolation, crypts were gravity-settled twice for 10 
minutes to remove single cells and fragments. To obtain a single cell suspension 
for flow cytometry, crypts were resuspended in TrypLE Express (Gibco), shaken 
at 37°C for 10-12 minutes, and 0.1mg/ml DNase I (Roche) and 10% fetal bovine 
serum (FBS) were added. Cells were passed through a 40µm cell strainer (BD 
Bioscience), pelleted at 400xG, resuspended in 2% FBS, 0.05% sodium azide 
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(Sigma), 2mM EDTA in DPBS and stained unfixed as follows. All cells were 
blocked with rat α-mouse CD16/CD32 (1:100, BD Bioscience), lymphocytes were 
excluded with CD45.2-PerCP-Cy5.5 (1:80, LifeTechnologies), epithelial cells 
were visualized with EpCAM-APC (1:80, eBioscience), and dead cells were 
excluded by DAPI incorporation. Cells were analyzed on a BD FACSCanto II and 
interpreted with FlowJo software (Treestar). GFP+ cells were sequentially gated 
for size, singlets, DAPI-, CD45.2-, and EpCAM+. 
  
Gene expression analysis 
RNA from full-thickness ileum was isolated by Trizol (Invitrogen) extraction 
followed by the RNeasy Mini kit (Qiagen) with DNAseI treatment. RNA from 
crypts was directly processed with the RNeasy Mini kit. cDNA was reverse 
transcribed with the iScript cDNA synthesis kit (BioRad) using 1µg of total RNA. 
Quantitative RT-PCR was performed as described21 with the primers listed in 
Supplementary Table 2-2. Assays were run in triplicate and normalized to 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as an internal control.  
 
Statistical analyses 
All experiments were performed with 3-6 biological replicates per group unless 
otherwise noted. Quantitative data are presented as mean + SEM, with all 
experimental groups normalized to time-matched tamoxifen-treated controls. 
Comparisons between two groups were conducted with unpaired two-tailed 
Student t tests. Comparisons between 3 or more groups were analyzed by one-
way ANOVA with Tukey’s or Dunett’s post-tests as noted. Significance is 
reported as * (P<0.05), **(P<0.01), ***(P<0.001), and ****(P<0.0001). Prism 
software (Graphpad) was used for statistical analyses. 
 
2.4: RESULTS 
Weight loss and secretory cell hyperplasia in N1-deleted intestine 
 To conditionally delete N1 in the intestinal epithelium, we crossed the 
N1F/F 15 allele to the tamoxifen-regulated Villin-CreERT2 19. After tamoxifen 
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treatment Villin-CreERT2; N1F/F (N1Δ/Δ) mice transiently lost weight with a nadir 
(92% of initial weight) occurring at day 8 (Figure 2-1A). Although N1Δ/Δ animals 
began to gain weight after day 8, they remained significantly lighter than controls 
until day 35.  
 As increased secretory cell differentiation is a hallmark of Notch inhibition, 
we assessed secretory cell populations in N1Δ/Δ intestines to determine if single 
receptor deletion was sufficient to induce aberrant secretory cell differentiation. 
PAS/AB staining for mucin-containing cells revealed a striking increase in goblet 
cell abundance in the N1Δ/Δ terminal ileum (Figure 2-1) and all other regions of 
the intestine (Supplementary Figure 2-1) one day after completion of tamoxifen 
treatment. To determine if the abnormal goblet cell differentiation was 
maintained long-term, we analyzed N1Δ/Δ animals on days 8, 19, and 60 after the 
start of tamoxifen induction. Interestingly, while goblet cell hyperplasia was 
observed in over 80% of crypts on day 8, the number of aberrant crypts 
significantly declined at later timepoints (Figure 2-1, Supplementary Figure 2-1). 
By day 60, only 6% of crypts still maintained evidence of goblet cell hyperplasia 
(Figure 2-1F), consistent with the stabilization of N1Δ/Δ weights (Figure 2-1A). 
 To investigate if other secretory cell types were increased in N1Δ/Δ mice, 
we stained for the Paneth cell marker MMP7. There was a marked increase in 
MMP7 staining (Supplementary Figure 2-2), as well as the presence of 
MUC2/MMP7 co-stained cells. MUC2 is a marker of goblet cells, and co-staining 
of the two markers indicates the presence of intermediate cells, a cell type that is 
also observed in pharmacological pan-Notch inhibition4. This finding was most 
striking in the colon, where only rare co-staining cells were observed in control 
tissue (Figure 2-1H, arrow). N1Δ/Δ colon, in contrast, contained abundant 
MUC2/MMP7 co-stained cells, which persisted for more than 60 days (Figure 2-
1I).  
 Analysis of secretory cell transcription factors and differentiated cell 
mRNA paralleled the observed secretory cell hyperplasia in the N1Δ/Δ intestine as 
well as the time-dependent phenotype regression (Figure 2-2). Atoh1, which 
drives the differentiation of all secretory cell types22, 23, was increased 3.3-fold on  
Figure 2-1. Intestinal epithelial N1 deletion leads to weight loss and 
aberrant secretory cell differentiation. (A) Weight curve of control and 
Villin-CreERT2; N1F/F (N1Δ/Δ) animals treated with 5 days of 100mg/kg tamoxifen. 
Bar represents duration of tamoxifen (TAM) treatment. Weights are compared 
with student t tests. (B-F) PAS/AB stained goblet cells in control (B) or N1Δ/Δ 
ileum (C-F) at the time points indicated. (G) Quantification of ileal goblet cell 
hyperplasia. Data are presented as percent total crypts and analyzed by ordinary 
one-way ANOVA with Tukey’s multiple comparisons test. (H-I) Colon sections are 
immunostained for goblet cell marker MUC2 (green) and Paneth cell marker 
MMP7 (red) from control (H) and N1Δ/Δ (I) animals 60 days after tamoxifen 
treatment. White arrowhead marks a single co-staining cell. N = 3-6 animals for 
all groups. Scale bar = 100μm.
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day 8. Ngn3 which is expressed in early endocrine cell precursors24 was likewise 
increased 2.7-fold at this time point. Expression of these factors returned to 
baseline by day 60. Spdef, which is important for the terminal differentiation of 
goblet and Paneth cells25,26, remained amplified 2.4-fold on day 60 (Figure 2-2C), 
consistent with the persistent expression of Paneth cell markers. Expression of 
Muc2 and CgA, markers of differentiated goblet and endocrine cells, respectively, 
peaked at day 8 and normalized by day 60. Similar to Spdef, Mmp7 expression 
remained elevated 1.7-fold on day 60, in agreement with the sustained MMP7 
staining (Figure 2-2F). These results suggest that N1 deletion promotes the 
formation of all secretory cell lineages. Differentiated goblet and endocrine cells 
are transiently increased after N1 deletion while increased Paneth cell markers, 
presumably expressed in Paneth/goblet intermediate cells, remained for at least 
2 months.  
 
Dynamic regulation of Notch ligands 
 Overexpression of Notch ligands is one mechanism that could account for 
epithelial recovery in N1Δ/Δ intestine. DLL1 and DLL4 have been shown to be the 
primary ligands regulating the intestinal stem and progenitor compartment7. To 
this effect, we analyzed transcript levels of Dll1 and Dll4 in N1Δ/Δ intestine. 
Expression of both ligands was elevated 2.6-fold compared to control on day 8 
(Figure 2-2G-H).  
 To determine whether the changes in Dll1 and Dll4 expression were 
directly linked to Notch signal, we took advantage of a Notch activation model. 
Previous use of such models has demonstrated the positive regulation of Hes13 
and Olfm44 as well as the negative regulation of Atoh1 and Ngn33. For our 
experiment, we crossed Villin-CreERT2 to Rosa26-LSL-NICD-IRES-nGFP17, 
which results in overexpression of stabilized N1 intracellular domain (NICD). 
Pan-epithelial activation of NICD leads to an immediate increase in epithelial 
proliferation, decreased secretory cell abundance, as well as decreased 
absorptive cell number (Supplementary Figure 2-3). Essentially, Notch activation 
transforms the intestinal epithelium into undifferentiated proliferative cells, rather 
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than absorptive cells as previously suggested1. In NICD-activated samples, both 
Dll1 and Dll4 expression was significantly decreased, mirroring the findings in the 
N1Δ/Δ intestine (Supplementary Figure 2-3J-K).  
 Importantly, the overexpression of Dll1 and Dll4 in N1Δ/Δ animals subsided 
over time, similar to the secretory cell markers discussed above, suggesting that 
the ligands are expressed on the aberrant secretory cells, and that increased 
ligand presentation is limited to the secretory cell expansion period.  
 
N1-deletion does not lead to intestinal epithelial proliferation changes 
 In addition to secretory cell differentiation, Notch signaling controls 
intestinal epithelial proliferation1, 3, 5. Thus, we analyzed whether intestinal 
epithelial deletion of N1 alone led to a proliferative defect. Interestingly, N1Δ/Δ 
intestine showed no decrease in proliferation at any time point as measured by 
morphometric counting of EdU+ cells (not shown). Flow cytometry for epithelial 
EdU+ cells also showed no change at 6 days after initiation of tamoxifen 
treatment (Supplementary Figure 2-4). 
 
Loss of CBC stem cells in N1 deletion 
 We have previously shown that Notch signaling is critical for maintenance 
of the LGR5+ crypt base columnar (CBC) stem cell population4, and thus 
questioned whether the secretory cell changes in the N1Δ/Δ intestine were 
coupled with altered stem cell homeostasis.  To address this, we first analyzed 
mRNA transcripts of the CBC markers Lgr5 and Olfm4. Expression of both genes 
was markedly depleted in the N1Δ/Δ intestine (not shown).  
 To further validate the N1-dependence of CBC stem cells, we crossed the 
Villin-CreERT2; N1F/F mice to Lgr5-GFP 20 to allow visualization of LGR5+ stem  
cells by GFP expression. In this experiment, control animals were tamoxifen-
treated Lgr5-GFP mice with wild type N1 alleles. After tamoxifen induction, we 
noted that the N1Δ/Δ mice appeared to have fewer GFP+ cells (data not shown). 
To quantify this change we employed flow cytometry on single cells isolated from 
N1Δ/Δ and control crypts. As there is a gradient of GFP expression in Lgr5-GFP 
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crypts27 (Figure 2-3A), we gated for GFPHI cells to explicitly measure changes in 
LGR5+ CBCs (Figure 2-3C-D). In controls, 30% of total GFP+ cells were GFPHI, 
while N1Δ/Δ mice retained only 14% GFPHI cells, a 53% reduction from baseline. 
 
Quiescent stem cell markers are not directly regulated by Notch 
 To determine if stem cell depletion was specific to CBC stem cells, or if it 
was generalizable to proposed quiescent stem cell (QSC) populations, we 
assessed mRNA transcript levels of Bmi1, Lrig1, and Hopx. While we observed 
no change in Bmi1 or Lrig1 transcripts, there was a 2.3-fold increase in Hopx 
expression in N1Δ/Δ intestine (Supplementary Figure 2-5). To our knowledge 
there is no established association between Hopx and Notch signaling, and 
indeed we saw no change in any of these markers in NICD activated tissues. 
   
N1 is required for post-irradiation recovery 
 Since N1 deletion results in changes in both differentiated and CBC stem 
cell populations, we investigated whether loss of N1 also limits intestinal repair 
functions. To assess this, we treated control and N1Δ/Δ animals with tamoxifen 
and then administered 12Gy of whole body irradiation. The N1Δ/Δ group quickly 
lost weight and had to be euthanized 3 days post-irradiation (Figure 2-4). It 
should be noted that while the control group also lost weight, a parallel 
experiment demonstrated that 12 Gy-irradiated control mice survive at least 8 
days post-irradiation before succumbing to bone marrow insufficiency (data not 
shown). PAS/AB staining showed increased goblet cells in the N1Δ/Δ group 
(Figure 2-4C), consistent with the phenotype observed in non-irradiated animals 
at this time point (Figure 2-1D). Normal intestine experiences a proliferative 
surge 3 days post-irradiation as part of the recovery response. This surge is  
mainly attributed to the expansion of QSC populations, as the majority of CBCs 
are destroyed by irradiation28-30. To evaluate this, we analyzed EdU incorporation 
in control and N1Δ/Δ intestine. While control animals did display a visible increase 
in number of EdU+ cells compared to non-irradiated intestine, the N1Δ/Δ tissue 
was almost completely devoid of proliferative cells. The CBC compartment is not  
Figure 2-3. LGR5+ stem cells are depleted with N1 deletion. (A) Lgr5-GFP+ 
crypt shows a gradient of GFP expression which is highest in the CBCs. (B) 
Control and Villin-CreERT2; Lgr5-GFP; N1F/F animals were injected with 
100mg/kg tamoxifen daily for 5 days and harvested on day 6. (C-D) Scatter plots 
of GFP expression in single, live, CD45.2- EpCAM+ crypt epithelial cells in 
control (C) and N1Δ/Δ (D) animals. Gates indicate GFPHI populations and GFPTOTAL 
populations. (E) Quantification of GFPHI cells. Data are presented as percentage 
of GFPTOTAL cells. N = 3-4 animals/group.
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CBC markers Lgr5 and Olfm4 in nontransgenic control mice treated with 0 or 12 
Gy whole body irradiation. Scale bar =100μm.
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expected to recover before approximately 1 week post-irradiation29. In fact, 
expression of CBC markers Lgr5 and Olfm4 do not recover until 8 days post-
exposure to 12Gy (Figure 2-4F-G). Thus the failed proliferation in irradiated N1Δ/Δ 
intestine is likely independent from the loss of CBCs discussed above. Although 
N1 deletion did not directly deplete QSC markers in non-irradiated tissue, the 
absence of N1 receptor may inhibit QSC activation when challenged with injury. 
 
N2-deleted intestine shows no change in differentiation  
 Since our N1Δ/Δ results identified previously unrecognized phenotypes of 
intestinal epithelial N1 deletion, we analyzed N2 deletion to determine if loss of 
this receptor led to any unappreciated epithelial changes as well. To achieve 
specific intestinal epithelial deletion we crossed Villin-CreERT2 to the N2F/F 16 
allele. In contrast to N1Δ/Δ, tamoxifen-treated Villin-CreERT2; N2F/F (N2Δ/Δ) 
animals did not lose any weight post-treatment (data not shown), and no goblet 
cell changes were evident in N2Δ/Δ intestine (Figure 2-5). Furthermore, no 
transcriptional changes were observed in any secretory cell transcription factors, 
differentiated cell markers, Notch ligands, or stem cell markers. 
 
Cooperation of N1 and N2 receptors  
 Although N2-deleted intestine had no overt phenotype on its own, double 
deletion of N1 and N2 receptors is known to be lethal. Since N1Δ/Δ animals 
survived and partially recovered, we aimed to compare the extent of the N1Δ/Δ 
secretory cell phenotype with full Notch receptor deletion. Indeed N1Δ/Δ;N2Δ/Δ 
animals had a more profound goblet cell hyperplasia compared to N1Δ/Δ alone 
(Figure 2-6). Secretory cell transcription factors and differentiated markers were 
significantly higher in N1Δ/Δ;N2Δ/Δ compared to the N1Δ/Δ animals. This suggests  
that N1 and N2 function synergistically rather than redundantly to regulate 
epithelial differentiation. 
 To better understand this relationship, we assessed whether N2 deletion 
sensitized the intestine to partial loss of N1. For this, we analyzed N1Δ/+;N2Δ/Δ 
animals. Interestingly, while we found that the secretory cell response was only  
Figure 2-5. N2 deletion in the intestinal epithelium does not result in 
secretory cell changes. Control or Villin-CreERT2; N2F/F animals were treated 
with 100mg/kg tamoxifen daily for 5 days (N2Δ/Δ) and harvested on day 6. (A-B) 
PAS/AB staining for goblet cells in control (A) and N2Δ/Δ (B) intestine. No marked 
increases in goblet cells were observed in the N2Δ/Δ animals. (C) qRT-PCR 
analysis of secretory transcription factors (purple), differentiated secretory cell 
markers (blue), Notch ligands (yellow) and stem cell markers (orange). Data are 
presented as mRNA fold-change compared to control, which was normalized to 1 
(dashed line). No significant changes were observed for any marker gene. 
(Ngn3, P=0.1364; Mmp7, P=0.1760). N = 3-6. Scale bar =100μm.
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Figure 2-6. Synergistic and redundant functions of N1 and N2 in the 
intestinal epithelium. (A) All animals were injected with 100mg/kg tamoxifen 
daily for 5 days and harvested on day 6. (B-E) PAS/AB staining for goblet cells in 
control (B), N1Δ/Δ (C), N1Δ/+; N2Δ/Δ  (D), N1Δ/Δ; N2Δ/Δ (E) ileum. (F-G) Quantitative 
RT-PCR analysis for secretory cell transcription factors (F) and differentiated 
secretory cell markers (G) in all groups. (H-K) Representative images of ileal 
proliferation as visualized by EdU uptake in all groups. (L) Quantification of 
proliferative cells. Data are presented as average EdU+ cells/crypt. Control group 
is pooled day 6 and day 8 controls, which were shown to the same. (M) 
Quantitative RT-PCR analysis for CBC stem cell markers in all groups. 
Quantitative data are compared with ordinary one-way ANOVA and Dunnett’s 
post-test. N = 3-5 animals/group. Scale bar =100μm.
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mildly more severe than N1Δ/Δ (Figure 2-6C, D), expression of secretory cell 
transcription factors was significantly increased in this group compared to N1Δ/Δ 
alone.  
 One crucial component of Notch epithelial regulation that was not 
appreciated in the N1Δ/Δ samples was disruption of overall epithelial proliferation. 
Interestingly, N1Δ/+;N2Δ/Δ intestine also showed no change in proliferation (Figure 
2-6J, L). Only full Notch receptor deletion resulted in decreased proliferation, 
suggesting that N1 and N2 function fully redundantly for this process. 
 Finally, we compared transcript levels of Olfm4 and Lgr5 in all three 
groups. Interestingly, while N1Δ/Δ;N2Δ/Δ animals had the highest suppression of 
CBC markers, N1Δ/Δ had a greater depletion of transcript levels than N1Δ/+;N2Δ/Δ 
(Figure 2-6M). This indicates N1 is the primary receptor functioning in this stem 
cell population. 
 
2.5 DISCUSSION 
 We present here evidence that the N1 receptor plays an important role in 
intestinal epithelial cell fate and stem cell maintenance. Epithelial deletion of N1 
results in a transient secretory cell hyperplasia, with overproduction of all 
secretory cell types. Overexpression of goblet and endocrine cell markers 
resolve by 2 months after N1 deletion, but Paneth cell markers and the presence 
of Paneth/goblet intermediate cells persist in N1Δ/Δ animals. Additionally, our 
study used the Lgr5-GFP mouse model in combination with N1 deletion to show 
that loss of N1 very acutely impacts CBC stem cell homeostasis. Furthermore, 
N1 deletion renders the intestine highly susceptible to irradiation injury, such that 
N1Δ/Δ animals die 3 days post-irradiation. Finally, our results further clarify the 
relationship between N1 and N2. We validate previous work that showed 
intestinal epithelial N2 deletion showed no obvious phenotype6, and report new 
evidence that N1 and N2 work redundantly to regulate proliferation, but work 
synergistically in regulating differentiated cell fate. 
 Previous studies implicated that N1 is important for stem cells since its 
expression was found to be highest in CBCs compared to other crypt cells31, 32.  
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Additionally, N1-expressing cells11 as well as cells undergoing active N1 cell-
surface cleavage33 have been shown to lineage trace, the gold-standard for 
defining stem cells in vivo. To our knowledge, though, only one other study has 
investigated the function of N1 in intestinal stem cells. Vooijs et al.33 used a 
chimeric N1 deletion mouse model to conclude that while N1 was active in stem 
cells, it was not required for stem cell maintenance since LacZ expression from 
deleted cells was still observed in adult chimeras. Our results are not in direct 
conflict with this study, as the sheer presence of crypts with goblet cell 
hyperplasia after 60 days demonstrates that at least some N1-deficient stem 
cells have survived. Indeed, we did not observe a complete loss of Lgr5 
transcript or LGR5-GFPHI stem cells in N1Δ/Δ intestine.  Rather, our data favors a 
model where N1-deficient stem cells are at a great disadvantage compared to 
normal stem cells. N1-deficient stem cells can survive if necessary, but this is the 
exception, not the rule. 
 Our study is the first to show the dynamic regulation of N1 deletion, as the 
epithelium almost completely normalizes within 2 months. This finding could be 
due to compensation for N1 loss by another Notch receptor or by competition 
with non-recombined cells. The N1 deletion efficiency in our tissues started at 
95% (data not shown), and since N1Δ/Δ stem cells are at a disadvantage, they 
could conceivably be outcompeted by neighboring unrecombined cells. This 
would lead to a patchy recovery over time as observed in both our N1 deletion 
time course as Rbpj partial deletion model (Supplementary Figure 2-6). 
 Although goblet and endocrine cell populations subsided during the period 
analyzed, Paneth cell markers continued to be expressed. While it is agreed that 
Paneth cells are much longer lived than other differentiated intestinal epithelial 
cells, the exact length of the Paneth cell lifespan is disputed, with estimates from 
18-60 days 34, 35. Interestingly, the Paneth cells produced in N1Δ/Δ animals co-
express goblet cell markers. The continued presence of these cells after 60 days 
suggests that once cells are specified as expressing both Paneth and goblet cell 
markers, that they do so for the duration of their life span. Of note, Dll1 and Dll4 
have both previously been shown to be expressed in Paneth cells36, 37 and Dll1 
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expression has additionally been demonstrated in secretory progenitors and to a 
lesser extent differentiated secretory cells37. Our results extend this finding to 
expression in Paneth/goblet intermediate cells as well.  
 Different approaches have been used to investigate the role of intestinal 
N1 in the past, but these published results are inconsistent. While our study 
bolsters the secretory cell findings reported with N1-inhibitory antibody 
treatment12 and chimeric N1-deleted intestine33, another study using the same 
model system we have employed in our experiments found that Villin-CreERT2; 
N1Δ/Δ mice had no phenotype14. Since this study used juvenile mice, we 
questioned whether the role of N1 in regulating differentiated cell populations 
was specific to fully mature intestine. When we repeated our experiment in 
juvenile mice, secretory hyperplasia was evident (Supplementary Figure 2-7). 
Thus we conclude that the differences between the previously published report 
and our own data may be due to tamoxifen treatment concentrations and chase 
times post-treatment, which were not made clear in the previous study, or 
variation in recombination frequencies due to using different floxed-N1 and N2 
lines.  
  Finally, we previously discovered that N1-inhibitory antibody-treated 
animals were susceptible to irradiation injury13. Because the antibody was 
administered systemically, however, it was not clear if the intestinal epithelial cell 
findings were the primary cause of animal death, or it was a secondary 
phenotype produced from an off-target pathology like vasculopathy.  Since N1 
deletion in the current study was limited to intestinal epithelial cells, we have 
strong evidence that intestinal N1 is required for injury response. The 
significance of this finding is self-evident. Since Notch receptors are promising 
pharmacological targets for cancer treatment and most successful therapeutic 
schemes are combined with injury-inducing chemotherapies or radiation, dual 
treatment with N1 inhibition could be deleterious. 
 In conclusion, N1 receptor plays a primary role in regulating intestinal 
epithelial cell fate and stem cell maintenance. Genetic deletion of the receptor 
leads to eventual epithelial recovery, but targeted inhibition of N1 should be 
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handled with caution due to the important role this receptor plays in intestinal 
epithelial homeostasis. 
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Supplementary Table 2-1. 
Allele Forward primer sequence Reverse primer sequence
Villin-CreERT2 ACAGGCACTAAGGGAGCCAATG GTTCTTGCGAACCTCATCACT
Lgr5-GFP CTGCTCTCTGCTCCCAGTCT GAACTTCAGGGTCAGCTTGC
Floxed-N1 CCAACTGCACTCTTCTCCCAGTAATCGAAG
TGCCTCAGTTCAAACACAAGATA
CGAGGGG
Floxed-N2 ACCCTGTCAGAAAGTTGGCTGGTCAGGTTT
TAGAGGACGCACTGACTGCTCA
TCTGACAA
Rosa-LSL-NICD AAAGTCGCTCTGAGTTGTTAT GAAAGACCGCGAAGAGTTTG
Floxed-Rbpj CTTGATAATTCTGTAAAGAGA ACATTGCATTTTCACATAAAAAAGC
Genotyping primer sequences
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Supplementary Table 2-2. 
Primer sequences for genes analyzed by quantitative RT-PCR
Gene Forward primer sequence Reverse primer sequence
Ascl2 CCTCTCTCGGACCCTCTCTCAG CAGTCAAGGTGTGCTTCCATGC
Atoh1 GCCTTGCCGGACTCGCTTCTC TCTGTGCCATCATCGCTGTTAGGG
Bmi1 TATAACTGATGATGAGATAATAAGC CTGGAAAGTATTGGGTATGTC
CgA AAGAAGAGGAGGAGGAAGAGG TCCATCCACTGCCTGAGAG
Dll1 CTGAGGTGTAAGATGGAAGCG CAACTGTCCATAGTGCAATGG
Dll4 TCGTCGTCAGGGACAAGAATAGC CTCGTCTGTTCGCCAAATCTTACC
Hopx GAGGACCAGGTGGAGATCCT TCCGTAACAGATCTGCATTCC
Lgr5 CGAGCCTTACAGAGCCTGATACC TTGCCGTCGTCTTTATTCCATTGG
Lrig1 GTGAACAGTGGCTCCCTCTATGG ACTCCGCTAGACTCTCCTCATCC
Mmp7 CAGACTTACCTCGGATCGTAGTGG GTTCACTCCTGCGTCCTCACC
Muc2 AGAACGATGCCTACACCAAG CATTGAAGTCCCCGCAGAG
Ngn3 ACCCTATCCACTGCTGCTTGTC CGGGAAAAGGTTGTTGTGTCTCTG
Olfm4 GCCACTTTCCAATTTCAC GAGCCTCTTCTCATACAC
Spdef GGACGGACGACTCTTCTGACAG GCTCCTGATGCTGCCTTCTCC
Supplementary Figure 2-1. N1 deletion in the intestinal epithelium results 
in increased goblet cells throughout the intestine. (A-H) PAS/AB staining 
for goblet cells is shown for control (A-D) and N1Δ/Δ (E-H) tissue harvested on 
day 6 after initiating tamoxifen treatment. Representative paraffin sections are 
shown from duodenum (A, E), jejunum (B, F), ileum (C, G), and proximal colon 
(D, H). Goblet cell hyperplasia is observed in all segments of N1Δ/Δ intestine. (I) 
Quantification of goblet cell hyperplasia in the duodenum shows phenotype 
regression over time with similar kinetics as observed in the ileum (see Figure 
2-1). Data are presented as percent total crypts and compared using one-way 
ANOVA with Tukey’s multiple comparisons test. N = 4. Scale bar =100μm.
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Supplementary Figure 2-2. Paneth cells are increased with N1 deletion. 
(A-B) MMP7 staining for Paneth cells in control (A) and N1Δ/Δ (B) duodenum on 
day 19 after the start of tamoxifen induction. Increased numbers MMP7+ cells as 
well as expansion of the zone of cellular localization is observed in N1Δ/Δ 
intestine. Duodenum is displayed since the change is especially striking in 
proximal intestine where there are normally few Paneth cells, although 
increased MMP7 staining was observed in all parts of the intestine. N = 6. Scale 
bar =100μm.
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Supplementary Figure 2-3. NICD overexpression results in production of 
undifferentiated proliferative cells. Control or Villin-CreERT2; Rosa-LSL-NICD 
mice were treated with 5 days of 100mg/kg tamoxifen and tissues were 
harvested on day 6. (A-C) Proliferation in control and NICD ileum as visualized 
by Ki67 immunostaining and quantified in (C). Data are presented as average 
number of Ki67+ cells per crypt. A significant increase in proliferative cells was 
observed in NICD intestine. (D-E) PAS/AB staining for goblet cells in control and 
NICD ileum. Goblet cell number was significantly decreased in NICD intestine. 
(quantification not shown). (F) Expression of the goblet cell marker Muc2 was 
also decreased in NICD animals. (G-H) Alkaline Phosphatase (A/P) staining for 
brush border enzymes marks enterocytes. A/P+ surface area is greatly 
decreased in NICD animals. (I) Expression of the enterocyte marker sucrose 
isomaltase (SI) is also significantly decreased in NICD intestine.  (J-K) 
Expression of Notch ligands Dll1 and Dll4 are decreased in NICD intestine. 
Comparisons were made with Student’s t test. Scale bar =100μm. Data in 
collaboration with Nichole Zayan.
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Supplementary Figure 2-4. No change in proliferation is observed in N1Δ/Δ  
intestine. Singly isolated control and N1Δ/Δ  epithelial cells were assessed for 
proliferation via EdU incoroporation and flow cytometry analysis. No change in 
proliferation was observed. Data are presented as % total EpCAM+ cells that 
were Edu+. N = 4 animals/group. 
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Supplementary Figure 2-5. Quiescent stem cell markers are not 
Notch-regulated. (A-F) Quantitative RT-PCR analysis of quiescent stem cell 
markers in N1Δ/Δ (A-C) or NICD-overexpressing (D-F) intestine. RNA was isolated 
from full-thickness ileum. N = 3-4 animals/group.
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Supplementary Figure 2-6. Complete blockade of Notch signaling by Rbpj 
deletion results in goblet cell hyperplasia that normalizes over time. (A) 
Villin-CreERT2; RbpjF/F mice were treated with two doses of 100mg/kg tamoxifen 
and tissues were harvested on day 7, 9, and 14.  (B-G) PAS/AB staining for 
goblet cells in duodenum (B-D) and ileum (E-G) at the time points indicated. 
Arrows indicate patches of villi that lack goblet cells. Arrowheads denote crypts 
that maintain goblet cell hyperplasia. N=1 per time point. Scale bar =100μm.
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Supplementary Figure 2-7. N1 deletion in juvenile mice has a mild but 
apparent secretory cell phenotype. (A) 10-day old control or Villin-CreERT2; 
N1F/F animals were treated with 100mg/kg tamoxifen for 5 days and tissues were 
harvested on day 6. (B-E) PAS/AB staining for goblet cells in control (B, D) and 
N1Δ/Δ (C,E) intestine. Increased goblet cell abundance is observed in both 
duodenum (C) and ileum (E) of juvenile N1Δ/Δ intestine. Interestingly N1Δ/Δ mice 
also appear to have more developed crypts than controls, which may be due to 
the altered differentiation program. N=1 control, 2 N1Δ/Δ. Scale bar =100μm.
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CHAPTER 3 
 
 
NOTCH REGULATION OF STEM CELL DYNAMICS 
 
 
 
3.1: SUMMARY 
 The Notch signaling pathway is an important regulator of intestinal stem 
and progenitor cells.  It has been previously shown that chronic blockade of 
Notch signaling leads to a marked reduction of proliferation, increased secretory 
cell formation, and decreased stem cell number. In this study, we show that 
acute inhibition of Notch signaling results in an unexpected increase in 
proliferation while maintaining robust secretory cell changes.  Transient blockade 
of Notch is sufficient to rapidly decrease the expression of the Notch-specific 
stem cell marker Olfm4, indicating that the stem cell compartment is targeted. 
Additionally, flow cytometry for GFP in Lgr5-GFP mice shows a shift from GFPHI 
to GFPINT, suggesting that loss of stem cells is due to flow from the stem cell 
compartment to the transit-amplifying (TA) cell compartment. Compartmental 
modeling of the intestinal crypt was used to test the hypothesis that symmetric 
division of stem cells into TA cells could account for the increased proliferation 
observed with acute DBZ treatment. Modeling supported the symmetric division 
hypothesis in the context of a Notch-regulated repopulation of the stem cell 
compartment. Acute DBZ in the post-irradiation setting suggests that Notch 
regulates repopulation by allowing crypt base columnar stem cell specification 
rather than directly regulating quiescent stem cell populations. 
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3.2: INTRODUCTION 
 The intestinal epithelium is one of the most rapidly renewing tissues in the 
human body, with an estimated 17 billion cells turning over each day1. This 
startling replenishment rate is fueled by highly active stem and progenitor cell 
compartments. Historically, a single population of intestinal stem cells (ISCs) was 
thought to direct this renewal. ISCs divide once per day, leading to both stem cell 
self-renewal as well as delivering cells to the transit-amplifying (TA) cell 
compartment2. TA cells subsequently divide approximately every 12 hours, 
undergoing several rounds of division, greatly augmenting the number of cells in 
the crypt3-5. Regulated differentiation of TA cells results in the formation of 
mature, differentiated intestinal cells: either absorptive enterocytes, the most 
common cell in the epithelium, or one of several secretory cell populations, 
including mucin-secreting goblet cells, hormone-secreting enteroendocrine cells, 
and antimicrobial peptide-secreting Paneth cells6.  
 The location and identity of the ISC has been debated for decades, with 
some favoring the crypt base columnar cell (CBCC) intercalated between the 
Paneth cells at the base of the crypt7, and others supporting the “+4 cell”, cells 
located on average 4 cells above the base of the crypt2, 3. A number of recent 
discoveries suggest that perhaps both of these populations are bona-fide ISCs. 
First, LGR5+ CBCCs were shown to actively cycle and produce all of the 
differentiated populations of the intestine in vivo8 and in vitro9. Second, several 
+4 cell markers (Bmi110, Lrig111, Hopx12, mTert13, and others) were discovered, 
and cells expressing these markers were shown to be capable of producing all 
types of mature intestinal epithelial cells. The +4 cells cycle much less frequently 
than CBCCs10-13 and are thus thought to represent quiescent stem cells (QSCs), 
which can replace CBCCs during times of injury and repair12, 14, 15. To further 
complicate this system, TA cells have also been shown to possess potential stem 
cell function during times of injury3, 16, 17 and QSCs markers have been shown to 
overlap with CBCCs as well as being diffusely expressed throughout the crypt18. 
 The Notch signaling pathway is one of many pathways crucial for intestinal 
epithelial homeostasis: regulating proliferation, differentiation and stem cell 
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maintenance19-24. Notch regulation of intestinal proliferation has been shown 
through both pathway activation and inhibition, as blocking Notch reduces 
proliferation21, 25 and Notch overactivation results in increased proliferating cell 
numbers20, 22. Notch is required for specification of enterocytes, as 
pharmacologic inhibition or genetic deletion of pathway components leads to a 
profound secretory cell hyperplasia19, 21, 23, 24. Finally, both pharmacological Notch 
inhibition as well as deletion of the Notch ligands Dll1 and Dll4 result in loss of 
CBCC stem cells19, 24. Although Notch inhibition showed reduced stem cell 
proliferation and function19, the mechanism behind these findings was unknown. 
 One of the functions of Notch signaling in stem cells in other tissues has 
been regulation of stem cell division asymmetry26. Asymmetric cell division 
occurs when the daughter cells of a division event assume different fates, i.e. 
one stem cell and one TA cell. This process is believed to be mediated by 
asymmetric inheritance of the Notch signaling pathway inhibitor NUMB in 
daughter cells26-28. The daughter cell that inherits NUMB turns Notch signaling off 
and becomes a TA cells, and the daughter that does not inherit NUMB continues 
to have active Notch signaling and remains a stem cell26-28. Studies in the 
Drosophila midgut29 and in human colon cancer cell lines30 suggest that NUMB 
might also function to inhibit Notch signaling in the intestine. The concept of 
NUMB-mediated asymmetric stem cell division in the intestine, however, has 
been contested by studies on neutral drift theory, the property that intestinal 
crypts become monoclonal over time31, 32. These reports contend that CBCC 
division does not occur asymmetrically, but rather symmetrically, forming two 
cells that are both capable of becoming either stem or TA cells31, 32. If this is the 
case, the role for Notch in regulating CBCCs remains unknown. 
 This study aims to further understand Notch intestinal epithelial function, 
specifically addressing the question how does Notch regulate CBCC 
maintenance? Combining in vivo experimentation with in silico modeling 
techniques, we provide evidence for a role for Notch in regulating CBCC-TA cell 
dynamics. We further probe the function of Notch in regulating QSC-CBCC 
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dynamics and determine that Notch functions permissively for CBCC 
specification.  
 
 
 3.3: MATERIALS AND METHODS 
Mice 
Floxed-Rbpjκ (RbpjF/F)33 (gift from T. Honjo), Villin-CreERT2 34 (gift from S. 
Robine), Bmi1-CreER10 (Jackson Lab, no. 010531) and Lgr5-GFP-IRES-CreERT2 
(Lgr5-GFP)8 (Jackson Lab, no. 008875) alleles were verified by PCR genotyping 
with the primers listed in Supplementary Table 3-1.  All crosses were maintained 
on a C57BL/6 strain background except Bmi1 crosses, which were on a mixed 
strain. Mice were housed in ventilated and automated watering cages with a 12-
hour light cycle under specific pathogen-free conditions. Protocols for mouse 
usage were approved by the University of Michigan Committee on Use and Care 
of Animals. 
 
Animal treatment protocols and tissue collection 
Mice were injected intraperitoneally with 30µmol/kg Dibenzazepine (DBZ)21 
(SYNCOM) for 1-5 days and tissue was harvested at the time points indicated. 
Mice in experiments using Bmi1-CreER were treated with 100mg/kg tamoxifen 
(Sigma) intraperitoneally or by oral gavage once per day for 5-8 days as noted. 
To induce intestinal injury, animals were exposed to one dose of 12Gy whole 
body irradiation from a 137Cs source. Animals were fasted overnight and injected 
intraperitoneally with 25 mg/kg 5-ethynyl-2´-deoxyuridine (EdU) (Life 
Technologies) 2 hours prior to tissue collection. Intestinal tissue was harvested 
and fixed in 4% paraformaldehyde overnight as previously described19.  Tissue 
prepared for frozen sections was fixed in 4% PFA for 1 hour and incubated in 
30% sucrose overnight before embedding in OCT (Tissue-Tek). 
 
 105 
Immunohistochemistry 
Paraffin sections (5µm) were stained with Periodic acid Schiff and Alcian Blue 
(PAS/AB) (Newcomer Supply) to visualize mucin-containing goblet cells. EdU-
Click-it (Life Technologies) was used to identify proliferating cells. 
Immunostaining with rat α-MMP7 (1:400, Vanderbilt Antibody and Protein 
Resource), rabbit α-MUC2 (1:200, Santa Cruz), goat α-CGA (1:10, Santa Cruz) 
and rabbit α-Ki67 (1:200, Thermo) was performed as described35.  GFP 
transgene expression was visualized on 5µm frozen sections. Images were 
captured on a Nikon E800 microscope with Olympus DP controller software.  
 
In Situ Hybridization 
Briefly, slides were deparaffinized, hydrated, and treated with 0.2N HCl for 15 
minutes at room temperature. Tissues were treated with Proteinase K for 30 
minutes at 37°C, post-fixed in 4% PFA for 10 minutes, acetylated for 10 minutes, 
incubated with hybridization buffer for 1 hour, then with Olfm4 probe diluted in 
hybridization buffer at 68°C overnight. The next day tissues were washed, 
incubated in blocking solution for 1 hour, then with anti-DIG antibody (Roche) 
diluted in blocking solution overnight at 4°C. The next day slides were washed 
then developed with NBT/BCIP solution (Roche). 
 
Quantitative morphometric analyses 
Ki67 morphometrics were performed by counting the number of Ki67+ cells on 
both sides of well-oriented crypts. At least 10 crypts were counted per animal for 
all analyses, and counts were average per animal. EdU morphometrics on 
irradiated tissue was accomplished by counting Edu+ epithelial cells per crypt 
area as measured from the base of the crypt to the crypt villus junction. EdU 
counts were summed over 8-15 images and averaged over the entire measured 
tissue area. Nuclei per crypt were counted on both sides of well-oriented crypts 
on H+E images. Crypt depth measurements were performed on H+E images 
measuring from the crypt villus junction to the base of the crypt along the crypt 
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center.  Morphometric analyses were completed using ImageJ software 
(http://imagej.nih.gov/ij/). 
 
Crypt isolation and flow cytometry 
Crypt isolation for flow cytometry was from the jejunum, centimeters 9-15 as 
measured from the pylorus. Tissue was incubated in 15mM EDTA (Sigma) in 
DPBS (Gibco) at 4°C for 35 minutes, vortexed for 2 minutes, and filtered through 
a 70µm cell strainer (BD Bioscience). To obtain a single cell suspension for flow 
cytometry, crypts were resuspended in TrypLE Express (Gibco), shaken at 37°C 
for 10-12 minutes, and 0.1mg/ml DNase I (Roche) and 10% fetal bovine serum 
(FBS) were added. Cells were passed through a 40µm cell strainer (BD 
Bioscience), pelleted at 400xG, resuspended in 2% FBS, 0.05% sodium azide 
(Sigma), 2mM EDTA in DPBS and stained unfixed as follows. All cells were 
blocked with rat α-mouse CD16/CD32 (1:100, BD Bioscience), lymphocytes were 
excluded with CD45.2-PerCP-Cy5.5 (1:80, LifeTechnologies), epithelial cells 
were visualized with EpCAM-APC (1:80, eBioscience), and dead cells were 
excluded by DAPI incorporation. Cells were analyzed on a BD FACSCanto II and 
interpreted with FlowJo software (Treestar). GFP+ cells were sequentially gated 
for size, singlets, DAPI-, CD45.2-, and EpCAM+. 
  
Enteroid culture 
Purified crypts from the first 6cm of duodenum were instilled in Matrigel (BD 
Biosciences) overlaid with DMEM + GlutaMAX (LifeTechnologies) with 5% each 
Wnt3a36 and Rspo237 conditioned medias. Additional growth factors included 2% 
B27 (Invitrogen), 1% N2 (Invitrogen), 100ng/ml Noggin (Peprotech), 50 ng/ml 
EGF (R&D Systems), and 10 µM Y-27632 (Sigma, used for initial plating only). 
Enteroids were grown and passaged several times prior to assaying. For 
proliferation assays, enteroids were passaged at the indicated time and treated 
with 25µM DAPT in DMSO (EMD4Biosciences) or 100% DMSO as vehicle. 
Living enteroids were imaged with a Leica DMIRB Inverted Microscope and an 
Olympus DB30BW camera with Olympus DP Controller software. EdU was 
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introduced at 10nM for 2 hours prior to cell harvest. Experimental time points 
were completed in triplicate with quadruplicate wells pooled together as one 
replicate. Single cell isolation of enteroids was accomplished by resuspending 
the enteroids and Matrigel in 15mM EDTA in DPBS. Enteroids were pelleted and 
resuspended in 2ml TrypLE Express and incubated at 37°C for 2 minutes. 500ml 
of DMEM was added to each sample and enteroids were mechanically 
dissociated into single cells by pipetting 40 times. 5ml of additional DMEM was 
added to each sample, cells were pelleted, and washed with 1% BSA in DPBS. 
Staining for EdU was completed with the Click-it EdU flow cytometry kit 
(Invitrogen) as per manufacturer’s instructions.  
 
Gene expression analysis 
RNA from full-thickness ileum was isolated by Trizol (Invitrogen) extraction 
followed by the RNeasy Mini kit (Qiagen) with DNAseI treatment. RNA from 
crypts was directly processed with the RNeasy Mini kit. cDNA from full tissue and 
crypts was reverse transcribed with the iScript cDNA synthesis kit (BioRad) using 
1µg of total RNA. Quantitative RT-PCR was performed as described35 with the 
primers listed in Supplementary Table 3-2. Assays were run in triplicate and 
normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as an 
internal control.  
 
Statistical analyses 
All experiments were performed with 3-6 biological replicates per group unless 
otherwise noted. Quantitative data are presented as mean + SEM. Comparisons 
between two groups were conducted with unpaired two-tailed Student t tests. 
Comparisons between 3 or more groups were analyzed by one-way ANOVA with 
Dunett’s post-test. Significance is reported as * (P<0.05), **(P<0.01), 
***(P<0.001), and ****(P<0.0001). Prism software (Graphpad) was used for 
statistical analyses. 
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3.4: RESULTS 
Chronic Notch inhibition is lethal 
 Pharmacological intervention with the gamma-secretase complex inhibitor 
Dibenzazepine (DBZ) has been widely used to probe Notch function in the 
intestine. A common treatment regimen, 5 daily doses of DBZ (referred to as 
“chronic DBZ” hereafter), results in a profound secretory cell hyperplasia as well 
as decreased epithelial proliferation (Figure 3-1). Previously, our lab determined  
that chronic DBZ also led to lost CBCC number19, implicating Notch in the 
maintenance of this stem cell population. Both the mechanism of Notch-related 
CBCC loss as well as the possibility of CBCC recovery, however, remained 
unknown. To probe the question if epithelial recovery was possible after Notch 
inhibition, mice were treated with chronic DBZ and monitored over time. Chronic 
DBZ led to weight loss and rapid animal lethality; with all animals succumbing 3-4 
days post treatment (Figure 3-1D). PAS/AB staining for goblet cells at the time of 
animal death revealed that the secretory hyperplasia had not resolved, 
suggesting that epithelial recovery was not possible after sustained Notch 
inhibition.  
 
Acute DBZ results in increased intestinal epithelial proliferation 
 Since animals treated with chronic DBZ did not live long enough to 
investigate the dynamics of Notch restoration and epithelial recovery, a milder 
treatment regimen was implemented. With “acute DBZ” treatment, only a single 
dose of DBZ was administered to transiently inhibit Notch activity. Animals 
tolerated this treatment and survived at least 2 weeks with no apparent ill effects. 
To pinpoint the timing of inhibition and recovery, animals were harvested at 
numerous time points post acute DBZ treatment (Figure 3-2A). Tissues were first 
assessed for changes in intestinal epithelial proliferation. Although all previous 
studies associated Notch inhibition with decreased proliferation19, 21, 38, acute 
DBZ treatment surprisingly resulted in a marked increase in intestinal epithelial 
proliferation, as measured by immunostaining for the proliferation marker Ki67 
(Figure 3-2). Significant increases in Ki67+ cells were observed as early as 2  
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Figure 3-1. Chronic DBZ results in lethal secretory cell hyperplasia and 
reduced proliferation. (A) Animals were administered 5 daily doses of 30μ
mol/kg Dibenzazepine (DBZ) for “chronic DBZ” treatment. (B-C) Co-staining for 
proliferation (Ki67) and mucin-containing cells (AB) in vehicle- (B) or chronic 
DBZ-treated (C) intestine. Pink bars show expanded crypt depth, orange arrows 
mark Ki67+ nuclei in chronic DBZ intestine. (D) Weight curve of animals 
post-chronic DBZ treatment. Statistical comparisons were made by upaired 
Student t test. N = 4 animals per group. (E-F) PAS/AB staining for goblet cells in 
vehicle (E) or 3 days after chronic DBZ (F) treatment. Scale bar = 100μm. 
Figure 3-2. Acute DBZ leads to transiently increased intestinal epithelial 
proliferation and crypt expansion. (A) Animals treated with “acute DBZ” were 
administered one 30μmol/kg dose of DBZ and harvested at the time points 
indicated. (B-E) Proliferation was assessed by immunostaining for Ki67 in 
vehicle-treated (B) or acute DBZ-treated mice (C-E). (F) Quantification of Ki67 
staining. Data are presented as number of Ki67+ nuclei per ileal crypt compared 
with One-way ANOVA and Dunnett’s post-test. Crypt depth (G) and number of 
cells per crypt (H) were measured in vehicle and 3 days post-acute DBZ ileum. 
Comparisons for G-H were made with unpaired Student t tests. N= 3-6 animals 
per group. Scale bar = 100μm.
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days post-acute DBZ. The proliferative surge continued on days 3-5, with a 1.7 
fold increase in proliferating cells compared to vehicle-treated samples on day 3. 
Proliferation normalized by day 7. Increased proliferation was accompanied by 
crypt expansion, which was increased 1.8-fold on Day 3 (Figure 3-2G). Total 
cells per crypt was increased 1.6-fold as well, suggesting that crypt expansion 
was due to hyperplasia (Figure 3-2H).  
 
Acute DBZ leads to the production of long-lasting secretory progenitors 
 Since acute DBZ treatment resulted in an unexpected increase in 
proliferation in vivo, we probed other hallmarks of Notch inhibition to determine if 
the DBZ dosage scheme was effective in adequately blocking the pathway. 
Staining with PAS/AB showed a progressive increase in goblet cells after acute 
DBZ (Figure 3-3), consistent with the secretory cell hyperplasia observed with 
chronic DBZ treatment. Goblet cells were detected in both the villus and crypt 
regions and present in all parts of the intestine (Supplementary Figure 3-1).  
Additionally, CGA+ enteroendocrine cells were greatly increased at the base of 
acute DBZ-treated crypts (Figure 3-3F) as were cells co-expressing the Paneth 
and goblet cell markers MMP7 and MUC2 (Figure 3-3H). These co-staining cells 
were also previously observed with chronic DBZ treatment19. The increased 
abundance of all of these secretory cell markers suggests that committed 
secretory progenitors are formed with only very short interruptions in Notch 
signaling and that they persist for several days after Notch signaling is re-
established. 
 Interestingly, both the appearance and the resolution of the secretory cell 
hyperplasia aligned with the timing of the crypt hyperproliferation. Co-staining 
with the mucin-marker AB and Ki67 showed both markers occupying the same 
crypt location (Supplementary Figure 3-2), suggesting that the proliferating cells 
are secretory progenitors. These data are consistent with a recent publication 
that described increased abundance of Ki67+ ATOH1+ cells 38 hours after DBZ 
treatment, and determined that Notch inhibition led to the expansion of the 
proliferating secretory progenitor compartment39.  
Figure 3-3. Acute DBZ results in a transient multi-lineage secretory cell 
surge. (A-D) PAS/AB staining for goblet cells at the timepoints indicated. (E-F) 
CGA immunostaining for endocrine cells in vehicle (E) or 3 days post-acute 
DBZ treatment (F). (G-H) Co-immunostaining for goblet cell marker MUC2 and 
Paneth cell marker MMP7 in vehicle (G) or 3 days post-acute DBZ treatment 
(H). N = 3-6 animals per group. Scale bar = 100μm.  
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Acute DBZ targets the stem cell compartment 
 To investigate if stem cells were affected by short interruption of Notch 
signaling, in situ hybridization was performed for the CBCC marker Olfm4. In 
addition to marking stem cells, Olfm4 is an exquisitely sensitive intestinal Notch 
target gene19, thus changes in Olfm4 indicate that Notch has been blocked 
specifically in CBCCs. Indeed, Acute DBZ led to complete loss of Olfm4 signal as 
early as 12 hours post acute DBZ treatment (Supplementary Figure 3-3). Such 
rapid control of Olfm4 was also observed in DAPT-treated human colon cancer 
cells in vitro. In the proximal intestine Olfm4 expression approached baseline 
levels by day 3 (Figure 3-4). To determine if this effect was limited to Olfm4 
transcript changes or indicated a loss in CBCC number, acute DBZ was 
administered to Lgr5-GFP mice8 which express GFP in CBCCs. A progressive 
loss in GFP expression was observed during the period of Olfm4 decline, with 
many fewer visible GFP+ cells on Day 2 after acute DBZ (not shown).  
 
Loss of GFPHI cells are linked to increased numbers of GFPINT cells  
 To quantify the change of CBCCs, flow cytometry was used to analyze 
cells marked by varying GFP levels in single cell isolates of acute DBZ-treated 
intestine. Since GFP expression occurs in a gradient in the crypts of Lgr5-GFP 
mice, cellular identity can be implied from the level of GFP expression. For our 
study, 3 levels of GFP were assessed: GFPHI, GFPINT, and GFPLOW, where 
GFPHI are CBCCs, GFPINT represent early TA progenitors (likely T1-T2, Figure 1-
3), and GFPLOW are later divisions of TA cells. Altered levels of GFPHI and GFPINT 
were observed with DBZ treatment (Figure 3-4E). GFPHI cells were decreased to 
40% control levels on Day 2.  Interestingly, GFPHI loss was coupled with a 1.5-
fold increase in GFPINT cells at this time point. As a TA cell population, increased 
GFPINT levels are consistent with the increased crypt proliferation observed with 
acute DBZ. Although not significant, similar trend decreases in GFPHI and 
increases in GFPINT were observed on Day 1, suggesting that the population 
changes occur together and that the process leading to these changes start early 
after acute DBZ treatment.   
Figure 3-4. CBCCs are decreased with acute DBZ treatment. (A-D) In situ 
hybridization for crypt base columnar cell (CBCC) stem cell marker Olfm4 in 
vehicle- (A) or acute DBZ-treated (C-D) mice at the times indicated. Insets are 
3x original magnification. (E) Scatter plot of GFP expression by flow cytometry 
analysis of vehicle-treated cells. Plot is sequentially gated for single, live, 
CD45.2-, EpCAM+ cells. Boxes represent gates used to assess GFPHI, GFPINT, 
and GFPLOW populations. Bar graphs display GFPHI and GFPINT as percent total 
GFP+ cells on Day 1 and Day 2 after acute DBZ normalized to vehicle treated 
levels which were set to 1 (dashed lines). Comparisons were made with 
unpaired Student t tests compared to vehicle controls. N=3-4 animals/group. 
Scale bars = 100μm
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Compartmental modeling of the crypt reveals a role for Notch in regulating stem 
cell division symmetry 
 Considering GFPHI cells were decreased as GFPINT cells were increased 
with acute DBZ treatment, an appealing hypothesis was that Notch inhibition led 
to direct shunting of CBCCs into the TA progenitor cell compartment. We 
questioned whether such a mechanism could explain the different proliferation 
trends observed in acute vs. chronic Notch inhibition.  
 To test this hypothesis, we turned to in silico modeling. As described in 
greater detail in Chapter 4, a theoretical compartmental model of the crypt was 
designed and used to identify a singular mechanism that could reconcile the 
proliferation differences observed between acute and chronic DBZ. (Figure 3-
5A). Modeling generated several conclusions: first, increased TA cell proliferation 
is linked with stem cell division (see Chapter 4). That is, shunting CBCCs into the 
TA compartment via differentiation in the absence of stem cell division would 
lead to decreased CBCCs but no overall increase in proliferation. Stem cell 
division, specifically symmetric stem cell division where both daughter cells of a 
stem cell division event become TA cells, is the other mechanism that results in 
CBCC to TA shunting.  
 The compartment model was used to test if symmetric stem cell division 
during Notch inhibition would result in the stem and TA cell numbers expected 
from the in vivo acute and chronic DBZ experiments. Simulated results showed 
that Notch regulation of stem cell symmetry alone would not result in the 
increased proliferation of acute DBZ and decreased proliferation of chronic DBZ. 
Instead, only a mechanism where Notch regulates both the symmetry of stem 
cell division as well as the repopulation of the CBCC compartment from another 
source (a QSC or de-differentiating TA cell) would result in the expected 
proliferation results (Figure 3-5B).  
 With this framework in place, the model qualitatively predicted the 
behavior of both acute and chronic DBZ treatment modalities: a transient 
increase in TA cell population after acute DBZ and a severe drop in stem cell 
number and TA cell population after chronic DBZ (Figure 3-5C-D). The model  
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Figure 3-5. Modeling Notch-regulated stem cell symmetry. (A) Schematic 
diagram of the discrete compartmental model of the intestinal crypt. 
Compartments include stem (S), TA (T), and Differentiated (D) cell 
compartments. X functions to regulate stem cell symmetry. X can range from 0-2 
and determines whether stem cells divide asymmetrically producing 1 stem cell 
and 1 TA cells, or symmetrically, forming either 2 stem cells or 2 TA cells. R is a 
gain or loss parameter that allows for repopulation of the stem cell compartment. 
(B) Diagram of hypothesis that Notch regulates stem cell symmetry as well as 
stem cell replacement. When Notch signaling is OFF, CBCCs divide 
symmetrically to form 2 TA cells, resulting in lost CBCC number. Only when 
Notch is turned back on can quiescent stem cells (QSCs) repopulate the CBCC 
compartment (C) Simulated data from testing the hypothesis in (B) To model a 
shift toward symmetric division, X = 1.5 for 1 day (acute Notch inhibition) or 5 
days (chronic Notch inhibition) during the periods indicated (purple bars). X is 
returned to 1 (asymmetric division) after treatment (green bar). Notch-dependent 
stem cell replacement uses R = 2 after the DBZ treatment window until St = S0.
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made two additional important predictions: 1) increased TA cell number would 
always occur after the initiation of Notch inhibition even with additional doses of 
DBZ and 2) stem and TA cell recovery should occur post-chronic DBZ (Figure 3-
5D). 
 
Validating compartmental model predictions in vivo 
 The first prediction of the model suggests that the increased proliferation 
observed 2 days after acute DBZ is a direct result of Notch inhibition rather than 
a post-DBZ recovery effect and thus, a similar proliferative response should be 
observed even with additional doses of DBZ. To test this hypothesis, animals 
were administered 2-4 daily doses of DBZ and assessed for proliferation 24 
hours later by Ki67 immunostaining (Figure 3-6). Interestingly, increased 
abundance of Ki67+ cells were observed after 2 doses of DBZ when compared to 
vehicle, consistent with the model prediction. A progressive decline in 
proliferation, however, was observed with subsequent doses of DBZ. 
 Flow cytometry of singly isolated cells from Lgr5-GFP mice was used to 
probe stem and TA cell levels after two doses of DBZ. When compared to 
vehicle, GFPHI CBCCs were decreased 0.6-fold while GFPINT TA cells were 
increased 1.5-fold. Of note, the same magnitude of change was observed in 
these values on day 2 after acute DBZ. 
 The second model prediction suggested that recovery of both stem and 
TA cell populations should occur post-chronic DBZ treatment. Although a 
recovery in differentiated cell populations did not occur at the time of animal 
death post-chronic DBZ (Figure 3-1F), both Ki67+ proliferative cells as well as 
GFP+ CBCCs were observed at this time (Figure 3-7). Interestingly, GFP+ cells 
were found to be displaced more highly in the crypt in these tissues (Figure 3-7C, 
orange arrowheads), suggesting that the stem cell niche was altered. 
 
Role of Notch in quiescent stem cell activation 
 Having validated these two predictions, more credence was given to the 
hypothesis underlying the qualitative behavior of the model: Notch regulates both  
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Figure 3-6. 2 doses of DBZ results in a proliferative surge and altered stem 
cell dynamics. (A) Animals were administered 2-4 doses of 30μmol/kg DBZ and 
harvested 24 hours later. (B-E) Ki67 staining for proliferation in vehicle- (B) or 
DBZ-treated (C-E) mice. (F-G) Flow cytometry for GFPHI (F) and GFPINT after 2 
doses of DBZ. Data are presented as percent total GFP+ cells. Comparisons 
were made by unpaired Student t test compared to vehicle. N=4 animals/group. 
Scale bars = 100μm.
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Figure 3-7. Stem and progenitor cells recover post-chronic DBZ. (A) 
Lgr5-GFP mice were treated with chronic DBZ and harvested on day 8-9 when 
moribund. (B) Proliferating cells were visualized by Ki67 immunostaining. (C) 
CBCCs were visualized by GFP transgene expression. Orange arrows mark 
upward displaced stem cells. N=4. Scale bars = 100μm.
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stem cell symmetry as well as stem cell repopulation. Notch-regulated stem cell 
repopulation could occur via two means 1) Notch could directly regulate the 
activity of QSCs much like its regulation of CBCCs or 2) Notch could be required 
for QSCs to become CBCCs. To differentiate between these roles, an irradiation 
injury model was utilized. Irradiation has been shown to cause both CBCC  
depletion as well QSC activation, which are then primed to repopulate the voided 
CBCC compartment12, 14, 15. If Notch is indeed required for QSC activation, DBZ 
treatment in the irradiation setting should prevent the post-irradiation proliferative 
response. To test this, acute DBZ was administered post-12Gy whole body 
irradiation (Figure 3-8). Strikingly, post-irradiation DBZ treatment led to a 
dramatic loss of intestinal architecture including villus blunting, as well as 
decreased goblet cell differentiation. When assessed for proliferation via EdU 
uptake, however, abundant proliferation was observed in both vehicle and DBZ 
treated animals, suggesting that Notch is not required for the post-irradiation 
proliferative surge. 
 To further assess if active Notch is directly required in QSCs, a genetic 
mouse model was used in which Notch function was disrupted by conditional 
deletion of the Rbpj gene, the DNA binding protein essential for Notch pathway 
activation (see Figure 1-5). Rbpj-floxed mice were bred to the tamoxifen-
inducible Bmi1-CreER mouse to delete Notch signaling in the QSCs expressing 
this marker. Treatment with tamoxifen results in deletion of Rbpj in BMI+ QSCs 
(referred to as Bmi1; RbpjΔ/Δ). Littermates with deletion of a single copy of Rbpj 
were used as controls (Bmi1; RbpjΔ/+). 
 Although BMI1+ cells are not thought to contribute very much to 
homeostatic intestinal epithelial populations, some baseline lineage tracing is 
observed from cells expressing this marker10, 14, 15. To look at the effect and 
specificity of inhibiting Notch in this cell population, Bmi1; RbpjΔ/Δ intestine was 
assessed for secretory cell changes. A modest but evident increase in PAS/AB+ 
cells was observed in Bmi1; RbpjΔ/Δ compared to Bmi1; RbpjΔ/+ (Supplementary 
Figure 3-4), suggesting a small percentage of BMI+ cells contribute to the TA 
pool and loss of Notch in these cells leads to specification of secretory  
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Figure 3-8. Notch is not required for post-irradiation 
hyperproliferation. (A) Animals were exposed to 12Gy whole body 
irradiation, treated with one dose of 30 μmol/kg DBZ, and euthanized 
three days later. (B-C) PAS/AB staining for mucin-containing goblet cells 
reveals decreased goblet cells as well as altered epithelial structure in 
DBZ-treated (C) irradiated intestine. (D-E) Proliferating cells were 
visualized by EdU incorporation. (F) Quantification of EdU staining. Data 
are presented as mean epithelial EdU+ cells per crypt area in mm2. 
Groups were compared with unpaired Student t test, no significant 
change was observed between groups. N = 3 animals/group. Scale bar 
= 100μm.
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progenitors. This is in line with other studies that have described BMI1+ cell 
contribution to the TA pool14. Since Bmi1 and Lgr5 markers have been shown to 
overlap cell populations18, 40, 41 quantitative RT-PCR was used to evaluate the 
transcript levels of Bmi1 and Olfm4 in these animals to determine if Rbpj was 
deleted in CBCCs. Interestingly while Bmi1 transcript was significantly decreased 
in RbpjΔ/Δ mice, Olfm4 was not changed, suggesting that Notch signaling is not 
being inactivated in CBCCs in this model (Supplementary Figure 3-4E).  
 Bmi1; RbpjΔ/Δ mice were exposed to 12Gy irradiation to directly determine 
if Notch was required for post-irradiation activation of these cells. Similar to the 
post-irradiation DBZ experiment, no apparent change in the post-irradiation 
proliferative surge was observed in Bmi1; RbpjΔ/Δ, suggesting that Notch 
blockade in BMI1+ cells does not limit the proliferative capacity of this cell 
population.  
 
 
3.5: DISCUSSION 
In this study, we have used short-term Notch inhibition to investigate stem 
and TA cell dynamics in the intestinal epithelium. As opposed to chronic Notch 
inhibition, which results in decreased proliferation, increased secretory cells, 
stem cell loss and animal death, acute DBZ treatment leads to increased 
proliferation and increased secretory cells. Co-localization of these phenotypes 
was consistent with an overall increase in proliferative secretory progenitor cells. 
These histological findings were coupled with decreased LGR5-GFP+ CBCCs as 
well as increased GFPINT TA cells. The progressive nature of these changes 
suggested that CBCC loss is actually due to shunting CBCCs into the TA cell 
compartment, and compartmental mathematical modeling was used to test this 
hypothesis.  
A model where Notch regulates both the symmetry of stem cell division as 
well as repopulation of the CBCC compartment was consistent with the stem cell 
and proliferation findings of both acute and chronic Notch inhibition. We validated 
this model in vivo by determining that increased proliferation is observed after 
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two doses of DBZ and that stem and TA cell recovery occurs post-chronic DBZ 
treatment as predicted.  
Finally, we tested the hypothesis that Notch is required for CBCC 
repopulation by inhibiting Notch in the post-irradiation setting. In these 
experiments, QSC activation post-injury was found to be Notch-independent. 
This suggests that if Notch truly regulates CBCC repopulation, that it occurs 
during CBCC specification rather than directly regulating QSC activity. 
Thus, our model suggests that when Notch signaling is active CBCCs 
divide asymmetrically and when Notch is inhibited CBCCs divide symmetrically to 
form TA cells. Although asymmetric stem cell division is known to occur in many 
tissues42-44, several elegant studies in the intestine have suggested that this type 
of division may not actually occur31, 32. These studies suggest, rather, that CBCC 
division results in the formation of two equipotential cells that either form CBCCs 
or TA cells depending on niche availability31, 32. In this system, homeostasis is 
achieved when the average result of a stem cell division results in specification of 
1 CBCC and 1 TA cell, rather than specific stem cell division asymmetry.  
Our data are not inherently in conflict with these findings. Describing our 
system in this context, Notch inhibition would lead to disruption of the CBCC 
niche, mandating TA specification of all equipotential cells. In fact, this niche-
specific model also aligns with the apparent Notch-independent activation of 
QSCs, as limited niche availability would not prevent QSC expansion but would 
only inhibit QSC transformation into CBCCs. Together, these ideas support a 
model where active Notch signaling is required for CBCC specification during 
both homeostasis and repair (Figure 3-9). 
 As the Notch pathway requires cell-to-cell contact for signaling activation, 
the majority of the intestinal Notch regulation is expected to occur within the 
epithelium. However, Notch receptors and ligands are also expressed in the 
underlying intestinal mesenchyme45, and Notch inactivation in these cells could 
conceivably lead to secondary effects on the epithelium. To determine if the 
increased proliferation observed with acute DBZ was epithelial-specific, we 
assessed acute Notch inhibition in an in vitro intestinal enteroid system. This  
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Figure 3-9. A model for Notch regulation of the CBCC niche during 
homeostasis and injury.
Active Notch signaling
QSC
CBCC
TA
CBCC niche
unspecified equipotential cell
HOMEOSTASIS
 REPAIR
Active Notch signaling
Notch inhibition
Notch inhibition
 125 
system, adapted from the Sato method9, contains only intestinal epithelial cells 
and no mesenchymal component. Surprisingly, increased proliferation was not 
observed at any of the time points tested (Supplementary Figure 3-5). At this 
time, it is unclear if this discrepancy indicates that the proliferative surge 
observed with acute DBZ treatment is not an epithelial-specific phenomenon, or if 
the current enteroid culturing system does not faithfully represent in vivo 
conditions. More work will be needed to confirm that the Notch component of the 
ISC niche is entirely epithelial. 
Our study is the first to investigate Notch regulation of QSCs. We found 
that QSCs may not be as Notch-sensitive as CBCCs, as specific deletion of Rbpj 
in BMI1+ cells results in a mild increase in secretory cells, but no deficit in post-
irradiation activation of Rbpj-deficient BMI+ cells. Interestingly, Yan et al.15 
showed that BMI1+ and LGR5+ cells responded differently to Wnt signaling15. Our 
study suggests that these cell populations may respond differently to Notch, and 
perhaps other components of the CBCC niche. 
Although our modeling favors the concept of increased TA cell 
specification as the mechanism for the increased proliferation observed in acute 
DBZ treatment, an alternate hypothesis for this finding could be Notch over-
activation as part of a post-treatment recovery response. Notch over-activation is 
associated with increased proliferation20, 22, and as DBZ is thought to be 
metabolized within 24 hours46, this type of activity is feasible within the timeline 
investigated. Such activity has been demonstrated in T cell systems where DBZ 
treatment led to a build-up of pre-cleaved Notch receptor on cell membranes47, 48. 
In our studies, we observed no increase in Notch target gene expression during 
the proliferative surge, which would indicate that Notch signaling had not rebound 
activated. Indeed, a decrease in both Olfm4 and Hes1 expression was observed 
during this period (data not shown). Further evidence that this mechanism was 
not responsible for the proliferative surge was that similar increases in 
proliferation and altered GFPHI/GFPINT levels were observed both 1 day after 2 
doses of DBZ and 2 days after a single dose of DBZ (i.e. both groups were 
analyzed on day 3 after the initiation of DBZ treatment, but were analyzed 24 
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hours apart after termination of treatment). If the proliferative response was due 
to rebound Notch activation we would expect to see altered proliferative 
outcomes dependent on the time post-DBZ treatment. 
Finally, our results shed light on the requirement of Notch signaling for 
overall intestinal function. Although acute DBZ led to dramatic stem, progenitor, 
and differentiated cell changes, these changes were transient and animals fully 
recovered. Chronic DBZ treatment, however, led to animal death within 4 days 
after drug removal. Our mathematical modeling and in vivo findings that stem 
and TA cells recover post-chronic Notch inhibition suggest that the lethality 
associated with chronic DBZ is not due to stem cell compartment collapse. This 
lethality is more likely a failure in epithelial barrier function. A recent report 
showed that Notch inhibition by genetic deletion of Rbpj resulted in bacterial and 
FITC-dextran translocation across the epithelium49, which is highly supportive of 
this hypothesis. Barrier malfunction is also likely involved with the rapid lethality 
of Notch inhibition in the irradiation setting. Thus, preventing barrier malfunction 
or implementing prophylactic antibiotic treatment may help prevent intestinal 
toxicity in therapeutic treatment regimes that combine irradiation injury and Notch 
inhibition. 
In conclusion, we propose a revised model of Notch activity in the 
intestinal epithelium. Notch is critical for CBCC niche specification and any 
interruption of Notch signaling leads to CBCC division and TA cell production. 
This results in an increased number of TA cells, leading to a transient 
proliferative surge. Notch activity is required for repopulation of the CBCC 
compartment, thus extended Notch inhibition results in TA cell compartment 
exhaustion resulting in a progressive reduction in epithelial proliferation. These 
studies underline the importance for Notch in CBCC maintenance as well as 
shine new light on the dynamic relationship between CBCCs, TA cells, and 
QSCs. 
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Supplentary Table 3-1. 
Allele Forward primer sequence Reverse primer sequence
Villin-CreERT2 ACAGGCACTAAGGGAGCCAATG GTTCTTGCGAACCTCATCACT
Lgr5-GFP CTGCTCTCTGCTCCCAGTCT GAACTTCAGGGTCAGCTTGC
Bmi1-CreER ACCAGCAACAGCCCCAGTGC AAAGACCCCTAGGAATGCTC
Floxed-Rbpj CTTGATAATTCTGTAAAGAGA ACATTGCATTTTCACATAAAAAAGC
Genotyping primer sequences
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Supplementary Table 2-2. 
Primer sequences for genes analyzed by quantitative RT-PCR
Gene Forward primer sequence Reverse primer sequence
Bmi1 TATAACTGATGATGAGATAATAAGC CTGGAAAGTATTGGGTATGTC
Hes1 GCTCACTTCGGACTCCATGTG GCTAGGGACTTTACGGGTAGCA
Olfm4 GCCACTTTCCAATTTCAC GAGCCTCTTCTCATACAC
Supplementary Figure 3-1. Cell fate changes in acute DBZ model 
are consistent throughout the small and large intestine. PAS/AB 
staining for goblet cells shows that there are increased goblet cells in all 
parts of the intestine 3 days after acute DBZ treatment (E-H) compared 
to vehicle (A-D). N = 6 animals per group. Scale bar = 100μm
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Supplementary Figure 3-2. Secretory cells and proliferating cells occupy the 
same crypt location. Co-staining with the mucin-marker AB and the proliferation 
marker Ki67 show abundant expansion of AB+ and Ki67+ cells in acute DBZ 
treated intestine compared to vehicle. Co-localization of the markers is observed 
in the upper two thirds of the crypt (red dashed box). Although some Ki67+ cells 
are observed at the base of the crypt in vehicle treated intestine (orange 
arrowheads), the proliferative zone is shifted upward in acute DBZ treated 
animals. 
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Supplementary Figure 3-3. Olfm4 mRNA is very rapidly decreased after 
Notch inhibition. (A-B) Olfm4 in situ hybridization 12 hours after acute DBZ 
treatment shows a complete loss of Olfm4 signal in duodenal crypts. (C) 
Quantitative RT-PCR for human OLFM4 various time points after LS174T colon 
cancer cells were treated with 40μM DAPT or vehicle. DAPT results in 
decreased OLFM4 expression as early as 8 hours after treatment. comparisons 
are made with student’s t test. N = 3 per group.
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Supplementary Figure 3-4. Notch inhibition in BMI1+ cells does not prevent 
irradiation-induced proliferative surge. Bmi1; RbpjF/+ and Bmi1;RbpjF/F animals 
were treated with tamoxifen and either euthanized on day 6 (A) or exposed to 
12Gy irradiation and euthanized on day 9 after continued tamoxifen treatment 
(F). (B-C) PAS/AB staining shows increased goblet cells in RbpjΔ/Δ compared to 
RbpjΔ/+ animals suggestive of effective Notch deletion on day 6. (D-E) 
Quantitative RT-PCR for Bmi1 and Olfm4 suggest specificity of Rbpj deletion in 
BMI1+ cells and not Olfm4+ CBCCs. (G-J) Differences in goblet cells and 
proliferation via EdU staining were not observed in RbpjΔ/Δ intestine, suggesting 
that Notch deletion in these cells does not prevent post-irradiation induced 
proliferative surge. N=3-4 animals/group. Scale bar =100 μm.
Supplementary Figure 3-5. Acute Notch inhibition in enteroids does not 
lead to increased proliferation. (A) Acute DAPT treatment: enteroids were 
treated with a 24-hour pulse of 25μm DAPT or vehicle. Media was changed to 
DAPT-free media and harvested 62 hours later after 2-hour incubation with 
EdU. (B-C) Live images of enteroids immediately prior to harvest. DAPT-treated 
enteroids appeared smaller with fewer budding structures. Scale bar = 100μm. 
(D) Proliferation as measured by flow cytometry for EdU+ cells showed 
decreased proliferation in the acute DAPT treated enteroids. Comparison was 
made with Student’s t test. (E) To ensure that a time window of increased 
proliferation had not been missed, enteroids were treated with DAPT at various 
times prior to harvest as indicated. Proliferation was significantly decreased 12 
and 24 hours after DAPT treatment, but no time point showed increased EdU 
uptake compared to vehicle. Comparisons were made with One-way ANOVA 
and Dunnett’s post-test. Experiments were performed in triplicate with pooled 
quadruplicate treated wells.
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CHAPTER 4 
 
 
COMPARTMENTAL MODELING OF THE INTESTINAL CRYPT 
 
 
 
4.1: SUMMARY 
 This chapter describes mathematical modeling approaches used to tackle 
the question posed in Chapter 3: Does Notch inhibition lead to symmetric division 
of stem cells into two transit-amplifying (TA) cells? I first tested the 
compartmental model of the intestinal crypt published by Johnston et al.1, and 
determined that a differential equation system was unsuitable for replicating the 
short timing and rapidly changing dynamics of intestinal Notch inhibition. Next, a 
discrete compartmental model was built and calibrated to simply describe stem 
and TA cell dynamics. Finally, the model was implemented by testing several 
hypotheses that could explain the proliferation findings of in vivo Notch inhibition 
including: forced differentiation, symmetric stem cell division, and apoptosis. A 
model where Notch inhibition results in symmetric division followed by Notch-
dependent stem cell repopulation most closely matched our experimental 
findings. 
 
 
4.2: INTRODUCTION 
 Mathematical and computational models are powerful instruments in the 
scientific toolbox. Modeling can take what has been learned from experimental 
observations and derive new knowledge without the confines of experimental 
constraints or limited sample size. Synergistically, these insights can be taken 
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back to the bench in the form of testable hypotheses allowing more informed and 
focused investigation. In the intestine, modeling has been used for discovery-
making for decades: examining steady-state crypt proliferation2, 3, crypt cell 
migration rates4, 5, intestinal epithelial differentiation6-9, neutral drift dynamics10, 11, 
and tumorigenesis1, 12-14. Confronted with the question of how Notch regulates 
stem and progenitor cell number, modeling was a natural avenue to take. 
 In Chapter 3 I found that chronic Notch inhibition with the gamma 
secretase inhibitor Dibenzazepine (DBZ) resulted in decreased proliferation and 
decreased stem cell number15 while acute DBZ resulted in increased proliferation 
and decreased stem cells. Since these experiments produced data in the form of 
broadly categorized stem and proliferating progenitor cell counts, this intriguing 
dichotomy lent itself well to a compartmental modeling approach. As discussed in 
detail in Chapter 1, compartmental modeling is a particular type of mathematical 
model that focuses on the flux between different types of cells, grouped into 
discrete compartments. In the intestine this usually comprises stem, progenitor or 
transit-amplifying (TA), and differentiated cell compartments, although any 
number of compartments or subcompartments could be created depending on 
the question.  
 In 2007, Johnston et al.1 revised a simple compartmental model of the 
crypt that had been initiated by Tomlinson and Bodmer13 in 1995. The Johnston 
model1 utilizes an ordinary differential equation system to describe the rates of 
flows between stem, TA, and differentiated cell compartments and incorporates 
feedback into the model to make the system more stable. Their model1 was 
shown to accurately describe the crypt during both homeostasis and 
tumorigenesis, and thus was the perfect starting point for this project.  
 For this study I aimed to find a singular mechanism that would explain the 
timing-dependent proliferation outcomes post-Notch inhibition. Since we 
observed an apparent shift from GFPHI stem cells to GFPINT TA cells (Chapter 3), 
the concept of Notch regulation of stem cell division symmetry was a key 
hypothesis I wished to test in silico.  
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4.3: METHODS 
Simulations for the Johnston et al.1 model were run in XPPAUT (v.6). Discrete 
compartmental model simulations were performed in Microsoft Excel and plotted 
in Graphpad Prism. 
 
 
4.4: RESULTS AND DISCUSSION 
Johnston et al. model of the crypt does not replicate limited TA cell lifespan 
 To test the hypothesis of Notch regulation of stem cell symmetry in the 
context of the Johnston et al.1 model, I started by modulating parameters in the 
system to approximate bulk movement from the stem cell compartment to the TA 
cell compartment. As discussed in Chapter 1.3, the Johnston et al.1 model 
divides the crypt into three compartments: stem cells (N0), “semi-differentiated 
cells” (TA cells) (N1), and fully-differentiated cells (N2) (Figure 4-1). Fluxes out of 
N0 and N1 include death, differentiation, and renewal (α1, α2, α3 and β1, β2, β3 
respectively). Flux out of N2 is cell removal (sloughing off) (γ). The ordinary 
differential equation system of the saturating feedback model are reproduced 
below in Eq 1-31, where k0, k1, m0, and m1 are rate constants. 
 
 Since I was interested in using this model to look at stem cell division 
symmetry in the context of Notch inhibition, the most relevant parameters were 
α2 and α3, the rates controlling differentiation from stem cells to TA cells and  
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Figure 4-1. Compartmental model of the crypt by Johnston et al.1. Cells are 
distributed into 3 populations: stem cells (N0), semi-differentiated cells (N1), and 
fully-differentiated cells (N2). Parameters governing flows between the 
compartments include cell death (α1, β1), differentiation (α2, β2), self-renewal (α3, 
β3) and cell removal (γ).
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stem cell self-renewal, respectively. Thus to effectively model symmetric division 
from 1 stem cell to 2 TA cells, α2 would increase while α3 would decrease. I 
performed several simulations testing the bounds of α2 and α3 modulation in the 
context of acute (1 day) or chronic (5 days) Notch inhibition and found that 
alteration of these parameters led to very mild increases in the N1 population 
when changed for either acute or chronic periods, but neither change led to any 
decrease in N1 or N2 number, which would be expected after the stem cell 
compartment had been fully depleted (Figure 4-2A,B). 
 Interestingly I found that even with an initial value for N0 of 0 stem cells, 
populations remained in the N1 and N2 compartments (not shown). It became 
clear that the N1 cell compartment in this model acts independently as another 
stem cell compartment since the parameter β3 allowed for indefinite N1 cell 
renewal. This is counter to the traditional view that TA cells possess limited self-
renewal, dividing 4-6 times prior to differentiating16-18.  
 To circumvent this issue, I simulated Notch inhibition such that 
contribution of β3 was eliminated during the time of α2 elevation, preventing 
unlimited TA self-renewal. Despite the fact that increased α2 should lead to a 
bolus of extra cells in the TA cell compartment leading to a transient increase in 
N1 cell number, loss of the unlimited TA cell self-renewal prevented any increase 
in this population (Figure 4-2C,D).  
 One of the strengths of the Johnston et al. model1 is that it provides ample 
feedback to prevent small changes in compartmental populations from 
destabilizing steady state populations. While this is ideal for analysis of crypt 
homeostasis over long periods of time, it leads to inability to describe short-term 
dynamics. To adequately test our hypothesis I needed to devise a crypt model 
were the TA cell compartment was not an independent entity, but very much 
dependent on the stem cell population and the outcome of stem cell division 
symmetry. 
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Figure 4-2. Johnston et al. model1 does not replicate short-term crypt 
dynamics. (A-B) Approximating symmetric stem cell division by increasing α2 (α
2 = 5) and decreasing α3 to (α3 = 0.001) during the period of “Notch inhibition” 
(red shaded boxes). Acute Notch inhibition is estimated as parameter changes 
for 1 day prior to normalization.  Chronic Notch inhibition is parameter changes 
for 5 days prior to normalization. (C-D) Analysis of N1 self-renewal removal. The 
self-renewal parameter β3 was decreased to 0 during the period of Notch 
inhibition. Symmetric cell division was estimated by increasing α2 to 1 during 
this period.  Homeostatic parameter values are α = 0.286, α2 = 0.3, α3 = 0.586, β 
= 0.432, β2 = 0.2, β3 = 0.732, γ = 0.323, k0 = 0.1, m0 = 0.1, k1 = 0.01, and m1 = 
0.01, as described in Johnston et al.1 where α = α3 – α1 – α2 and β = β3 – β1 – β2 
except during the Notch inhibition intervals as noted above.
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Discrete compartmental model  
 Since a differential equation system did not allow the flexibility of 
observing compartmental changes due to small, transient fluctuations in cell 
numbers, I switched to a discrete (difference equation) modeling approach. Like 
the Tomlinson and Bodmer13 and Johnston et al.1 models, my model also 
contains, in essence, 3 compartments: stem (S), TA (T), and differentiated (D) 
cells, although compartment D is not directly assessed in the following analyses. 
Instead of cell division fueled by intrinsic cell cycle rates, compartment population 
numbers are determined by amplification from the previous compartment. To 
accurately amplify the TA compartment I started with a number of T 
compartments to be consistent with the idea of 4-6 rounds of TA cell division 
(Figure 4-3). I thus crafted the following set of difference equations Eq 4-8. 
 
where S(t) is the population of stem cells at time t. X is the parameter that 
governs stem cell division. Thus if X = 1 an equal amount of stem cell and TA 
cells are produced from each stem cell division event, the definition of 
asymmetric stem cell division. When X = 0, stem cell division is symmetric but 
produces only stem-like daughter cells, and when X = 2, stem cell division 
produces only 2 TA cells (Figure 4-3B). R is a net gain or loss parameter. Tn(t) is 
the population in any one of several TA cell compartments at time t for n>1. 
146
Figure 4-3. Discrete compartmental model of the intestinal crypt. (A) 
Schematic diagram of compartmental model. Compartments include stem (S), 
TA (T), and Differentiated (D) cell compartments. Multiple TA cell divisions are 
listed in subcompartments where n = 4-6 divisions. (B) X functions to regulate 
stem cell division symmetry. X can be 0, 1, or 2 and determines whether stem 
cells divide asymmetrically producing 1 stem cell and 1 TA cells, or 
symmetrically, forming either 2 stem cells or 2 TA cells.
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T compartment population is calculated by simply doubling the population of the 
previous compartment and n is the total number TA divisions. Finally, D(t) is the 
population in the differentiated cell compartment at time t and G is the number of 
cells removed from D due to sloughing off at any time. 
 
Calibration of cell division timing  
 First, I addressed the dissimilarity in cell cycle times intrinsic to various cell 
populations. Stem cells are thought to divide on average once per day10, 19, while 
TA cells divide approximately every 12 hours16, 17. Johnston et al.1 determined 
that age-matching cells was not necessary and that continuously averaging the 
population was sufficient for compartment analysis. It was unclear, however, how 
important the scale of time step t was for system dynamics in an iterative model 
of the crypt.  
 To assess this, I first set t = 12 hours to be on scale with TA cell divisions, 
but only allowed stem cell division every other time step. Not surprisingly, this 
resulted in periodic gaps in TA cell compartments leading to oscillation in total T 
population (Figure 4-4A). I then compared this outcome with t = 1 day, with both 
stem and TA cell divisions occurring every time step (Figure 4-4B). Notably, 
summation over a 24-hour period in the 12-hour time step model gave the same 
outcome for total T population as the 1 day time step. These simulations were 
performed in the setting of asymmetric stem cell division (X = 1) but identical 
conclusions were made with other values of X (not shown). 
 The oscillations in the 12-hour time step model are an artifact caused by 
the inherent assumption that cell division is synchronized. In an actual crypt, cell 
division is asynchronous and thus no gap in S to T transition would ever truly 
occur. Because the overall T population numbers were identical between the two 
timescales when summed over a 24-hour period, and as the comparable 
experimental data was collected on a daily basis, the model was scaled to a 1 
day time step.  
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C
Figure 4-4.  Compartmental model calibrations. (A,B) Simulated data for the 
discrete compartmental model with iterations run every 12 hours with stem cell 
division occurring every other iteration (A) or iterations run every 24 hours with 
stem cell division occur every iteration (B). (C) Comparison of total TA cell 
counts derived when various combinations of TA compartment number and 
rounds of division are used. Only combinations with # of divisions that were 
divisible by compartment number were used. Identical population values are 
shaded with the same color. Initial values for all calculations were S = 4, T1 = 4, 
X = 1, R = 0. 
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TA cell compartments can be lumped 
 Next, I aimed to determine if multiple TA cell compartments were 
necessary to accurately describe an amplifying system. To test this I condensed 
multiple TA compartments into larger compartments and calculated whether the 
resulting total TA population differed than if the amplifications had occurred in 
individual compartments. The results are plotted in Figure 4-4C. In summary, it 
does not matter computationally how many compartments the TA cells are 
spread between, only the number of divisions affect overall TA cell population. 
Thus, the Eq 5-7 can be simplified as Eq 9: 
 
where ω is an amplification constant dependent on the number of TA divisions. 
(For example, when n = 4, ω = 15 and when n = 6, ω = 63). 
 
Forced differentiation versus symmetric stem cell division 
 I favored a hypothesis that symmetric stem cell division could explain the 
increased proliferation and decreased stem cells observed with acute DBZ 
treatment, because such a division event would inherently decrease the number 
of stem cells and would increase the amount of TA cells primed for amplification.  
I questioned, however, if stem cell division was even necessary to lead to this 
outcome. In our experimental system this would indicate that Notch inhibition led 
to the differentiation of stem cells into TA cells rather than division of stem cells 
into TA cells. To test this, I compared whether simply moving the entire S 
compartment into T1 would result in increased TA cell number (Figure 4-5A). 
Strikingly, without stem cell division, no amplification above initial T population is 
observed. As expected, with loss of the stem cells, TA cells become depleted 
over time. When symmetric stem cell division is implemented however (X = 2), a 
robust doubling in population is observed over initial TA levels (Figure 4-5B). 
Without stem cells, this too is depleted over time, but the increased population is 
observed for several days prior to crypt collapse. Through this comparison,  
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Figure 4-5. Stem cell differentiation versus symmetric division. (A) Stem 
and TA cell populations resulting from S compartment shift to T1 compartment in 
the absence of stem cell division. Initial values: S = 4, T1 = 4, R = 0, X = 1, ω=15 
(B) Simulation of discrete compartmental model with symmetric stem cell 
division. Initial values: S = 4, T1 = 4, R = 0, X = 2, ω=15.
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I concluded that although differentiation of stem cells into TA cells moves cells 
into the proper compartment, without stem cell division no amplification is 
observed. 
 
Utilizing non-integer values of X   
 Having determined that symmetric stem cell division (X = 2) can lead to 
decreased stem cells and a transient increase in TA cells (Figure 4-5B), I was 
encouraged that this was a viable mechanism to test in our Notch inhibition 
model. I noted, however, that the stem cell population number was completely 
depleted after a single round of division when X=2. Since our experimental 
findings did not suggest that the entire stem cell compartment is lost after DBZ 
treatment, I considered relaxing the stringency of stem cell symmetry in our 
model, allowing non-integer values of X. This removes the strict definition of 
asymmetric versus symmetric symmetry from the model, but allows description of 
stem cell progeny on a population level. Any value of X between 1 and 2 (I used 
X = 1.5) would indicate a greater likelihood of TA cell specification. Thus Notch 
inhibition could lead to more, but not all, stem cell progeny becoming TA cells.  
 
Hypothesis-testing: Stem cell symmetry in acute and chronic Notch inhibition 
 The first hypothesis I wanted to test was if change in stem cell symmetry 
alone could account for the differing proliferation outcomes observed in acute 
and chronic Notch inhibition. To test this, we started our simulations with 
“homeostasis” such that X = 1, R = 0. During the period of Notch inhibition X was 
set at 1.5 to simulate preference for TA cell production over stem cell production. 
X was increased for 1 day (acute Notch inhibition) or 5 days (chronic Notch 
inhibition). The results of this simulation are shown in Figure 4-6A. As observed 
in our experimental data obtained after acute Notch inhibition with DBZ, the 
simulation showed a transient increase in TA cell population while stem cells 
were decreased. Both populations return to homeostasis after treatment, but, 
notably, at lower than initial value levels. Chronic Notch inhibition shows the 
same trends, although the stem cell compartment is completely depleted and TA  
152
Figure 4-6. Hypothesis testing with the discrete compartmental model. The 
effect of Notch-regulated stem cell symmetry in the context of acute and chronic 
Notch inhibition is evaluated in three scenarios. To model a shift toward 
symmetric division X = 1.5 for 1 day (acute) or 5 days (chronic) during the 
periods indicated (purple bars). X is returned to 1 after treatment (green bar). 
Symmetry is tested alone (A), with Notch-independent stem cell replacement 
(B), and with Notch-dependent stem cell replacement (C). Notch independent 
stem cell replacement is accomplished by R = S0 – St during Notch inhibition 
window. Notch-dependent stem cell replacement uses R = 2 after the Notch 
inhibition window until St = S0.  Initial values: S = 4, T = 60, R = 0, X = 1, ω=15.
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cell populations progressively decline before reaching much lower resting levels. 
While the chronic Notch inhibition outcomes resemble the decreased stem and 
proliferating cell findings we observed experimentally, the acute Notch inhibition 
simulation did not mirror our results since experimental proliferation returned to 
baseline by 7 days, rather than remaining lowered post-treatment. 
 
Hypothesis-testing: Stem cell symmetry with Notch-independent stem cell 
replacement 
 Since the decreased homeostatic resting levels observed above were 
fueled from a persistent loss in stem cell number, I probed the idea of stem cell 
replacement in conjunction with altered stem cell symmetry. Numerous studies 
have shown that lost or damaged crypt base columnar stem cells can be 
replaced by quiescent or facultative stem cell populations20-23. Thus repopulation 
of the S compartment is possible independent from stem cell symmetry and self-
renewal. The model takes this into account with the net gain or loss parameter, 
R. Positive R values function to allow repopulation of S, presumably by a 
quiescent stem cell. 
 In Figure 4-6B, I simulated Notch-regulated stem cell symmetry as above, 
but allowed for replacement of lost stem cells throughout the Notch inhibition 
window. Constant stem cell replacement was determined by Eq. 10: 
 
where S0 is the initial stem cell population and St is the decreased stem cell 
population at time t. With these parameters, stem cell populations remained 
unchanged throughout the entire test window in both acute and chronic Notch 
inhibition conditions. TA populations increased during the period of treatment and 
normalized after restoration of Notch signaling. Neither of these scenarios 
reflected the stem cell trends observed in our experimental system. Notch-
independent stem cell replacement showed no loss in TA cell number in the 
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chronic Notch inhibition model, which did not at all reflect the significant loss in 
proliferating TA cells observed with chronic DBZ treatment experimentally.  
 
Hypothesis-testing: Stem cell symmetry with Notch-dependent stem cell 
replacement 
 Finally, I tested Notch-regulated stem cell symmetry with Notch-regulated 
stem cell replacement (Figure 4-6C). In this simulation, R was altered only after 
Notch restoration. In the post-Notch inhibition window R was arbitrarily set at 2 
until St returned to S0 levels. In acute Notch inhibition this resulted in transiently 
decreased stem cells and transiently increased TA cell population, both of which 
returned to baseline homeostatic levels, although a transient decrease in TA cell 
number was observed prior to normalization. With chronic Notch inhibition, this 
resulted in a complete loss of stem cells and a marked reduction in TA cell 
number. After Notch restoration, a slow but complete recovery of both 
populations is observed.  
 In comparing these simulations with our experimental findings, the stem 
cell symmetry with Notch-dependent stem cell replacement is the best 
approximation thus far reconciling both acute and chronic DBZ results. Although I 
did not directly observe a dip in TA cell number prior to restoration with 
experimental acute DBZ, all other aspects of this simulation closely resembled 
the stem and proliferating cell profiles obtained in those experiments. The lack of 
this TA cell dip could be because I did not directly measure TA cell number, or it 
could have occurred transiently at a time point I did not analyze.  
 If this system is a rough approximation of what actually occurs with crypt 
dynamics in the setting of Notch inhibition, then the chronic Notch inhibition 
simulation provides several interesting testable outcomes. First, increased TA 
cells are observed prior to decreased TA cells. Second, stem and TA cells 
eventually recover post-Notch inhibition. As discussed in Chapter 3, both of these 
outcomes were tested in our in vivo system and were found to closely resemble 
these predictions, an encouraging validation of the model.  
 
 155 
Apoptosis: an alternate hypothesis 
 To avoid being short-sighted in my consideration of possible mechanisms, 
I used the model to test an obvious alternate mechanism of stem cell loss, 
apoptosis.  In our in vivo system, I did not find a significant increase in cleaved 
caspase+ cells in the crypts after acute DBZ. I questioned, however, whether I 
had simply missed a narrow window of apoptosis as other stem cell damage 
models have shown a wave of apoptosis ending within 6 hours post-injury24. 
Since decreased stem cell number was observed with both acute and chronic 
DBZ, apoptosis can be modeled with a negative R value in both scenarios. 
Apoptosis alone results in total crypt collapse (not shown), so replication of the 
proliferative cell expansion observed in acute DBZ would require either 
independent increased TA cell replication or a rebound increase in stem cell 
number. I modeled the latter hypothesis in Figure 4-7. Although the general 
trends are similar to our experimental data there are several key differences. 
First, increased TA cell proliferation is greatly delayed from the time of Notch 
inhibition and only appears after a transient decrease in TA cell number. Neither 
of these findings were observed in our experimental setting. Second, the chronic 
Notch inhibition simulation showed no transient increase in TA cell number, 
which we have now established occurs prior to decreased proliferation. These 
discrepancies in addition to the absence of in vivo evidence of increased 
apoptosis make this an unlikely mechanism regulating Notch-dependent 
proliferation changes. 
 
4.5: CONCLUSIONS AND FUTURE DIRECTIONS 
 I devised and implemented a simple compartmental model of the intestinal 
crypt to test the hypothesis that Notch inhibition results in symmetric division of 
intestinal stem cells. I found that Notch-regulated stem cell symmetry did 
approximate our in vivo findings of stem and TA cell number with acute and 
chronic Notch DBZ treatment, but only in the context of Notch-regulated stem cell 
replacement. These findings provided important predictions such as increased 
TA cell number after multiple doses of DBZ and recovery of both the stem and  
Figure 4-7. Testing apoptosis and Notch-dependent stem cell recovery as a 
mechanism of differential proliferation outcomes. Apoptosis is modeled by R 
= -2 during the Notch inhibition window (purple bar) and R = 4 immediately after 
Notch restoration (green bar). Initial values: S = 4, T = 60, R = 0, X = 1, ω=15.
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TA cell compartments post-chronic DBZ that I was able to take back to the bench 
to test directly for model validation. 
 This discrete compartmental model is composed of a very simple 
framework, which makes it approachable for non-experts of mathematical and 
computational biology, and thus ideal for interfacing with experimental efforts. 
The limited parameters and assumption of synchronized cell division inherent in 
the model, however, also limits its predictive power, allowing only general 
qualitative behavior to be assessed. To garner more quantitative simulated data, 
I would need to generate a model with more precise parameters such as cell 
cycle times and rates of flow between compartments. An ordinary differential 
equation system could be employed to model average rates, but this system 
would need to ensure that the TA cell compartment remained dependent on stem 
cell number. Alternatively, a probabilistic agent-based model could be employed 
to individually track cells moving through crypt compartments. 
 Future revisions to the model could include a more explicit investigation of 
stem cell replacement. In the simulations above, R was a bulk gain or loss 
parameter. I arbitrarily chose a value for stem cell replacement (R = 2) in my 
Notch-dependent stem cell replacement model, which assumes that only two 
new stem cells can be added to the compartment each day either by quiescent 
stem cell division or de-differentiation. More precise testing of timing and 
amplitude of R modulation could determine if the dip in TA cells observed in that 
simulation is a necessity of the system or an artifact of timing. Furthermore, some 
studies suggest that TA cells can de-differentiate to repopulate the stem cell 
pool23, 25. Addition of a term that would allow movement from the TA 
compartment back into the stem cell compartment would allow investigation of 
this process in the context of Notch inhibition. 
 In conclusion, mathematical models do not need to be particularly 
complex to be extremely useful in in silico hypothesis testing and hypothesis 
generation. The data that we generated in these simulations proved to be very 
helpful for directing the next phases of our experimental work. These types of 
models can be tailored to address many aspects of ISC biology. 
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CHAPTER 5 
 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
The research undertaken for this thesis has advanced the field of intestinal 
stem cell (ISC) biology by furthering our understanding of how the Notch 
signaling pathway regulates ISC dynamics. I have tackled this question with two 
broad approaches: (1) determining the specificity for Notch receptors in 
regulating intestinal epithelial homeostasis, and (2) probing the relationships 
between stem and progenitor compartments in the context of Notch inhibition.  
 In this chapter, I will put my research in the context of the field and discuss 
some questions that my work raises. I present some preliminary data and 
discuss experimentation that can be undertaken to address these questions 
regarding intestinal Notch signaling and ISC regulation. 
 
Notch1 is the primary receptor regulating intestinal epithelial differentiation  
 In Chapter 2, I discovered a specific role for the Notch1 (N1) receptor in 
controlling differentiation in the intestinal epithelium, as deletion of N1 alone 
results in a dramatic secretory cell hyperplasia. The role of N1 in regulating 
intestinal epithelial differentiation has been contested in the literature. Previous 
work using specific Notch inhibitory antibodies showed a mild secretory cell 
defect with α-N1 antibody treatment1 as did chimeric deletion of N12. In contrast, 
Riccio et al.3 used the Villin-CreERT2 Cre driver to conditionally delete N1 and N2 
in the intestinal epithelium. This study3 found that neither single deletion had any 
phenotype, and only double deletion of N1 and N2 resulted in secretory cell 
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hyperplasia. The conclusion that N1 and N2 are functionally redundant in the gut 
has since propagated throughout the literature.  
My work also took advantage of the Villin-CreERT2 mouse model to 
conditionally delete N1 and N2 specifically in the intestinal epithelium. While it is 
unclear why the Riccio et aI.3 study did not uncover the N1Δ/Δ secretory cell 
phenotype, my study provides definitive evidence that N1 is indeed required for 
proper intestinal epithelial cell fate decisions. 
 
N1 is the primary receptor for stem cell maintenance 
Our lab discovered that pan-Notch inhibition with the gamma-secretase 
inhibitor Dibenzazepine (DBZ) resulted in a loss of crypt base columnar stem cell 
(CBCC) number and function, suggesting a role for Notch in CBCC survival4. 
Additional work from the Radtke lab5 demonstrated that dual deletion of the 
Notch ligands Dll1 and Dll4 also leads to stem cell loss, bolstering our finding that 
Notch is required for CBCC maintenance.  
In Chapter 2, I utilize the Lgr5-GFP mouse model, which marks CBCCs 
with GFP, in conjunction with Villin-CreERT2-mediated N1 deletion. In this 
system, I showed that deletion of N1 is sufficient to reduce GFPHI CBCC levels to 
below 50% of baseline levels. Only one other report2 previously assessed a 
specific role for N1 in stem cell maintenance. Vooijs et al.2 used a chimeric 
mouse model where N1-deficient cells were marked by expression of LacZ. 
Although N1 had been missing from these cells since development, some LacZ+ 
crypt/villus units were observed in adult animals2. These LacZ+ cells also 
contained an increased proportion of secretory cells compared to normal, 
suggesting that a N1-deficient ISC was capable of survival and production of 
progeny2. 
Together, these data suggest that N1 deletion results in an initial loss of 
some (~50%) of CBCCs, but not all. This raises the question of why some stem 
cells would be susceptible to N1 deletion but others are not. One explanation is 
that not all stem cells, even CBCCs, are created equal and thus might have 
different requirements for Notch receptor activation. A recent study utilizing 
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intravital imaging of stem cell division has separated the LGR5+ CBCC 
compartment into two functional groups “central cells” which occupied the lower 
positions in the crypt and “border cells” which occupied positions 3-4, adjacent to 
TA cells6. As an aside, the presence of two functional CBCC groups might 
explain why the Winton group recently found that the number of functionally 
active stem cells was likely to be 6 per crypt7, despite LGR5-GFP counts showing 
14-16 cells per crypt8, 9. Although both central and border cells can function as 
stem cells, central cells were shown to have a “survival advantage,” which might 
be linked to niche exposure10. Since Notch is a critical component of the niche, 
cells that require more niche signals might be at a selective disadvantage with 
N1 is deleted.  
Our finding that the secretory cell hyperplasia in N1Δ/Δ intestine almost 
completely disappears by 2 months is consistent with N1-deficient stem cells 
having a selective disadvantage. These cells could be slowly replaced by normal, 
unrecombined stem cells over time. The Vooijs et al. study2 discussed above did 
not disclose the age of animals at the time of analysis, but based on my results I 
would expect that the number of LacZ+ crypts would reduce as the mice aged. 
 
LGR5+ stem cells are intolerant of Notch modulation 
The observation of decreased CBCCs with N1 deletion is consistent with a 
number of findings that stem cells are exquisitely sensitive to loss of Notch. In 
data that I did not present in this thesis, I used the LGR5-GFP-CreERT2 mouse 
model to investigate deletion or activation of Notch signaling components 
specifically in CBCCs. In these experiments, I expected to see secretory cell 
hyperplasia as evidence of Notch inhibitory phenotype in a patchy nature due to 
the mosaic nature of the Cre driver. Instead I observed no visible phenotype 
when Lgr5-GFP-CreERT2 was crossed to RbpjF/F, DNMAMLF/F, or combined 
N1F/F;N2F/F.  
Interestingly, a similar finding was observed even with Notch activation. In 
Chapter 2, I used a Notch activation model to understand how constitutive Notch 
signaling affects the intestinal epithelial proliferation and differentiation profiles. 
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To assess this I utilized the Villin-CreERT2 ; Rosa26-LSL-NICD-nGFP model, 
which leads to expression of activated NICD in the intestinal epithelium. In this 
system I found that proliferation is increased, and that all types of differentiated 
cells are decreased. This is important since earlier works suggested that Notch 
activation results in an increase in the absorptive lineage at the expense of 
secretory cells11, 12.  
Since Notch activation resulted in an undifferentiated phenotype and 
Notch is activated in a number of cancers, we were interested in determining if 
Notch activation specifically in CBCCs could induce intestinal adenoma 
formation. To study this we utilized the Lgr5-GFP-CreERT2 mouse crossed to 
Rosa26-LSL-NICD-nGFP. Interestingly, while NICD activation in LGR5+ cells in 
the stomach led to formation of antral polyps (Figure 5-1, Demitrack et al., 
unpublished), no polyps were observed in the intestine.  
Our hypothesis is that modulation of Notch signaling, either activation or 
inhibition, in CBCCs is deleterious such that these cells are at a competitive 
disadvantage compared to normal neighbors. This may explain why Notch 
signaling is not thought to be an inducing force for intestinal and colonic 
neoplasias. The fact that this phenomenon does not appear to occur in the same 
manner in the stomach introduces important questions of how LGR5+ cells may 
be differentially regulated by Notch in the stomach and intestine. 
  
Compensation versus loss of N1 deletion 
While selective disadvantage would be consistent with the above findings 
and would result in the secretory cell hyperplasia disappearance observed in the 
intestinal epithelium of N1Δ/Δ animals, an obvious alternate hypothesis is that 
compensation by another Notch component or alternate pathway occurs leading 
to restoration of the tissue. We have utilized both in situ hybridization as well as 
quantitative RT-PCR for N1 transcript to try to determine if N1 deletion rates 
change throughout our timecourse. At this point, both arms of the study are 
inconclusive, although it appears that at least a partial restoration of N1 occurs.  
Figure 5-1. NICD activation in LGR5+ cells results in polyp formation in the 
stomach but not intestine.  (A-B) Gross histology of Lgr5 and Lgr5; NICD 
stomachs 6 months after tamoxifen activation. Large antral polyps are visible in 
NICD stomachs (arrows) (C-D) H+E staining shows epithelial hypertrophy and 
glandular dysplasia in NICD polyps. (E-F) No abnormalities were observed 
along the entire length of the small and large intestine. Scale bars, 100 μm. 
(Stomach data aquired by Elise Demitrack, unpublished)
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Future optimization of N1-antibody staining would help these efforts in 
pinpointing the extent of N1 recovery. 
In terms of compensation, while we did observe increased expression of 
Dll1 and Dll4, these genes returned to baseline over time and are thus not likely 
for the long-term normalization of N1Δ/Δ. N2 is the most likely candidate for long-
term compensation of N1, although we did not observe an increase in N2 
expression transcriptionally. Since much of Notch receptor activity occurs post-
translationally, however, a more informative approach would be to look at 
changes in N2 surface expression in N1Δ/Δ animals. Preliminary flow cytometry 
data staining for N2 suggests that this is a feasible approach to take in the future 
(Figure 5-2). 
 
A specific role for N2? 
In Chapter 2, deletion of N2 appeared to have no secretory cell 
phenotype, consistent with previously published results1, 3. By combining different 
combinations of N1 and N2 deletion I show that N1 and N2 are synergistic for 
epithelial differentiation and redundant for proliferation. 
Previous in situ hybridization studies reported a range of N2 expression in 
the crypt, from a few cells13 to the entire crypt14, and a transgenic mouse model 
which expresses Cre in cells expressing N2 showed rare lineage tracing14. The 
reason for the rarity of the tracing is unknown, and could be due to mosaic 
expression of the transgene, or that N2 is functionally active on TA cells, and that 
lineage-traced crypts had TA cells that sporadically de-differentiated into the 
stem cell compartment. 
My preliminary flow cytometry data discussed above (Figure 5-2) suggest 
that N2 is membrane-associated for all GFP+ cells in the crypt which would 
include stem and TA cells. Future work requires better-controlled trials to be 
confident that this staining is legitimate. In any case, moving in the direction of 
assessing membrane protein expression is the right path to obtaining a better 
understanding of Notch signaling in the intestine.  
 
Figure 5-2. Preliminary N2 staining of intestinal epithelial cells. Singly 
isolated cells from Lgr5-GFP jejunum were stained with anti-N2 antibody or 
isotype control. Cells were sequentially gated for size, singlets, DAPI-, CD45.2-, 
EpCAM+, and GFP+. Low background staining is observed in isotype-stained 
control, but N2 staining is observed in GFPHI, GFPINT, and GFPLOW populations 
suggesting that N2 has surface expression on a subset of all stem and TA cells. 
This is a promising technique to investigate compensation of N2 in N1-deleted 
intestine.
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Acute Notch inhibition leads to increased proliferation and shifted stem cells 
In Chapter 3, I turn back to a pharmacologic inhibition model with DBZ to 
understand what happens to a stem cell once Notch signaling is turned off. Since 
chronic Notch inhibition is typically associated with decreased proliferation and 
increased secretory cells, I was surprised to find that a single (acute) dose of 
DBZ led to both increased proliferation and increased secretory cell production. 
 Exploiting the gradient GFP expression in the crypts of the Lgr5-GFP-
CreERT2 mouse model, I used flow cytometry to analyze GFPHI and GFPINT cells 
which are expected to be CBCCs and first level TA progenitors, respectively. 
With this technique I found that acute DBZ treatment led to a decrease in GFPHI 
cells that was always associated with an increase in GFPINT cells, consistent with 
a bulk shift from the stem to progenitor cell compartments.  
I used mathematical modeling (discussed below) to test the hypothesis 
that the increased proliferation of acute DBZ is caused by symmetric stem cell 
division and determined that Notch was also involved in CBCC replacement, 
presumably by a QSC population. 
 
Notch regulation of CBCC replacement 
To test the role of Notch in CBCC repopulation, I performed acute DBZ in 
the post-irradiation setting. Since irradiation leads to CBCC death15-17 this model 
aimed to block Notch signaling in the remaining QSCs. Increased QSC 
abundance is observed after irradiation15, 18, 19, and indeed increased overall 
epithelial proliferation was observed in our post-irradiation DBZ animals, despite 
intestinal architecture collapse. This suggests that Notch is not required for QSC 
activation. Additional experiments using the Bmi1-CreER; RbpjF/F model in the 
irradiation setting resulted in similar results, as proliferative cell expansion was 
observed despite inactivation of Notch signaling.  
These experiments are admittedly difficult to interpret. Timing of DBZ 
treatment and tamoxifen induction with the timing of irradiation injury could have 
major effects on the outcome. For instance, we administered DBZ 24 hours after 
12Gy irradiation. Studies have shown that BMI1+ cells are more proliferative by 2 
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days after 12 Gy15. It is possible, however, that this process starts within 24 
hours after irradiation exposure and that the DBZ was administered too late to 
effectively block activation. Additionally, acute DBZ itself led to increased 
proliferation. Since division of CBCCs into TA cells is thought to be the source of 
the increased proliferation in acute DBZ, and CBCCs are killed by irradiation, it is 
likely that the proliferative cells are QSC-derived rather than CBCC-derived. 
Including a lineage trace reporter gene or utilizing the Bmi1-GFP transgenic 
mouse20 would help to differentiate between these possibilities. The fact that the 
post-irradiation DBZ led to rapid lethality and total epithelial collapse despite a 
proliferative surge is another interesting avenue that needs to be followed up. 
  
Notch is required for post-irradiation recovery 
I have shown that various means of Notch inhibition render the intestine 
incapable of irradiation recovery: N1-deletion (Chapter 2), α-N1 inhibitory 
antibody treatment21, and DBZ treatment in the post-irradiation setting (Chapter 3 
and Tran et al.21). While the cause of death is not clear in these animals, it is 
clear that combination of irradiation and Notch inhibition is deleterious. This is 
one of the most striking and important findings in my thesis, as it implies that 
potential Notch-inhibiting cancer drugs should not be used in combination 
regimes with therapeutic or palliative radiation treatment.  Interestingly, Notch 
inhibition in the post-irradiation setting (post-irradiation DBZ or inhibitory 
antibodies) appears to lead to decreased secretory cell determination, the exact 
opposite of Notch inhibition on its own. Additionally, in Chapter 2, I found that the 
Notch target gene Olfm4 is markedly reduced immediately after irradiation 
treatment. This gene is expected to decline since it is a CBCC marker, and 
CBCCs are killed by irradiation, but its loss of expression precedes the loss of 
Lgr5, suggesting that Notch may be directly inhibited by irradiation damage. If 
this is the case, it will be important to determine if intestinal epithelial Notch is 
required for recovery from other injury modalities or if this extreme sensitivity is 
specific to irradiation treatment.  
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Compartmental mathematical modeling of the intestinal crypt 
Part of my thesis work has been devoted to understanding the state-of-
the-art in terms of compartmental mathematical modeling of the intestinal crypt. I 
published a review22 in a journal geared to integrate biological and computational 
themes to educate both sides of the community about models that have 
successfully described intestinal homeostasis and tumorigenesis, post-irradiation 
recovery, and crypt development. I have outlined methods that could be 
undertaken to use compartmental modeling in conjunction with experimentation 
to answer several of the lingering questions that remain in the ISC field such as: 
How is stem cell number regulated? Are ISCs completely defined by the niche? 
Is there a dedicated QSC population? What is the nature of the TA 
compartment?  
In Chapter 4, I directly take advantage of compartmental mathematical 
modeling to test my hypothesis: Does Notch regulate the symmetry of stem cell 
division? In this chapter, I first exploit one of the most valuable aspects of in silico 
work; the ability to use previously published models to test new hypotheses. I 
used the ordinary differential equation model of crypt homeostasis and 
tumorigenesis by Johnston et al.23 to test my Notch regulation of stem cell 
symmetry hypothesis. I found that while this model is suitable for evaluating 
stem, TA, and differentiated cell populations averaged over long periods of time, 
it was not appropriate to look at short-term changes like those expected during 
Notch inhibition.  
I then designed my own discrete compartmental mathematical model of 
the crypt to test my hypothesis. With this model I was able to obtain qualitative 
predictions of stem and TA cell numbers where inhibition of Notch results in 
symmetric stem cell division resulting in formation of 2 TA progenitors. I found 
that alteration of symmetry alone did not replicate the restoration of homeostasis 
observed in acute Notch inhibition. Rather, I found that my experimental findings 
of increased TA cells/decreased stem cells with acute DBZ and decreased TA 
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cells/decreased stem cells with chronic DBZ were replicated by a mechanism 
where Notch regulates symmetry as well as CBCC replacement. 
This approach allowed me to test some of my modeling predictions in vivo, 
but future revisions of the model integrating robust cell counting data as well as 
accurate cell division rates would allow for more quantitative predictions. 
Importantly, my work demonstrates a simple scaffold that can be adapted to test 
many other signaling pathways that may be involved in regulating stem cells. 
 
Asymmetric stem cell division in the ISC 
Although the concept of stem cell division asymmetry is commonplace for 
other tissue stem cells24-27, the idea is controversial in ISCs. This is due to neutral 
drift dynamics studies that determined that ISCs divide symmetrically to form 
equipotential cells, which are equally capable of becoming stem cells or TA cells 
depending on niche availability9, 28. A revision of this model now suggests that 
stem cells can either become a central CBCC, a border CBCC, or a TA cell, and 
that there is priority in central CBCCs staying in the stem cell compartment10. 
These authors10 still contend that these decisions are based off of niche 
availability rather than any intrinsic asymmetry of division. 
  Interestingly, asymmetric stem cell division was directly observed during 
crypt development29. Either ISCs lose the ability to divide asymmetrically with 
maturity or these studies are incapable of adequately visualizing asymmetric 
stem cell division. A study in adult drosophila ISCs showed localization of Par 
complex and integrins on the spindle to position NUMB for successful 
asymmetric stem cell division30. Many drosophila ISC findings have been 
replicated in mammals, so it is disconcerting that such a stark difference exists in 
the method of stem cell division. A better evaluation of NUMB and other proteins 
associated with asymmetric stem cell division is required before eliminating this 
as a possibility for adult mammalian ISCs. Whether ISCs truly divide 
asymmetrically or not, my data suggests that Notch plays an important role in 
eventual population asymmetry of crypt.  
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In conclusion, the Notch signaling pathway is important for many aspects 
of intestinal epithelial homeostasis. My thesis work has illustrated an important 
role for the N1 receptor in regulating epithelial cell fate and stem cell 
maintenance, especially in the post-irradiation setting. Additionally, I have shown 
that loss of Notch signaling leads to CBCC removal from the stem cell 
compartment by division into the TA cell compartment. Prolonged Notch 
inhibition results in TA cell collapse since CBCC replacement can only occur with 
active Notch signaling providing a CBCC niche. 
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